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A b s t r a c t
The paradoxical nature of M. furfur colonisation versus infection in dermatological disease 
is subject to much research. The aim of this experimental work was to measure the innate 
immune response of the skin to M. jurfur, via the use of skin models. Living skin 
equivalents (LSE), excised breast reduction tissue (BRT) and keratinocyte (KC) 
monolayers were all utilised in an attempt to elucidate the possible immune evasive and 
stimulatory capabilities of M. furfur.
The constitutive production of human p defensin 2 (HBD-2), an inducible antimicrobial 
peptide, was measured KC monolayers, LSEs and BRT. In addition the skin model’s 
response to fungal challenge was elucidated. Wide variation in the basal expression of 
HBD-2 was detected in all skin model donors. M. furfur cell wall and killed whole M. 
Jurfur initiated a slight depression in HBD-2 expression by KC monolayers, however these 
results were not statistically significant in all donors and merely indicated a trend. Likewise 
KC monolayers, BRT and LSEs reacted to viable M. furfur with slight inhibition of HBD-2 
production at 24hr with subsequent stimulation of expression. However donor variation in 
this pattern was detected and these results were not continuously significant. Due to the 
non-continuous nature of these measurements these results were inconclusive
As M. furfur infection of the skin is associated with alteration of the normal pigmentation 
in patients, melanin synthesis by B16 mouse melanoma cells and BRT was assessed in 
response to M. furfur. Viable M. furfur and C. albicans stimulated an increase in melanin 
synthesis in B16 mouse melanoma cells. The ability of viable M. furfur cells to stimulate 
melanin synthesis appeared to be localised within the cytoplasm of the organism. However, 
this ‘viable cell stimulation’ did not appear to be restricted to M. furfur, as C. albicans also 
stimulated melanin synthesis. On BRT there was little difference in the melanin and 
tyrosinase production of BRT in réponse to M. furfur and C. albicans growth. The capacity 
of M. furfur and C. albicans cell wall to alter the cytokine profile of KCs was also 
measured and KC monolayers exhibited a time-dependent increase in IL -la , IL-8 and ET-1 
expression in response to M. Jurfur and C. albicans cell wall. C. albicans cell wall initiated 
a significantly greater increase in the expression of these cytokines by the KCs. However 
little correlation between the mRNA production and peptide production was measured
using RT-PCR.
Growth of M. furfur and C. albicans on the skin models was assessed using scanning 
electron microscopy (SEM) and histological observation of the colonized tissue. Growth 
was also compared by means of viable cell counts. The effect of growth on the proliferation 
of the epidermis was measured by counting the number of proliferating cells in the basal 
layer of the epidermis of each tissue. Growth of M. furfur and C. albicans was detected on 
LSE and BRT and hyphal transformation of both organisms was observed on BRT and 
LSE, although hyphal transformation of C. albicans was found more commonly on the 
LSE. Indeed, overall growth of C. albicans was more widespread and rapid on LSE than it 
was on BRT. By contrast M. furfur appeared to undergo hyphal transformation more 
frequently on BRT, and this feature was donor-dependent. The viability of M. furfur varied 
when tested on BRT from different donors or on different batches of LSE. The proliferative 
index of the tissues indicated that growth of both M. furfur and C. albicans initiated an 
increase in the proliferation of the BRT and LSE epidermis. Overall, these studies show 
that growth of M. furfur and C. albicans differs in the various skin models and this effect 
was dependent on the different qualities of the donor tissue and donor KCs. The growth of 
M. jurfur, while slower than that of C. albicans, does stimulate a larger increase in the 
proliferation of the BRT epidermis.
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I  I n t r o d u c t i o n
I I  M a l a s s e z i a  FURFUR
1.1.1 History
The role of fungi in dermatological disease has been controversial with regard to the genus 
Malassezia. Yeast cells were first reported by Eichstedt (1846) and Robin (1853) in 
association with skin scrapings from pityriasis versicolor (PV). Subsequently Rivolta 
(1883) described yeast involvement in psoriasis and Malassez (1874) was the first to 
associate the yeast with scalp scaling. Much controversy surrounds the correct 
nomenclature for both genus and species of Malassezia/Pityrosporum; the latter term is 
still used, most predominantly by J. Faergemann (Faergemann, 1993). Malassezia has, 
however, been more widely accepted by the scientific community and in particular by 
Gordon who had initially adopted the name P. orbiculare to describe the organism he 
isolated from PV (Gordon, 1979). Until recently, controversy surrounded the distinction 
between what were considered to be two different species: P. orbiculare and P. ovale. By 
karyotyping it has been shown that these organisms represent two different morphological 
stages of the same organism (Gueho and Meyer, 1989). Hence the round P. orbiculare, 
oval P. ovale and mycelial M. furfur are in fact the same organism which can be grouped 
under the common nomenclature of Malassezia Jurjur (Table 1). Seven organisms are 
currently identified within the Malassezia genus including M. Jurfur, M. pachydermatis, M. 
sympodialis, M. globosa, M. obtuse, M. restricta and M. slooffiae (Boekhout et al., 1998). 
The majority of these organisms are implicated in the pathogenesis of veterinary infections, 
particularly M. pachydermatis and M. sympodialis in otitis externa. Due to the previous 
confusion surrounding nomenclature, the naming of Malassezia organisms in disease has 
been widely misinterpreted. It is, however, widely accepted that M. furfur is the primary 
human pathogen, implicated in a range of human skin and systemic infections.
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Table 1: Classification oî Malassezia species.
O r g a n is m F e a t u r e s P a t h o g e n ic it y
M. jurjur Lipophilic, dimorphic. Mycelial stage of organism associated with 
P V  Seborrheic dermatitis (SD), dandruff, 
and an allergen for atopic dermatitis etc.
M. pachydermatis Non-obligatory lipophile. 
Small ovoid yeast cells.
Common veterinary pathogen, found also 
on human skin.
M. sympodialis Lipophilic, dimorphic, 
oval/globose yeast cells.
Often implicated in systemic infections 
following lipid emulsion therapy.
M. globosa Large, cylindrical, 
dimorphic yeast cells.
Commonly associated with otitis externa in 
cattle.
M, obtuse Large, cylindrical, 
dimorphic yeast cells.
Lipid-dependent organism recently 
associated with canine otitis.
M. restricta Spherical/oval yeast cells 
with no evidence of 
budding.
Lipophilic organism identified as sldn 
commensal in humans.
M. sloojjiae Short, cylindrical cells. Also associated as a veterinary and human 
pathogen with otitis infection.
1.1.2 Structure / Grow th
M. Jurjur displays characteristics common to other yeast species. The organism can be 
observed in culture in both its oval and cylindrical forms, ranging in size from 2.5 to 5.0p.m 
and 1.5 to 3.0 to 2.5 to S.O i^m respectively. Hyphal transformation can be induced in vitro 
by the addition of exogenous sterols, cholesterol and cholesterol stearate (Porro et al., 
1977). Standard culture of the organism requires the addition of long chain, C12-C24, fatty 
acids as the organism cannot synthesise the lipids de novo, and they are essential for its 
membrane integrity (Porro et al., 1976). Optimum growth is achieved in the temperature 
range of 22-37^C. The cell wall has been studied by electron microscopy revealing a 
glycan-rich structure with extensive invaginations on the periplasmic side with indentations 
into the plasma membrane and a distinct lamellar layer (Mittag, 1995). It has been 
hypothesized that one of the major allergens of M  JurJur, the Malf-1 protein, is attached to 
the cell wall (Schmidt et al., 1997), possibly at the periplasmic side, and is revealed during
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reproduction. As M. furjur is an obligatory lipophile it cornes as no surprise that it 
produces both a soluble and insoluble lipase and lipoperoxidase that is essential for growth 
(De Luca et al., 1996).
1.1.3 A n tifungal  SENSITIVITY
The in vitro antifungal sensitivity of M. furfur is broad ranging, as measured by various 
growth inhibition assays. Azoles-agents which interfere with membrane ergosterol 
biosynthesis by interference with the cytochrome P-450 enzyme, lanosterol-14-a 
demethylase-have been shown to be effective in inhibiting growth (Strippoli et al., 1997). 
In vitro activity has also been shown with climbazole (Schmidt, 1997), zinc pyrithione, 
selenium disulphide (Van Cutsem et ah, 1990), piroctone-olamine (Pierard-Franchimont et 
ah, 2000), itraconazole (Rhie et ah, 2000), fluconazole and terbinafine (Gupta et ah, 2000). 
Antifungal activity has also recently been attributed to the 1,8-cineole-1 -terpinen-4-ol 
component of tea tree oil (Hammer et ah, 1997). It is also interesting to note the in vitro 
sensitivity of M. furfur to androgenic steroids, testosterone and dehydropoandrosterone; by 
contrast these compounds have no activity on C. albicans (Brasch, 1993). This finding is 
not consistent and conflicts with the effect in vivo as there is an accumulation of these 
androgenic steroids in the pilosebaceous unit, which is thought to be the site of M. furfur 
colonisation in SD. This study points out the disparity between in vitro and in vivo 
antifungal sensitivity and highlights the danger of extrapolating in vitro data for in vivo 
usage.
1.1.4 HABITAT
M. furfur can be isolated from the scalp and skin of the majority (74-100%) of the normal 
healthy population (Roberts, 1969). There is a greater frequency of colonisation of the 
sebaceous areas of the back and chest as has been shown by comparative quantification of 
organism numbers isolated from skin scrapings at both sites (Abraham et al., 1987; 
Faergemann, 1984). This is also supported by the increase in infection in adolescents when 
lipid production by the sebaceous glands is at its peak (Powell et al., 1984). In infants it has 
been shown that colonisation of the arms, back and chest affects approximately 32% of the 
neonatal population (Broberg, 1995; Broberg and Faergemann, 1989). The source of infant 
colonisation is thought to be either health care workers (Chang et al., 1998) or parents 
(Ahtonen et al., 1990), and length of hospital stay directly correlates to increased frequency
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of colonisation (Bell et al., 1988).
1.1.5 PATHOGENICITY
As M  furfur can be isolated from various body sites of a large percentage of the 
population, it has been difficult to establish the role of this commensal in dermatological 
disease. Evidence for the organism’s role in various cutaneous infections comes primarily 
from the correlation between disease resolution and response to antifungal treatment.
1 .1 .5 .1  P it y r ia s is  v e r s ic o l o r
The clinical presentation of this infection is characterised by chronic scaling of the upper 
trunk, chest, back and neck, often accompanied by hypo- and hyper pigmentation of the 
affected area (Faergemann, 1989), The lesions often coalesce to form large areas with 
abnormal pigmentation, with the colour of the lesion dependent upon exposure of the area 
to sunlight and the underlying pigmentation of the individual (Karaoui et al., 1981). The 
highest incidence of this infection occurs in areas of high relative humidity, which 
correlates to increased frequency of infection in tropical climates (Kim et al., 1999). Due to 
the predisposition of the organism for lipid, it is hardly surprising that the areas most 
affected are those with elevated lipid content, namely the sebaceous regions of the body, 
trunk and back. This corresponds to the elevated rate of infection in post-pubertal males 
who have high sebum secretion rates (Noble and Midgley, 1978). Clinical diagnosis is 
made by distribution and appearance of lesions, confirmed by fluorescence of infected 
areas under a Wood’s lamp. Sldn scrapings also yield culturabie M. furfur and KOH 
digestion of samples should reveal the organism in both yeast and mycelial forms, 
commonly referred to as 'spaghetti and meatballs' (Faergemann et al., 1983b). In biopsies 
of infected areas the organism is confined to the epidermis and is generally observed in the 
stratum corneum with a mild mononuclear infiltrate in the upper epidermis often evident. 
Increased pigmentation in the basal layers and hyperkeratosis are also features (Janaki et 
ah, 1997). It has been shown recently that the organism, although restricted to the stratum 
corneum, can elicit an increase in IgG and IgM-specific responses compared to unaffected 
(non-PV+ve) individuals (Silva et ah, 1997). Treatment for PV includes synthetic detergent 
with added antifungal agents including ketoconazole (Borelli, 1980), zinc pyrithione and 
selenium sulphide at 2-5% (Chu, 1984). In chronic cases prophylaxis with fluconazole 
(Strippoli et ah, 1997), itraconazole (Galimberti et ah, 1987) and ketoconazole (Meisel,
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1983) must be used to ensure non-recurrence.
Controversy surrounds the ability of the organism to alter pigmentation in PV. It has been 
hypothesised that inhibition of tyrosinase production (Nazzaro-Porro and Passi, 1978), 
disruption of melanosome distribution and size (Karaoui et al., 1981) and phospholipase 
production (Riciputo et al., 1996) may all be organism-derived factors that alter 
pigmentation. It has not been established which of these mechanisms, if any, predominate 
in the control of pigmentation changes seen in PV.
1 .1 .5 .2  M a l a s s e z ia  f o l l ic u l it is .
Folliculitis, resulting from M. furfur infection, presents as an erythematous papulopustular 
rash commonly found on the back, shoulders, anterior chest and neck (Klotz et al., 1982). It 
is thought that the organism plugs the pilosebaceous unit, where budding cells are found in 
the infundibulum, resulting in follicle destruction and perifollicular inflammation. Funds 
and crusting of the lesion leads to a chronic infection (Ford, 1984) and diagnosis is made 
on clinical presentation and histopathology of the infected follicles (Lim et al., 1988). The 
efficacy of antifungal agents, including selenium sulphide shampoos, ciclopirox and topical 
azoles (Parsad et al., 1998), all point towards fungal aetiology and can aid in the 
differential diagnosis between acne vulgaris and acneiform exanthema (Sandin et al.,
1993). Again an association between host immune status and M. furfur infection has been 
indicated by the latest folliculitis study (Rhie et al., 2000), further supporting a role for the 
immune response in regulating the pathogenicity of this commensal yeast.
1 .1 .5 .3  S e b o r r h e ic  D e r m a t it is
SD presents as a yellow/ brown greasy scaling most often affecting the scalp, but also 
found on the face and upper trunk (Bergbrant, 1995). The link between Malassezia and SD 
has only recently been established in treatment studies showing the efficacy of antifungals 
in disease resolution (Heng et al., 1990; Skinner et al., 1985) corresponding to declining 
frequency of colonisation (Shuster, 1984). SD affects 1-3% of the general population, 
accounting for 7% of all dermatological out patients and presenting in 20-83% of patients 
with acquired immunodeficiency syndrome (AIDS) (Schechtman et ah, 1995b). Although 
clinical diagnosis is often facilitated by the obvious characteristics of infection, differential 
diagnosis must also be made between psoriasis vulgaris, PV and histocytosis X in infants.
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Dandruff is a mild non-inflammatory form of SD confined to the scalp (Hay and Graham- 
Brown, 1997; Priestley and Savin, 1976; Shuster, 1984) which is treated effectively using 
one of the many commercial applications (Pierard-Franchimont et al., 2000). Histologically 
the disease presents as hyperkeratosis with increasing frequency of nucleated corneocytes 
in the upper epidermis and a significant increase in scalp colonisation with M. furfur 
(McGinley et al., 1975). The increasing incidence of SD in AIDS patients (Aly and Berger, 
1996; Ross et al., 1994) can be correlated with a declining T-cell count (Figure 1); hence, it 
is thought that the loss of an immunological response in AIDS patients may contribute to 
the initiation of SD.
Recent immunological studies have shown that decreased IgG reactivity to protein extracts 
of M. furfur correlates with increased severity of SD (Kieffer et al., 1990); however, other 
authors have shown increased IgG and IgA production (Ashbee et al., 1994). Unchecked 
proliferation of the organism in the skin could induce inflammation, triggering the 
hyperkeratosis and increased KC proliferation seen in SD. Production of IL-2 and IFN-y is 
found to be decreased in SD sufferers while there is a marked increase in CD4+ expression 
on infiltrating T-cells, and increased NIC-cell circulation and IL-10 production (Bergbrant 
et al., 1991b). It has still not been established with any clarity whether M  furfur can initiate 
a primary immune response in skin; however, recent studies have shown that it is able to 
stimulate Langerhans cell (LC) maturation and migration, indicating its ability to stimulate 
the adaptive immune response (Buentke et al. 2000). Conventional SD treatment is 2% 
ketoconazole and this results in marked improvement in the symptoms of SD (McGrath 
and Murphy, 1991).
1 .1 .5 .4  In f a n t il e  S e b o r r h e ic  D e r m a  titis
Infantile SD presents in a similar way to the adult form of SD (Broberg and Faergemann, 
1989). Greasy scales on the scalp thicken and compress to form a cap, which overlies 
mildly erythematous skin-hence the generalised use of the term ‘cradle cap’ (Ruiz- 
Maldonado et ah, 1989). Involvement may also occur over the body with erythema 
particularly affecting the flexural folds and nappy area. It has been shown that infants with 
infantile SD share a common disruption in their essential fatty acid metabolism and that 
correction of this abnormality with maturation results in disease resolution (Tollesson et 
ah, 1997). The role therefore of M  furfur in this disease may be associated with an altered
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lipid profile, encouraging growth of the organism (Broberg and Faergemann, 1989).
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Fig. 1. b. Opportunistic skin infections during the course of HIV infection. (Courtesy of World 
Health Communications, New York, N.Y.)
Figure 1: Decreasing CD4 T-cell count (Fig. l.a.) and onset of AIDS correlates to 
increased incidence in SD and other dermatological diseases (Fig. l.b) (Faergemann,
1994).
1 ,1 .5 .5  C o n f l u e n t  AND Re t ic u l a t e  P a p il l o m a t o s is
This rare disorder, which generally affects young women, presents as grey-brown 
pigmented papules which coalesce, most commonly at the neck and upper trunk, to form 
hyper-pigmented patches (Faergemann et al., 1980; Kirby and Borrie, 1975). Although the
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organism can be identified from lesions, its role in the initiation of infection is unclear 
(Kumar and Pandhi, 1984). It is thought that a genetically predisposed abnormal immune 
response towards M. furfur may be responsible (Broberg and Faergemann, 1988).
1 .1 .5 .6  A t o p ic  D e r m a t it is
The role of M. furfur as an allergen in individuals with AD has recently been assessed 
(Tengvall Linder et al., 2000). It has been established that the organism is an important 
allergen in individuals with AD localised to the face and neck (Waersted and Hjorth, 
1985), as 78% of these patients show positive skin prick test reactivity to M. furfur extracts 
(Young et al., 1989) and positive skin prick test also correlates to efficacy of oral 
ketoconazole in AD resolution. In this M. /wr/wr-sensitive population there is a greater 
frequency of IgE antibody specific to the organism, and serum shows elevated overall IL-4 
and IL-10 levels (Jensen-Jarolim et al., 1992; Kroger et al., 1995). T-helper cells play an 
important role in the pathogenesis of AD, and allergen-specific T-cells isolated from 
individuals are often of the Th2 subclass. Treatment with antifungal agents does not, as in 
SD, correspond to disease resolution in general AD sufferers but does in individuals with 
AD localised to the head and neck (Broberg and Faergemann, 1995). Interestingly there 
appears to be a cross-reactive component of both M. furfur and C. albicans for atopies, 
who express a common and cross-reacting IgE response to these organisms (Zargari et al.,
1994). How these commensals exacerbate AD is subject to much hypothesis, and it is 
possible that gastrointestinal sensitization to C. albicans growth in AD sufferers may result 
in a cutaneous reaction to M. furfur following exposure on the skin.
1 .1 .5 .7  P s o r ia s is
Controversy also surrounds the putative role of M. furfur in the initiation of lesions in 
psoriasis. Animal models develop psoriatic-like lesions following application of M. furfur 
(Rosenberg et al., 1980) and, as M. furfur activates the alternative components of 
complement, this is a possible mechanism by which the organism could induce 
inflammation in psoriasis (Squiquera et al., 1994). It has been recently established that 
Malassezia-dQnvQd lipase stimulates release of arachidonic acid, a precursor for various 
pro-inflammatory agents from epithelial cell culture (Plotkin et al., 1988), and that a 
specific immunoglobulin response to this organism is detected in psoriatics but not in 
healthy individuals (Mathov et al., 1996). In some susceptible psoriatics M. furfur-dQuvod
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proteins may initiate an inflammatory immune response, resulting in plaque formation; this 
has been substantiated by the initiation of psoriatic plaques by M. /wr/hr-derived 
components (Bunse and Mahrle, 1996; Lober et al., 1982). The inflammatory response 
initiated by the organism may accumulate, resulting in the hyperproliferative, neutrophil- 
rich plaque common to psoriasis. This susceptibility to M. furfur may be due to the genetic 
predisposition identified for psoriatics, where a mutation in the human lymphocyte antigen 
(HLA) gene shows a positive correlation to disease allowing inflammatory agents to 
exacerbate the already pre-existing condition (Baker et al., 1997).
1.1.6 Sum mary
M  furfur is a lipophilic dimorphic yeast which is implicated, often inconclusively, in many 
dermatologie diseases. Much still has to be established regarding the relevance of this 
organism in these disorders, particularly the role it plays in the initiation of the immune 
response of the skin. An investigation into the immunomodulating activity of Malassezia 
on the skin may provide an insight into the organism’s role in the pathophysiology of the 
infections mentioned above.
1 .2  C . ALBICANS
C. albicans is a dimorphic yeast belonging to the genus Candida. C. tropicalis and C. 
albicans can be isolated from normal skin as part of the cutaneous microflora. The 
spectrum of human infection caused by C. albicans is vast; however, in relation to skin, 
this organism only becomes relevant when the host becomes severely 
immunocompromised. Chronic mucocutanous candidiasis is a group of symptoms 
characterized by chronic superficial Candida infection of the skin, nails and oropharynx. 
Increased incidence of C. albicans involvement in skin infection has been associated with a 
declining T-cell population, but as yet no distinct reversion of this commensal to 
pathogenicity has been identified during normal cutaneous colonisation. C. albicans is 
however implicated in onychomycosis, where the production of a keratinolytic proteinase 
has been identified as a pathogenic factor (Hattori et al., 1984) and, as C. albicans exhibits 
cross-reactivity with a M. furfur-specific antibody, there is a possible role for this yeast in 
aggravating cutaneous disease (Doekes et al., 1993). It is possible that the yeast stimulates 
the skin via the mannose receptor, beta- glucan receptor and complement receptor type 3,
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which upon binding activates the alternative pathway of complement (Suzuld et ah, 1998).
1 3  Sk in  M o d e l s  AND SKIN
1.3.1 H istory
Preliminary work on attempting to create ‘skin models’ originated from research on the 
interactions between the epidermal and dermal cells in co-culture as opposed to 
monolayers (Ponec and Kempenaar, 1995). Cell differentiation and proliferation mimic in 
vivo patterns of growth more representatively in three dimensional culture systems and 
these findings have revolutionised the field of tissue engineering (Stoppie et ah, 1993). 
More recently the need for replacement tissues, not exclusively skin, has induced research 
in applied tissue engineering with specialisation in various tissue equivalents becoming 
more refined. The use, therefore, of LSEs for both toxicological and immunological studies 
has become more commonplace (LeClaire and de Silva, 1998).
1.3.2 Structure
The LSE is a three dimensional model with a viable stratified epidermis supported upon a 
fibroblast-contracted collagen matrix. Many different protocols for formulating a LSE have 
been devised, utilising hair follicle KCs, neonatal KCs, de-epidermised dermis and 
fibroblast-embedded collagen matrices (Lenoir and Bernard, 1990). The most commonly 
used protocol incorporates a fibroblast-embedded collagen matrix, seeded with neonatal 
KCs. This skin equivalent produces a differentiated stratified epidermis which expresses 
the appropriate keratin markers (Coulomb et ah, 1998) with a distinct deposition of laminin 
and type IV collagen at the basement membrane (Sugihara et ah, 1991). Although skin 
equivalents do represent normal skin in many respects they lack some cellular components, 
such as melanocytes (MCs) and LCs, which also contribute to tissue homeostasis 
(Asselineau et ah, 1986). To utilize the LSE as an experimental model the investigator 
must be aware of the practical constraints of the model and compare the reactivity of the 
LSEs to the known activities of skin. Two areas in which the skin equivalent fails to be 
representative of real skin, and which are particularly relevant to M. furfur infections, are 
its lipid profile and immunological responses.
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1.3.3 L i p i d  c o m p o s i t i o n
With reference to the stratum corneum, the lipid profile of the skin is high in ceramides, 
converted from glucosyl ceramides, long chain C22-C30 free fatty acids, free sterols and 
cholesterol sulphates. The lipoprotein of corneocytes is cross-linked to the ceramides of the 
horny layer and recent studies have shown that the lipid content or ceramide profile of the 
LSE does not correspond to the in vivo level (Ponec et al., 2000). Hence the functioning of 
the LSE stratum corneum differs substantially from normal skin in that it is more 
absorbent, and has less of a barrier function than natural skin. It has recently been shown 
that the addition of vitamin C (50 pg/ml ascorbic acid in the medium) improves epidermal 
cell morphology and normalises the lipid content of the stratum corneum, and in particular 
the ceramide content (Ponec et ah, 1997b). It is thought that by optimising the lipid profile 
of the skin equivalent, the balance between differentiation and proliferation exerted by 
ceramides and glucosyl ceramides respectively, will result in the normalisation of the 
desquamation rate of the LSEs stratum corneum (Vicanova et ah, 1996). Other methods for 
normalising the lipid content of reconstructed epidermis involve supplementing the 
medium with essential fatty acids or reducing the relative humidity and temperature (Ponec 
et ah, 1997a).
1.3.4 I m m u n o l o g i c a l  A c t i v i t y
Although the basic structural, morphological and biochemical interactions of the skin 
model are equivalent to the situation found in normal skin, the lack of systemic humoral 
and cellular immunological responses makes the model limited in its immunological 
relevance. Although certain cytokine profiles have been measured (de Brugerolle de et ah,
1999), little work has been carried out into the immunological response of the skin model 
to infection. Hence, although we cannot mimic the humoral in vivo immune response, we 
can easily investigate some of the cellular response of the skin equivalent to infection. 
Macrophages and granulocytes participate in the amplification of the cytokine network of 
the skin, while LCs and dermal dendritic cells present antigen to activated T-cells (Figure 
2). The role of MCs, LCs and KCs in the SIS will be discussed.
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Table 2: Cellular components of the SIS. Table modified from (De Bos and 
Kapsenberg, 1993).
C e l l u l a r  c o n s t it u e n t s  o f  t h e  sk in  im m u n e  r e s p o n s e
In n ate A daptive
Tissue Macrophage Langerhans cell
Monocyte/ Granulocyte Dermal dendritic cells
Keratinocyte T-cells
Mast-cells Endothelial cells
Activated T-cell 
migration to the 
epidermis^'”^  "
* Pifokine release 
 ^ KÜ Proliferation
processing O
*»yLCs
Maturation and 
movement of 
activated LCs to 
the lymphatics
/
i
-Antigen presentation j  
to naive T-cells _____
® < 0
Figure 2: Cellular components of the skin immune response. Figure modified from 
(Grabbe and Schwarz, 1998)
1.3.5 KERATINOCYTES
KCs are one of the major immune cells of the epidermis capable of initiating a cytokine 
response which has a myriad of effects on the cells of the SIS. Culture of these cells on a 
dermal equivalent results in a comparable differentiation and stratification of the KCs into 
basal, spinous, granular and stratum corneum layers.The main KC function in the SIS is in 
the production of cytokines which follow a microbial/inflammatory challenge. Following 
direct exposure of certain ligands to the epidermis, KC respond with IL-la release and this 
in turn effects the epidermis in several ways including increased proliferation and further 
cyokine production.
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1.3.5.1 KC ANTIGEN PRESENTATION
KC are considered the non-profesional antigen presenting cells of the epidermis. As KCs 
express the MHC class HIA-DR protein it is thought that antigen can be expressed in 
association with this molecule. Expression of HLA-DR associated antigen results in 
upregulation of further HLA-DR expression, attracting T cells to the site of inflammation 
(Myint et al, 2000). While KCs do express HLA-DR constitutively, y IFN has been shown 
to upregulate expression of this molecule on KCs (Basham et al, 1985) and while KC can 
produce y IFN (Howie et al, 1996) it is thought that the recruitment of T cells to the site of 
antigen expression amplifies this expression as T cells express y IFN. In terms of infection 
no evidence as yet exists as to the ability of KCs to directly process microbial or fungal 
antigen. While KCs do possess some phagocytotic ability (Luger et al, 1981), this has not 
been demonstrated in relation to fungal particles. Viral components, which do not require 
KC processing are however thought to be presented in association with HLA-DR 
molecules (Londei et al, 1984). Therefore as KC possess antigen presenting molecules they 
may amplify the initial immune response of the skin to infection by fungal agents.
1 .3 .5 .2  C y t o k in e s
KCs function in vivo on the skin as the main source of cytokines in an inflammatory 
response following trauma or infection (See table 3). The production of cytokines in the 
LSE has been measured in response to infectious agents (Fucso et al., 1993) and UV 
(Corsini et al., 1997), and has shown an equivalent response, due mostly to KC-derived 
cytokines. The innate immune response function of KCs in vitro seems to be equivalent to 
the in vivo profile. Aside from their immense cytokine profile, it has only recently been 
established that KCs also secrete complement component C3, a precursor for C3d and 
C3dg required for the activation of the alternative pathway of complement stimulation 
(Seguin et al., 1997). KCs also produce an anti-leukoproteinase which is a soluble serine 
protease inhibitor and one of the innate antimicrobial agents of human skin (Wiedow et al., 
1998). This inhibitor directly acts as an antimicrobial agent by inhibiting proteolysis, 
contributing further to the innate SIS. Non-specific stimulation of the KC results in 
expression and release of these factors that act as primary immunological agents in the 
initiation and amplification of several non-specific and specific responses.
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1 .3 .5 .3  D e f e n s in s
Antimicrobial peptides are an integral component of the innate immune system of many 
species of plants and animals (Boman, 1995). KCs produce HBD-2 and HBD-3 in response 
to inflammatory mediators, TNFa and killed whole bacterial and fungal cells (Harder et al., 
1997). However the exact role of defensin in the SIS has not been fully elucidated. Over 70 
defensin peptides are known, all sharing close structural and sequence homology, and five 
distinct types of peptide can be characterised; these will be discussed in chapter 2 in more 
detail. Those peptides with two or more disulphide bonds, commonly p-sheet structures 
and anti-parallel chains, are called p-defensins. These peptides are on average 29-34 amino 
acid residues in length, contain four or more interlinked half cysteines and are very basic 
with a high arginine residue content (Ganz and Lehrer, 1994). They are genetically coded 
as propeptides and are modified on secretion from cellular vacuoles into the active peptide. 
The common action of these defensins is on the membrane integrity of the organism 
(Lehrer et al., 1989). Primary electrostatic interactions facilitate the attachment of the 
peptides (cationic) to the organism’s membrane (anionic), and heterodimerisation of the 
peptides results in pore formation and cell lysis. Human defensins have been mapped to 
chromosome 8, band 23, and they are found to be constitutively expressed in many 
mucosal sites; upregulation of transcription is found in states of infection/inflammation 
(Ganz and Lehrer, 1995). This has been linked to the presence of a NFkB (heterodimer) 
binding site upstream of the defensin gene and the presence of this binding site, and an IL- 
6 CTGGGA responsiveness binding site, point towards transcriptional upregulation of 
human p defensins in response to inflammatory mediators. The role of HBD-2 in 
protecting the skin from microbial challenge will be discussed in chapter 2 in more detail.
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Table 3: Cytokine production by KCs.
C y t o k in e s  p r o d u c e d  b y  K é r a t in o c y t e s
IL -la
IL-1 a  accumulation in the KC is released 
by non-specific trauma to the skin. This 
cytokine in turn stimulates further cytokine 
production by KCs.
IL-6
Produced by KCs following IL -la  
paracrine stimulation. Functions in B- and 
T-cell proliferation and differentiation and 
is an endogenous pyrogen.
IL-10
Increased transcription in response to 
cytokines, LPS etc. Stimulates IL-lra 
production limiting IL -la  effects. Is 
chemotactic for monocytes, neutrophils and 
T-cells.
Co l o n y  st im u l a t in g  f a c t o r s  (C S F )
GM-CSF, G-CSF, M-CSF and IL-3 which 
induce stem cell proliferation. LPS and IL- 
l a  increase KC CSF production.
T N F a
Transcription is initiated by UV, cytokines 
and tumor promoters. Crucial for LC 
viability it stimulates NFkB transcription.
E n d o t h e l in -1
Produced by KC and endothelial cells in 
response to cytokine, stimulates aMSH 
production and vasoconstriction.
IL-8
Produced in response to IL -la , a 
chemokine which acts as a chemoattractant 
for neutrophils.
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1.3.6 L a n g e r h a n s  c e l l
These dendritic cells are the main antigen-presenting cells of the skin and, until recently, 
have not been applied in skin models. By immunohistochemical analysis of skin it has been 
revealed that the main area of residence of LCs is the basal layer of the epidermis with 
dendritic extensions of the cells reaching into the stratum corneum. LCs are the main 
professional antigen presenting cell of the skin and interact with exogenous antigens, 
presenting them to the appropriate T cell population.
1.3 .6 .1  A n t ig e n  p r o c e s s in g  a n d  P r é s e n t a  t io n
Following skin exposure to antigen, LCs express maturation cell markers and in response 
to changes in their cell adhesion molecule expression and lymphatic and epidermal factors, 
they migrate to peripheral lymphatic organs (Weinlich et al, 1999). It is thought that LC 
movement from the epidermis occurs as the antigen is being processed (Axelrod et al,
1994). Once activated into maturation following antigen internalisation, the LC migrates 
through the epidermal/dermal junction, dermal perivascular unit and to the peripheral 
draining lymph nodes, where it stimulates T-cell populations by presentation of antigen in 
association with MHC complex. Migration is in response to both efferent lymphatic and 
skin-derived factors, and as such, LC antigen presentation is essential for the stimulation of 
the adaptive immune response of the skin (Kripke et al, 1990).
1.3.7 M elanocytes
MCs are found at low frequency in the normal epidermis and are the resident pigment- 
producing cells of the epidermis. The major function of MCs is the production of 
melanosomes, the pigment-producing centres of the skin, which are transported to KCs by 
secretion and endocytosis. These melanosomes then function in the production of melanin 
which protects cellular DNA from UV irradiation damage. The MC is also essential in 
amplifying the immune response of the skin, as it has recently been shown that these cells 
are capable of transcribing various cytokines in response to stimuli, including TGF-a, EGF 
and TGF-(3 (Morelli, 1993). MC control is exerted in part by KCs which have recently been 
shown to secrete pro-propiomelanocortin, a precursor of a-M C stimulating hormone 
(aMSH) and KC-derived IL -la  production stimulates aMSH receptor expression on MCs 
(Schauer et al., 1994).
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1 .3 .8  E N D O T H E L IA L  CELLS
Endothelial cells act as important regulators of cell trafficking throughout the body. As 
these cells line the vasculature of the body they have a myriad of functions on many cell 
types including smooth muscle cells, where they can regulate growth and on fibroblast 
growth, as they secrete FGF. Most importantly endothelial cells regulate the 
transendothelial movement of material and cells between blood and interstitial fluid, thus 
regulating immune cell traffic. As one of the main components of the perivascular unit this 
is particularly relevant in the regulation of immune cells into and out of the epidermis. 
Thus in response to an immune signal, often cytokine production, endothelial cells express 
cell adhesion molecules which act as a chemoattractant for immune cells and this process 
has been termed ‘Endothelial cell activation’(Pober, 1988). Signals from the epidermis 
stimulate adhesion molecule expression and ICAM-1, MHC class 1 and VCAM-1 have all 
been shown to be upregulated in response to inflammatory mediators (Schneemann et al, 
1993). Expression of these receptor encourage B and T lymphocyte migration to the 
affected area. With particular reference to fungi, dissemination of C. albicans results in 
endothelial cell phagocytosis of the organism and increased ICAM-1 and VCAM-1 
expression (Orozco et al, 2000). In skin, endothelial cells react mainly to the 
immunomodulating cytokines produced by the resident dermal and epidermal cells. It has 
been suggested that endothelial cells may themselves act as antigen presenting cells as they 
express HLA-DR (Hirschberg et al, 1980). However this has been shown to be unlikely, 
with LC thought to account for the vast majority of dermal antigen presentating cells of the 
skin.
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1 4  A i m s  AMD OBJECTIVES
The aim of this work was to create and assess a series of skin models which would yield 
definitive answers as to M. furfur’s role in the various cutaneous diseases. The major 
questions to be addressed, regarding M. jurfur infection were:
1. Does M. furfur initiate an innate immune response? The possibility of host- 
specific reactions to M. furfur in donor tissue might account for the reversion from 
commensal to pathogen in only some individuals.
2. Do M, furfur or M. futfur-àeriyeA products directly alter melanin synthesis? 
Clarification of the effects of M. furfur on melanin synthesis might directly 
implicate the organism in the pigmentory changes associated with PV.
3. Does M. furfur grow at different rates on different donor tissue and in 
different skin models? Differences in the growth patterns of the organism on 
different host tissues might account for the pathogenic nature of M. furfur in some 
individuals only.
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2  A n t im ic r o b ia l  p e p t i d e s  
2.1 In t r o d u c t io n
The innate immune response of multicellular organisms provides a rapid, specific and 
effective defence against possible invading pathogens. Whereas clonal expansion of 
antigen-specific B and T-cells is a lengthy process, the innate immunity, and its multitude 
of constituents, provide an immediate barrier against the array of environmental pathogens 
encountered by the host. Antimicrobial proteins, first recognised in the form of lysozyme 
(Fleming, 1922), are some of the main constituents of innate immunity in plants, 
amphibians and mammals (see Table 4). These molecules represent one of the principal 
lines of non-specific innate defence and in particular the smaller antimicrobial peptides, 
classified as those less than 100 amino acids in length, are common throughout nature. The 
smaller antimicrobial peptides show common structure, function, sequence and 
transcriptional regulation indicating either a functional convergence or evolutionary 
divergence for these molecules. In light of the recent discoveries in Drosophila (Hoffmann,
1995) the theory of an evolutionary divergence has been widely accepted. The 
antimicrobial peptides remain a common and important constituent of the innate immune 
response of many organisms and they are an ancient component of this protective response. 
The smaller cationic peptides are a significant element of this non-adaptive immune 
response and they are ubiquitously found in a variety of epithelial secretions and in specific 
cellular compartments.
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Table 4: Antimicrobial protein components of the human innate immune response.
P r o t e in L o c a t io n A c t io n
Transferrin Phagosomes Competes for Fe^ "^  with the 
organism, inhibiting 
growth.
Defensin Epithelial cells Pore formation in 
organism’s membrane 
resulting in cell lysis.
SLPI Kératinocytes Proteinase inhibitor which 
protects elastin fibers from 
proteolytic damage and is 
directly antibacterial.
Properdin Plasma Activates complement 
synthesis in absence of 
antigen/antibody 
stimulation.
Lysozyme Phagosomes Disrupts cell wall linkage 
resulting in cell lysis. *
Disrupts N-acetylmuramic acid and N-acetylglucosaraine linkage.
41
2 .1 .1  G E N E R A L  FEATURES
The majority of information amassed on antimicrobial peptides is based on research carried 
out in insect systems (Boman, 1991). It was observed early in the 1980s that injection of 
the giant silkworm Hyalophora cecropin haemolymph with bacteria resulted in 
phagocytosis and clearance of the organism with a resultant overall increase in both RNA 
and protein synthesis (Steiner et al., 1981). The 9 proteins which were isolated from this 
moth were later found to have structural homology with each other and were subsequently 
termed the Cecropins. Much of the information regarding mammalian antimicrobial 
peptides has been generated in line with the development in knowledge of the Cecropins. 
Over the years the antimicrobial peptides, with now over 400 known, have been classified 
into 4 overall groups as determined by sequence, functional and structural homology 
(Boman, 1995).
2 .1 .1 .1  L in e a r  h e l ic a l  p e p t id e s  w it h o u t  c y s
This grouping is composed mainly of the insect-derived molecules, particularly the 
Cecropins. These peptides have a strong basic N-terminus with a long hydrophobic stretch 
at the C-terminus. They have a 12 amino acid consensus sequence that is virtually 
unchanged throughout and are approximately 40-70 amino acids long.
2 .1 .1 .2  L in e a r  PEPTIDES w it h o u t  c y s  a n d  a  h ig h  p r o  a n d  a r g  c o n t e n t
The first peptide to be isolated with this structure was an apidaecin from the honey bee 
(Casteels et al., 1989). These peptides incorporate the bovine neutrophil peptides Bac 5 and 
Bac 7 and include the Drosophila drosocin peptide (Frank et ak, 1990).
2 .1 .1 3  P e p t id e s  w it h  o n e  d is u l p h id e  b o n d
This group includes bactenecin, isolated from bovine neutrophils (Romeo et al., 1988) and 
several antimicrobial amphibian skin peptides (Clark et al., 1994). These molecules are 
short, loop-forming peptides with 1 disulphide bond, often located at the C-terminus.
2 .1 .1 .4  P e p t id e s  w it h  t w o  o r  m o r e  d is u l p h id e  b o n d s
This group contains the most biologically important class of mammalian antimicrobial 
peptides, the defensins. They contain six invariant cys residues and are basic peptides 
which form |3-sheet structures with anti-parallel chains.
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2.1.2 Defensins
Defensins are the best studied family of what have been termed antibiotic peptides. Human 
defensins were first recognised in 1966 having been purified from phagocytic granules of 
neutrophils (Zeya and Spitznagel, 1966). The isolated peptide was subsequently recognised 
as a major component of the non-oxidative killing mechanism of neutrophils which is 
required to kill bacteria, and human neutrophil peptide 1 (HNP-1) was the first defensin 
ever formally classified (Selsted et al., 1983). By studying the innate immune mechanisms 
of neutrophils, and comparing this to the immunity of other insect and mammalian species, 
much progress has occurred in our understanding of defensins. These cationic peptides are 
produced by proteolytic cleavage of a 29 amino acid precursor and are antimicrobial for a 
range of bacteria, fungi and enveloped viruses. They are produced by a variety of species 
and are abundant in nature. They include:
Insect: Drosomycin is produced by the liver-like fat body of the insect and is extremely 
active against the fungal pathogens of Drososphila (Meister et al., 1997).
Plant: Inducible production of Raphanus sativus antifungal peptide is initiated in the plant 
Raphanus sativus when the radicle places pressure on the outer lamellar layer of seed. This 
is thought to protect the germinating seed from initial fungal infection (Tailor et al., 1997). 
Mammalian: Tracheal antimicrobial peptide (TAP) and lingual antimicrobial peptide 
(LAP) of bovine origin are produced in response to infection and inflammation of the cows 
trachea and tongue respectively (Diamond et al., 1991).
2.1.3 H u m a n  DEFENSINS
With particular reference to humans there are only 8 defensins presently identified. 
HNPI-4: Human neutrophil peptide is isolated from the auzorophil granules of neutrophils 
and accounts for 85% of the protein content of neutrophils. These peptides are stored in the 
specialist auzorophil granules and act when bacteria are phagocytosed. They function by 
initiating pathogen cell permeabilisation.
HNP5-6: These molecules are produced by Paneth cells of the small intestine, and are 
secreted into the intestinal villi crypt. They are also referred to as human antimicrobial 
defensin 5 and 6 (HAD5-6).
HBD-1: Human (3 defensin-1 is secreted mainly in the genito-urinary epithelia and is also 
isolated from trachea and conjunctiva.
HBD-2: HBD-2 is found in skin and pulmonary epithelia and is released from the cells in
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response to inflammatory stimuli.
The human defensins can be further classified into two major groups, a  and p, as 
determined by their structure.
2.1.4 a  DEFENSINS
These peptides have 6 invariant cys residues and hence 3 disulphide bonds at C l-6, C2-4 
and C3“5. They are synthesised in a 90 amino acid precursor form, which becomes an 
active peptide of approximately 29-30 amino acid length. X-ray crystallography of the 
HNP-1 homologue, rabbit NP-1, has shown its 3D secondary structure to be composed of a 
triple stranded beta sheet with connecting hairpin loop. This group contains HNPl-3 and 
the intestinal defensins HNP5-6 (Hill et al., 1991).
2.1.5 P DEFENSINS
These peptides are slightly longer, 38-47 amino acids long, with high Arg and Lys residue 
content. Disulphide bonding occurs at C l-5, C2-4 and C3-5 with dimérisation of the p- 
defensins occurring at the opposing hairpins. This results in a 4-stranded hydrophobic P- 
sheet and these peptides are expressed in a range of animals. HBD-1 and HBD-2 belong to 
this p defensin classification (Table 5).
2.1.6 Hum an  p defensin-1
HBD-1 was first isolated in 1995 when experimentation to improve the extraction of 
peptides from human haemofiltrate revealed a novel molecule with extensive homology to 
the bovine p defensins (Bensch et al., 1995). This peptide was later named human p 
defensin 1 (HBD-1) and has the characteristic 6 Cys repeat sequence common to human, 
bovine and other mammalian defensins.
2 .1 .6 .1  S it e s  o f  p r o d u c t io n
Purification of the peptide from vaginal lavage fluid has permitted sequencing and cloning 
of the gene, allowing construction of mRNA probes and monoclonal antibodies specific for 
the peptide to measure expression of transcription and effective translation of HBD-1 in 
tissues. Following these experiments it has been established that the peptide is produced by 
a range of epithelial tissues including the respiratory tract (Zhao et al., 1996), urogenital 
epithelia (Zhao et al., 1996), ocular epithelia (Haynes et al., 1999), placenta (Svinarich et
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al., 1997) and intestinal epithelia (O'Neil et al., 1999). At least sixteen isoforms of the 
peptide, ranging from 36-47 amino acids in length, have been shown to be produced by the 
genito-urinary epithelia (Hiratsuka et al., 2000).
Table 5: p-Defensins from various animal species.
Na m e  o f  pe p t id e A n im a l T issu e  ex pr e sse d
TAP/LAP: Tracheal and 
Lingual antimicrobial 
peptide
Cow Trachea & tongue 
epithelia.
SBD-1, 2: Sheep p 
defensin-1,2
Sheep Gastrointestinal tract.
HBD-1; Human p 
defensin-1
Human Kidney, salivary gland & 
trachea.
HBD-2: Human p 
defensin-2
Human Skin.
Gallinacins Chicken Heterophils.
THP 1-3; Turkey 
heterophil peptide-1-3
Turkey Heterophils.
PBD-1: Porcine p 
defensin-1
Pig Tongue, respiratory and 
gastrointestinal tract.
2.1.6.2 R o l e  i n  d is e a s e
Using semi-quantitative RT-PCR and in situ hybridisation/immunohistochemistry, it was 
possible to establish that there is no upregulation of HBD-1 transcription in response to 
inflammatory stimuli in most infection models (Zhao et al., 1996). In nude mice models it 
has been shown that the antimicrobial effects of bronchial fluid are due to HBD-1, as 
treatment of the cells with antisense HBD-1 results in loss of the bacteriostatic activity of 
the fluid (McCray and Bentley, 1997). These results indicate that this defensin, in common 
with many antimicrobial peptides, has a role in maintaining the innate immunity of the 
epithelia from which they are produced. In addition there is a putative connection between 
a lack of HBD-1 production in some malignancies. It has been proposed, following a study
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on the lack of HBD-1 production in selected carcinoma epithelial cell lines, that lack of 
control of the microflora and subsequent establishment of a damaging infection may be 
responsible for conversion to malignancy (Abiko et al., 1999). This is the hypothesis 
linking Helicobacter pylori infection to intestinal cancer and hence warrants further 
investigation particularly in oral carcinoma. Finally the production of HBD-1 in mammary 
gland epithelia supports the hypothesis that this peptide may also be essential in neonatal 
immunity via colostrum (Tunzi et al., 2000).
2.1,63 Ge n e t ic  INFORMATION
Production of cDNA allowed cloning and isolation of the HBD-1 gene on human 
chromosome 8, band p23 (Figure 3). This locus is 150bp away from the a-defensin human 
neutrophil genes indicating common phylogénie ancestry between these defensins, despite 
their structural and sequence differences.
2.1.7 H u m a n  p D efen sin -2
HBD-2 (Figure 4) was first isolated in 1997 following investigation into the infrequency of 
cutaneous infections in psoriatics (Harder et al., 1997). On dissolution of psoriatic scales, 
this peptide was isolated and purified and shown to have sequence similarity to bovine 
LAP and TAP. In common with its homologues, HBD-2 is produced by lung, Iddney, 
stomach and small intestine at a basal level, as shown by both Northern blotting and RT- 
PCR (Bals et al., 1998).
2.1.7.1 S it e s  o f  p r o d u c t io n
HBD-2 mRNA and peptide production has been detected in many epithelial cells including 
lung gland and pulmonary epithelia (Becker et al., 2000). Basal expression of HBD-2 is 
found primarily in skin, lung, trachea, and salivary gland epithelia (Singh et al., 1998; 
Weinberg et al., 1998).
2.1.7.2 Ge n e t ic  in f o r m a  t io n
Isolation of the HBD-2 gene reveals its location on chromosome 8, region 8p21. HBD-1 
and HBD-2 share the same 1.5MB region; hence, this area is thought to be responsible for 
the coding of human p-defensins. Drawing comparisons from the work accumulated on 
bovine and porcine p-defensin expression, HBD-2 was thought to be induced in a similar
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way by inflammatory stimuli. Several lines of experimental data support this theory:
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Figure 3: Diagram of chromatin fiber FISH mapping of human defensin genes (Liu et 
al., 1998).
In  vivo models. HBD-2 expression has been shown in situ in wounded skin (Ali, 2000). In 
addition, lung epithelia expression is increased as measured in bronchioalveolar lavage 
fluid (BAL) in response to pneumonia (Hiratsuka et al., 1999).
In  vitro models. In addition to TAP and LAP experimental models, human tracheal 
epithelial cells are shown to up-regulate HBD-2 expression in response to TNFa, IL-1 p 
and LPS (Becker et al., 2000).
NFkB consensus sequence. Sequence data from the TAP and LAP defensins show an IL- 
6-responsive element upstream of the 5 ’flanking region. This sequence is not evident in 
HBD-2, and in vitro experimental data show that the gene is not induced by the exogenous 
addition of IL-6. There are however 4 NFKB-binding sites associated with the gene, one 
approximately 208 base pairs upstream of the TATA box region, indicating inflammatory 
stimuli as promoters. (Diamond et al., 1991).
Toll-like receptors (TLRs). Having obseived the stimulatory capacity of IL-ip, it was
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assumed that the TLR, IL -lR l, was involved in transduction of the signal for HBD-2 
activation. Binding of the TLRs in association with receptor-associated molecules, thought 
to be CD 14 in humans, results in receptor-associated kinase recruitment and 
phosphorylation of the kappa kinase subunits. This in turn results in proteolytic destruction 
of the Ik p a  subunit, NFkB inhibitor, which then allows NFkB to advance to the nuclei and 
bind to the NFkB consensus sequences. Recent experimentation on this theory supports the 
association of CD 14 and TLRs, or as they are also known, pathogen pattern recognition 
receptors (PPRRs), in the activation of NFkB. By producing a monoclonal antibody for 
CD 14, in vitro upregulation of HBD-2 transcription was blocked in an experimental 
bronchial model (Becker et al., 2000). Although limited evidence exists for this PPRRs 
selective interaction in humans, in Drosophila it has been shown that drosomycin 
expression is selectively expressed in response to fungal challenge, but not gram-negative 
bacteria. This suggests a discriminatory response to pathogens by inducible-specific 
peptides, and hence a selectivity by the Toll receptors in induction of these genes (Lemaitre 
et al., 1997).
2 .1 .7.3 R o l e  i n  d is e a s e
The production of defensins and antimicrobial peptides in the mucosa of animals is thought 
to prevent the establishment of infection by controlling commensal colonisation and 
preventing infection by exogenous microorganisms. To test this hypothesis it had to be 
established whether there was any change in expression of defensins at sites of infection. 
Alternatively any loss in activity or expression of antimicrobial peptides might also result 
in faster or more aggressive disease progression.
2 .1 .7 .4  Up r e g u l a t io n  IN INFECTION
The upregulation in transduction of the p-defensins in infection has been demonstrated in 
the bovine p defensins for some time (Schonwetter et al., 1995). Isolation of LAP from 
bovine tongue epithelia allowed the measurement of p-defensin expression from the tongue 
epithelia in cases of chronic infection, indicating the dramatic increase in p defensin 
expression in the infected tissue. In humans. Harder et al (1997) were able to quantitate the 
increase in expression of HBD-2 in psoriatic skin and demonstrated the inducibility of this 
peptide in response to the inflammatory stimuli, LPS and TNF-a. HBD-2 upregulation was
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also detected in vivo in patients suffering from bacterial pneumonia (Ashitani et al., 1998).
2 .1 .7 .5  I n a c t iv a t io n  OF PEPTIDES
One of the most interesting pathological consequences of defensin inactivation occurs in 
cystic fibrosis where the establishment of chronic pulmonary infections occurs in patients. 
Mutational defects in the gene transcribing the cystic fibrosis transmembrane conductance 
regulator results in a reduction in the effectiveness and distribution of this channel on the 
pulmonary epithelia. The consequence of this abnormality is an alteration in the ionic 
composition of the surface airway fluid. The exact measurement of the ionic composition 
of airway surface liquid has been fraught with difficulty and is greatly disputed; however, 
there is a general consensus that the concentration of Cl" is higher in the airway surface 
liquid of cystic fibrosis patients (Knowles et ah, 1997; Olson et al., 1996). Both HBD-1 
and HBD-2 have been shown to be ‘salt-sensitive’ at the physiological levels proposed in 
cystic fibrosis and in particular one of the main respiratory pathogens of cystic fibrosis 
patients, B. burgdorferi, is resistant to the action of defensin at these higher salt 
concentrations. In another inactivation model, the creation of a drosomycin knockout in 
Drosophila resulted in a fatal pulmonary infection indicating how important this peptide is 
in respiratory defence of Drosophila (Meister et al., 1997).
2 .1 .8  F U N C T IO N  A N D  STR U C TU R E OF A N T IM IC R O B IA L  PEPTIDES
2 .1 .8 .1  F u n c t io n
Defensins exert various effects on mammalian, bacterial and fungal cells. The main 
putative consequence of defensin expression is its selective permeabilisation of bacterial 
and fungal cell membranes, however several other effects that are thought to assist in 
immunity and healing have been investigated.
Chemoattractant: Several experiments have demonstrated the chemoattractant capabilities 
of defensins. Cryptidin, from Paneth cells, is a chemoattractant for chemokine receptor six 
(CCR6)-expressing cells (Wilson et ah, 1999). These cells include memory T-cells, LCs 
and CD34+ cells, and these are shown to migrate in situ in response to a cryptidin gradient. 
This indicates a role for defensin in linking innate and adaptive immune responses when in 
states of infection; the chemoattractive concentration gradient of defensin produced at the 
site of infection attracts a cellular response. In this respect the innate immune response
49
(defensin) links the adaptive (T-celi and LC) immune responses together; in addition 
defensin is also shown to bind the Cl component of complement (Panyutich et al., 1994).
C ./ C /
Figure 4: Stereo drawing of the dimérisation of HBD-2 (Hoover et al., 2000).
Anti-tumour: When a magainin-expressing construct was transfected into mouse bladder 
carcinoma cells, tumourogenicity, as measured by tumour size, was greatly reduced 
(Winder et al., 1998). In addition, Cecropins have been shown to lyse both leukaemia and 
lymphoma cell lines (Moore et al., 1994). Although both of these experiments are 
examples of insect defensin acting against animal tumourogenic cell lines, some evidence 
exists of an immunosurveillance role in human cancer for defensins. HNP-1 is expressed in 
the duct cells of the submandibular glands of oral cancer patients, detected by 
immunohistochemistry (Mizukawa et al., 2000). In addition, there is a significant increase 
in the concentration of HNP-1 isolated from the saliva of oral squamous cell carcinoma 
patients, as measured by HPLC (Mizukawa et al., 1998) and a decline in HBD-2 expression 
(Abiko et al., 1999). This rise in squamous cell carcinoma HNP-1 expression coupled with 
a decline in HBD-2 expression may be responsible for some of the pathology associated 
with the tumours or it may be a by-product of the cellular disruption associated with the 
metabolism of the tumour cells.
Mitogenic: There is sparse evidence for the mitogenic properties of defensin, but DNA 
synthesis assays show the stimulatory effects of Human neutrophil defensins 1-3 on 
epithelial cell lines and fibroblasts (Murphy et al., 1993). This supports the evidence that
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purified mouse defensin promotes the healing of aseptic wounds by exerting a ‘growth 
factor-like’ effect (Gallo et al., 1994).
Corticostatic: The N-terminal regions of some defensin peptides inhibit rat adrenocortin. 
The adrenocorticotropic hormone ACTH releases cortisol, an immunosuppressive 
molecule on binding of this ligand to its adrenocortin receptor. Defensins are thought to 
compete with ACTH, so preventing the release of this immunoinhibitory peptide (Zhu et 
ah, 1988). The role therefore of antimicrobial peptides in the innate immune response is 
not solely confined to protective mucosal and neutrophil immunity.
Supplementation o f  immune response: Defensins exert a greater-than-accumulative effect 
with lysozyme in the killing of Gram- negative bacteria. This positive co-operation is 
greater than the sum of the bacteriolytic effect of each individually (Hancock and Scott,
2000). In addition, HNPs enhance both antigen-specific IgG responses and T-cell 
proliferation in mouse models, as compared to antigen alone (Lillard et ah, 1999).
DNA control: In contrast to the mitogenic effects as previously discussed, defensins have 
been shown to act in an immunosuppressive manner. In LPS-induced sepsis, cytokine 
release from macrophages occurs and cationic peptides inhibit this reaction by suppressing 
both TNF-a and IL-6 production. Hence these peptides act in a negative feedback loop, 
controlling and limiting the damage of infection as well as attempting to directly control 
the growth of infectious agents (Scott et ah, 1999). In support of this theory it has been 
recently demonstrated that the cathelicidin-like peptide PR-39 directly interacts with the 
NFkB inhibitor iKBa, directly preventing NFkB activation (Gao et ah, 2000). As 
mentioned previously, NFkB is instrumental in the transcription of many inflammatory 
agents, and by binding to this inhibitor this peptide prevents transcription of the NFkB- 
sensitive genes (Tsutsumi-lshii et ah, 2000). Defensins have also been shown to interact 
with DNA backbone, inducing single strand breaks (Gera and Lichtenstein, 1991).
2.1.8.2 M e m b r a n e  p e r m e a b il is a t io n
The most widely examined action of defensins involves their ability to initiate membrane 
permeabilisation of microorganisms. Much of the work investigating membrane- 
antimicrobial peptide interactions has utilised the lipid bilayer model, and this has allowed
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the elucidation of several theories on the function and action of these peptides on bacterial 
and fungal membranes (Vaz Gomes et ah, 1993). Some of the first experiments carried out 
showed the need for a charged target membrane; hence a biologically active microorganism 
is required. It is thought that this charged membrane and electromotive force allows initial 
electrostatic interactions that constitute the first binding stage of the peptide to the target 
membrane. In this way alone defensins would specifically target negatively charged 
pathogen membranes; as most eukaryotic cells have a positive membrane thus the defensin 
cannot select ‘self’ for destruction. By producing synthetic chiral peptides and assaying 
their antimicrobial activity, it was been shown that there is no difference between the D 
and L enantomers (of magainin) indicating a non-stereospecific binding; therefore the 
primary electrostatic interactions may account for a large proportion of the binding process. 
Defensins act against the inner membrane of Gram-negative bacteria since disruption of the 
outer membrane with mannitol produces no change in their bacteriolytic capacity (Lehrer et 
ah, 1989).
In lipid bilayers, HNP-1 produces voltage-dependent, ion-permeable channels and this 
interaction is dependent on the charge of the peptide (Kagan et ah, 1990). As the human 
defensins also contain a 10 amino acid, anti-parallel (3 sheet that is homologous to the 
porins, it is thought that, like the porins, they dimerise in the target membrane forming a 
pore. Recently groups from Texas (Huang, 2000) and Koto (K. Matsuzaki 1998) have 
proposed a ‘Barrel stave’ model (Figure 5), which combines many of the known aspects of 
antimicrobial peptide interaction with membranes. The Barrel stave model suggests an 
initial binding to the membrane, due to cationic (antimicrobial peptide) and anionic 
(bacterial membrane) interactions. The a-helix of the peptide is then thought to lie parallel 
to the target membrane, with heterodimérisation and insertion into the membrane 
occurring. At least 5 a-helices and several lipids bond to form a pore and the resultant ion 
transport produces fatal cell permeabilisation and cell death. Ion-permeable pores are 
produced by the a-defensins and in particular HNP-3, which forms a 20Â membrane- 
spanning pore when 12 monomers aggregate. However another model termed ‘the carpet 
model’ also exists. In this model the peptides are thought to interact with the anionic lipid 
headgroups of the target membrane, thus neutralising a distinct area and disrupting overall 
ion transport. Recent elucidation of the quaternary structure of HBD-2 suggests that this is 
the mechanism of action for this peptide (Hoover et ah, 2000).
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BFigure 5: Barrel stave model figures for the formation of magainin pores (Ludtke et 
al., 1996).
A/ Monomers hydrophobic and hydrophilic regions represented by the red and blue region 
of the cylinder respectively.
8 / Magainin monomers embedded in the lipid headgroup region (Huang, 2000).
2 .1 .8 .3  S t r u c t u r e
Analysis of the cDNA sequences of the various isoforms of HBD-1 isolated from urine 
indicates that defensins are translated as propeptides and subsequently enzymatically 
activated (Hiratsuka et al., 2000). Analysis of the 16 isoforms of HBD-1 shows the same 
‘active’ C-terminal with differing N-terminal sequences (Figure 6).
These peptides are thought to be produced as a 68 amino acid prepropeptide which on loss 
of its signal peptide is a 47 amino acid pro-HBD-1 peptide. This peptide is then 
proteolytically cleaved into the mature 36 amino acid peptide. Further evidence exists for 
this post-translational cleavage mechanism of activation for antimicrobial peptides. The 
Paneth cell peptide cryptidin is co-localised in crypt cells with a matrix metalloproteinase 
(MMP), matrilysin. Procryptidin, the peptide isolated from the crypt cells, is not active 
until proteolytically cleaved by matrilysin (Wilson et al., 1999). In addition, transgenic 
mice that are MMP-deficient are not protected from intestinal infection by their Paneth cell 
peptides as they do not become activated in the absence of the MMPs. Tertiary structural 
analysis has been carried out on many of the animal defensins; however, the cx-and |3- 
defensins differ only in their location of disulphide bonding (Figure 7).
Figure 6: Diagrammatic representation of the inactive pre-propeptide that is post-
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S i g n a l  p e p t i d e  P r o p e p t i d e F e p t i d e
A n i o n i c  C a t  i o n  ic
translationally modified to active form.
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Figure 7: HNP-3 a  defensin structure and bovine p defensin-2 structure
A/B: 3D structural representation of the HNP-3 (A) and BBD-2 (B) molecules
C/D: Sequence comparison of the a-helical and p-sheet domains of the a-defensin (C) and
p-defensin (D).
Depicts p sheet structural and sequence homology 
Depicts a  helical structural and sequence homology 
Sequences and 3D peptide models obtained from the NCBI protein data bank web pages 
(http://www4.ncbi.nlm.nih.gov/PubMed), viewed using CD-3D programme.
2.1.9 A ntimicrobial peptides and skin
Two classes of peptide have been isolated from mammalian skin, all isolated in cases of
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infection and inflammation.
2 .1 .9 .1  Ca t h e l ic id in s
Two types of peptide belonging to this family have been isolated from mammalian skin.
PR-39'. This proline-rich peptide was first isolated from porcine intestine in response to 
infection. It is a basic molecule secreted as a pre-protein and post-translationally modified 
into a mature 39 amino acid (Agerberth et al., 1991). Although belonging to the 
cathelicidin family of peptides, on the basis of its pre-protein sequence, this is a novel 
molecule that is isolated from porcine wound fluid and induces proteoglycan synthesis 
including syndecan -1  and -4  (Gallo et al., 1994). It is thought that this peptide is produced 
in wounds by migrating neutrophils and as yet no localisation of production by KCs has 
been observed.
LL-37: This peptide is also termed human cationic peptide 18 (hCAP-18) and its mature 
form is a cys-free a-helical amphipathic peptide. It is produced as a pre-protein FAL-39 
which belongs to the cathelicidin family, sharing the homologous N-terminal pro-region. 
This peptide is the only member of the cathelicidin family to be expressed in humans and 
its production has been observed in granulocytes, testes, wound fluid and bone marrow 
(Frohm et al., 1996). In contrast to PR-37, LL-37 production is localised to KCs, and in 
addition it is widely expressed in psoriasis and nickel allergies. IL-8 and acute-phase 
response factor binding sites have been mapped upstream of this gene, indicating 
inflammatory control of transcription (Frohm et al., 1997).
2 .1 .9 .2  j8D e f e n s in s
Two p defensins have been identified in mammalian skin.
LAP: LAP shares substantial sequence homology with HBD-2 and is produced in bovine 
skin in response to experimental infection (Stolzenberg et al., 1997).
HBD-1 and 2: HBD-2 was initially isolated from psoriatic skin and is thought to contribute 
to the low incidence of cutaneous infection in psoriatics (Henseler and Christophers, 1995). 
The SIS is composed of a multitude of resident cellular and humoral components, and
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HBD-2 is an inducible peptide associated with maintaining the skin’s tegument. HBD-2 is 
expressed by KC monolayers in response to TNF-a, Gram-positive, Gram-negative 
bacterial cells and fungi (Harder et al., 1997). HBD-1 is constitutively produced in normal 
skin, localised to suprabasal KCs (Fulton et al., 1997). These data are consistent with 
recent findings that show constitutive production of HBD-1 in burn wounds with a lack of 
HBD-2 expression (Milner and Ortega, 1999). It is thought that the primary action of HBD- 
1 is to prevent colonisation of the sldn by commensal bacteria, accounting for its 
constitutive transcription. In contrast, HBD-2 is induced in response to infection or 
wounding, and as yet, little information surrounding its role in infection control exists.
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2 .1 .1 0  O b j e c t i v e s
The purpose of this work was threefold;
• To determine the levels of expression of HBD-2 in different skin models, ie. KC 
monolayers, LSE and BRT.
• To measure any changes in defensin expression in response to in vitro infection with M. 
furfur.
•To establish whether there are any donor differences in the HBD-2 response to the 
organism.
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2.2 M e t h o d s
2.2.1 T is s u e  p r e p a r a t i o n
2.2.1.1 L SE
Preparation o f  dermal equivalent: All tissue culture medium components were obtained 
from Life Technologies, Paisley, UK and all tissue culture plastics were obtained from 
Costar UK Ltd, The Valley Centre, High Wycombe, Bucks, UK. Type I collagen was 
extracted from rat tail tendons in 0.5M acetic acid, precipitated by the addition of an equal 
volume of 10% (w/v) NaCl, redissolved in G.25M acetic acid and extensively dialysed 
against 1/1000 acetic acid, with the final solution being adjusted to 2.5mg collagen/ml. 
Collagen gels were prepared by mixing 8  volumes of collagen solution with 1 volume of 
lOx minimal essential medium (MEM), 1 volume of 0.22M NaOH; the pH was finely
adjusted to 7.2 with NaOH. One volume of foetal calf serum (PCS) containing 7.5 x 10  ^
human adult breast skin fibroblasts^ / 1 0 ml of gel mixture was added, thoroughly mixed, 
and 4.0ml added to 35mm petri dishes. The gels were allowed to set at 37°C for 15min, 
after which 1ml of MEM supplemented with penicillin (100 units/ml), streptomycin 
(lOOug/ml), L- glutamine (2mM) and 10% PCS was added, the gels detached from the 
dishes, and incubated for approximately 10 days. Cultures were incubated at 37°C in a 
humidified atmosphere of 5%COa in air, with medium changes every 3 days. The gels at 
this stage are highly contracted, with the fibroblasts adopting a spindle-shaped morphology.
KC culture: Human juvenile foreskins, derived from donors between the ages of 2-5 yrs 
old undergoing routine circumcision, were cut into 3mm strips after removal of 
subcutaneous fat. These strips were then floated on to 0.5% (w/v) dispase (Sigma-Aldrich, 
Poole, Dorset, UK) in phosphate buffered saline (PBS) and the tissue incubated overnight 
at 4°C. The epidermis was peeled off with forceps, finely chopped with a scalpel, and 
treated with 0.25% (w/v) trypsin in PBS for 5min with pipetting to obtain a predominantly
Fibroblasts obtained from explant cultures of reduction mammoplasty skin from one 43yr 
old female Caucasian, and used between passages 4 - 9 .  Same fibroblasts used 
throughout.
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single cell suspension. The cell suspension was passed through sterile gauze, centrifuged 
(4min at 400xg) with the cell pellet resuspended in Dulbecco's MEM supplemented with 
10% PCS to give an inoculating suspension of 2 x 10  ^cells/ml. This was then added to the 
surface of contracted collagen lattices in 24-well multiwell dishes. Following incubation at 
37°C for 5/6 days as submerged cultures in 5% CO2 , the gels were then raised to the 
air/liquid interface and incubated for at least a further 6  days, after which a substantial 
stratified epidermis was obtained with a well developed stratum corneum. 15 \xl of 
microbial cell suspension was then added to the dorsal surface of the skin model.
2 .2 .1 .2  E x c is e d  Tis s u e
Breast reduction tissue: BRT was obtained from consenting female donors undergoing 
breast reduction operations at Canniesburn Hospital, Bearsden, Glasgow. Following 
excision of tissue, within 24hr of surgery, subcutaneous fat was removed aseptically with a 
scalpel. The tissue was then cut into Icm^ pieces, mounted onto sintered glass discs in a 
35mm dish with medium added to just below the epidermal surface (CÜ2-independent 
MEM supplemented with 10% PCS). The specimens were then incubated at 37°C in a 
humid atmosphere until inoculation, no more than four hours after preparation. 15 fxl of test 
sample or organism was then added to the surface, incubated at 37^0 in a humid 
atmosphere and epidermal RNA isolated.
2 .2 .2  C e l l  c u l t u r e
2 .2 .2 .1  KC M o n o l a y e r s
Foreskin KCs obtained from juvenile circumcisions, as detailed above, were seeded into 
24-well multiwell dishes at approximately 2 x 10  ^ cells/well. Cells were then incubated in 
MEM supplemented with 10% PCS, at 37°C, 5% CO2 for 10-14 days (depending on the 
viability of the initial cell suspension) until they formed a standard monolayer. Monolayers 
were incubated with serum-free MEM for 48hr and washed with 1ml PBS prior to 
inoculation with test organism/ extract.
2 .2 .3  O r g a n i s m  P r e p a r a t i o n
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2 .2 3 .1  M . FURFUR
A  single strain of M. furfur was isolated from PV-positive microscopic skin scrapings 
received at the Regional Mycology Reference laboratory, Western Infirmary, Glasgow. 
Skin scrapings were inoculated into Dixon’s medium^ and incubated at 37°C for 72hr. M. 
furfur ‘Hook’ isolate alone was used throughout and maintained as a stock lawn culture.
Viable organism: A loopful of M. furfur from a pure lawn culture was emulsified in 5ml 
PBS. lOmg of sterile glass beads were then added to the universal and this was shaken at 
230rpm for 2hr. The resultant supernatant was removed, centrifuged (SOOOxg, 15min) and 
the cell pellet washed twice in PBS. The pellet was resuspended in MEM (KC monolayer 
experiments) or PBS (LSE, BRT experiments) and in a cell suspension of 1 x 10"^  cells/ml 
was obtained after counting cells in a haemocytometer.
Killed whole cells: A  loopful of M. furfur from a pure lawn culture was emulsified in 5ml 
PBS, autoclaved (120°C, 20min) and centrifuged (5000xg, 15min). The pellet was then 
washed twice in PBS and the killed whole cells resuspended in either MEM (KC 
inoculation) or PBS (LSE or BRT inoculation) to give a cell suspension of 1 x 10"^  cells/ml.
2 .2 .3 .2  C . A l b ic a n s
A single strain of C. albicans was isolated from oral epithelial swabs received at the 
Regional Mycology Reference Laboratory, Western Infirmary. Swabs were spread over 
GPC^ agar and grown at 37°C for 24hr. This C. albicans isolate alone was used throughout 
and maintained as a stock lawn culture
Viable organism: A  loopful of C. albicans from a stock culture on GPC agar was 
emulsified in 5ml PBS. The resultant cell suspension was centrifuged at SOOOxg for 15min, 
the pellet washed twice in PBS and then resuspended in MEM (KC monolayer 
experiments) or PBS (LSE, BRT experiments) to give a cell suspension of 1 x 10"^  cells/ml.
 ^Dixons agar: 26g malt extract, 6g peptone, lOg agar, 20g ox bile, 10ml tween (40), 2ml glycerol, 
2ml oleic acid, 10ml chloramphenicol, 10ml actidione in 976ml H2O autoclaved.
 ^ GPC: 20g agar, 40g glucose, lOg peptone in 990ml of distilled water. Following autocalving 
10ml chloramphenicol added and agar poured and set.
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2 .2 .3 .3  C e l l  W a l l  P r e p a r a t io n
M. furfur and C. albicans cell walls were prepared by staff in the Infection and Immunity 
Division of the University of Glasgow, Scotland. In brief, 500ml of Dixon’s broth was 
inoculated with a loopful of organism taken from a stock culture (GPC agar for C. 
albicans; Dixon’s agar for M. furfur). Following incubation at 3 T C  for 48hr the culture 
was centrifuged (SOOOxg, Smin) and the cell pellet washed three times in PBS (20ml). The 
final pellet was resuspended in PBS (10%, w/v) and added to 30 ml of Ballotini beads in a 
Braun bottle. Following Ihr incubation on ice, cells were disrupted in a Braun 
homogeniser. Following microscopic confirmation of cell breakage, the suspension was 
filtered and centrifuged (SOOxg, Smin) to deposit whole cells, and further centrifuged 
(ISOOOxg, 20min) to isolate cell wall fragments. The cell wall pellet was then washed six 
times in PBS and three times in distilled H2O, and was finally shell-frozen in a round- 
bottomed flask prior to freeze drying.
2 .2 .4  M o l e c u l a r  m e t h o d s
2 .2 .4 .1 RN A PREPARATION
LSE: By shearing the upper epidermal layer from the underlying collagen matrix, a full 
epidermis was isolated from the LSE. Homogenisation of this sheet was achieved by fine 
chopping with a scalpel blade and the chopped tissue was added to a DEPG^-treated 
Eppendorf (500p,l DEPC in 50ml H2O microwaved with tubes for Ihr). RNA was isolated 
by using a Qiagen ‘RNAeasy’ preparation kit (Qiagen, UK). In brief, 600p.l of RLT lysis 
buffer (a highly denaturing guanidinium isothiocyanate-containing buffer with 10% |3- 
mercaptoethanol) was added to the tissue and incubated at room temperature for lOmin. 
Tissue was then homogenised by repeated passage of the buffer/tissue mixture through a 
1000p,l pipette tip (Gilson) until a clear thick suspension was obtained. The sample was 
further homogenised by adding the 600|il of homogenate to a QIAshredder column and 
centrifuged for 2min at 5000xg. One volume (600[xl) of 100% ethanol was added to the 
sample which was then added to the RNAeasy column and centrifuged for 15s at 5000xg.
DEPC (Diethylpyrocarbonate)
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The silica membrane in the column was washed once with buffer RPI (to remove debris) 
and twice with buffer RPE (to ethanol-precipitate the RNA). RNA was eluted by adding 
50p,l of DEPC-treated to the membrane, incubating for Imin at room temperature and 
centrifuging the column for 2min ISOOOxg.
BRT\ Epidermal RNA was isolated by cutting the tissue into 5 x 2mm strips. These strips 
were then floated on to 0.4% (w/v) dispase in PBS and the tissue incubated overnight at 
4°C. The epidermis was peeled off with forceps, finely chopped with a scalpel, and treated 
with 0.25% (w/v) trypsin in PBS for 5min with pipetting to obtain a predominantly single 
cell suspension. The cell suspension was passed through sterile gauze, centrifuged (4min at 
400xg) and the cell pellet was lysed in 600p,l RLT buffer. Thereafter the isolation of BRT 
was identical to LSE RNA retrieval.
KCs: Monolayers were washed in PBS (2ml) and thereafter 600pil of RLT buffer was 
added directly to each well of the multiwell dish. Cells were homogenised by repeated 
pipetting with a lOOOp.1 Gilson until a clear lysate was achieved and this was added directly 
to the RNAeasy spin column after the addition of 1 volume of ethanol.
RNA Integrity: lOp.1 of RNA was added to 5p,l of loading buffer and visualised on a 1% 
IxMOPS^, RNAse-free mini gel run at 60 volts for Ihr.
RN A Quantity. RNA was quantified by adding 5-lOpl of purified RNA to RNAse-free 
H2O in a 0.5^im quartz cuvette. Purity of the sample was determined by the A260/A280 ratio. 
In brief the wavelength was blanked at 260nm of the RNAse-free H2O. An A260 value of 1 
for H2O plus RNA is equal to 44.19p,g/ml of pure RNA. Hence;
A260 value X dilution factor x 44.19 = RNA pig/ml in sample.
RN A purity: The purity of the RNA sample was determined both by PCR (PGR of RNA 
that was negative was considered to have no DNA contamination) and the A260/A280 ratio
DEPC-treated water: 1000ml H2O with 1ml DEPC, microwaved for Ihr.
lOx MOPS: pH 7.0, 4.1g Na Acetate (0.05M), 3.7g Na EDTA (O.OIM), 41.8g MOPS (0.2M) in 
1ml DEPC in 1000ml H2O.
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of the sample. The ratio was determined by adding 5-10 p,l of RNA to 1ml DEPC-treated 
H2 O and the absorbance at 260 and 280nm was measured. The purity was assessed by the 
calculation; A260 (RNA) - A260 (Blank)/ A280 (RNA).
The value given was expressed as a ratio and a value of 1.5 ± 0.5 was assumed to be pure 
and free of DNA.
2.2A.2 R T P C R /P C R
Primers were assembled by Sigma-Genosys (London Road, Pampisford, Cambridgeshire, 
UK) and were constructed to correspond to a 300 bp region specific to HBD-2 RNA, as 
determined by the published sequence (NCBI, Entrez nucleotide query accession number 
Z71389).
Normal defensin primers
Anti-sense AS HBD-2 - GGAGCCCTTTCTGAATCGCA
Sense S HBD-2 - GCCATCAGCCATGAGGGT
MIMIC primers
S HBD-2 GCCATCAGCCATGAGGGT
Superprimer-
CCAGCCATCAGCCATTGAGGT(TTGAAACCAGCTGTGTGAAA)*
*(Junk region from MAGE2)
Cellular RNA was isolated from primary culture KC monolayers, BRT and LSE following 
the Qiagen RNAeasy isolation protocol as detailed above. 2pil of template RNA was 
subjected to RT-PCR using a Gibco BRL SS-one step reaction (Life Technologies, 
Paisley). In brief, 25 [xl of 2x reaction buffer, Ipil of a lOpM primer mixture (HBD-23 and 
HBD-25), Ijrl RT-Taq polymerase, 2pil template RNA and 21 pi RNAse-free H2O was 
added together per reaction. cDNA was initially synthesised by incubating this reaction at 
50°C for 30min in a Perkin-Elmer thermal cycler. cDNA was then denatured at 94°C for 
2min and amplification was achieved by 35 cycles (determined the optimum number by 
analysis of reaction limits) of;
Denature: 94°C, 15s
Anneal: 55-60°C, 30s
Extension: 70°C, Imin.
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Control PCR was carried out using a Qiagen PCR kit. In brief, 2pl of template RNA was 
added to lOpl of 10 x buffer, 20pl of 5 x Q buffer, 2pl of lOpM dNTP mixture, Ip l of 
10pm HBD-23 primer, and Ip l of lOpM HBD-25 primer, 63.5pl H2O and 0.5pi of 
template RNA. The amplification protocol was the same as used for RT-PCR as detailed 
above.
lOpl of amplified samples were added to 5 pi of bromophenol blue loading buffer and run 
on a 1% agarose gel at 70 volts for Ihr. Samples were subsequently viewed using a UV 
transilluminator and checked against 100 bp markers (Life Technologies). Using the 
primers specific to defensin (HBD-23/25), revealed the need to quantitate expression as 
constitutive levels are expressed, hence a ‘MIMIC’ competitor sequence had to be 
constructed to add to the RT-PCR reaction to act as an internal comparison.
2 .2 .4 3  MIMIC PRODUCTION
For the production of a MIMIC fragment, RNA from defensin-positive samples was 
amplified using the standard defensin primer (HBD25) and a ‘superprimer’. This primer 
was composed of the HBD-2-specific sequence, shown above, with an additional junk 
sequence derived from MAGE 6 melanoma antigen sequence (NCBI, Entrez nucleotide 
query accession number D32076). Hence the HBD-2 defensin primers 23 and 25 amplify a 
native region in the defensin-specific RNA while the superprimer and normal defensin 
primer amplify and produce a larger fragment from defensin-positive RNA. Further 
amplification of this competitor product revealed the necessity for cloning to obtain a pure 
sample of this fragment and to allow for the production of an RNA competitor.
2 .2 .4 .4  L i g a t i o n .
The excised MIMIC-specific band from an agarose gel was purified using the QIAquick 
spin gel extraction kit (Qiagen), resulting in a pure solution of MIMIC PCR product. This 
PCR product was ethanol-precipitated by adding 2 volumes of ice-cold ethanol (60pl of 
100% research grade ethanol) to the purified PCR product and incubating at 70”C for 
60min. The sample was then centrifuged for 15min at 5000xg and the supernatant 
removed. The pellet was washed once with 1ml 70% ethanol and re-spun for 5min at 
5000xg. The pellet was then incubated at room temperature until completely dry when it 
was resuspended in 1/5**^  the volume of the original PCR solution (6jxl). Thereafter a PCR
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Script Amp cloning kit (Stratagene, Gebouw California, Hogehilweg 15, Amsterdam, The 
Netherlands) was used to polish and ligate the PCR product into the plasmid vector (see 
Figure 8). Promoter sequence and restriction enzyme site information of cloning vector in 
Appendix 1.
Rccirculariscd 
pC’R-Scripf vector
T4 D N A  lig ase
4-
+
'l'4 D N A  l .igasf
T  ra n s lorm etl
C'ircular D N A
Figure 8: PCR-Script Amp phagemid cloning vector.
2 .2 .4 .5  P r é p a r a  t io n  o f  c o m p e t e n t  E . c o l i
5ml of LB’ broth was inoculated with a loop of E. coli XLIO cells (Life technologies. 
Paisley, UK) and incubated in a shaking incubator overnight at 3 T C  (20()rpm). 100ml of 
LB broth was then inoculated with 1ml of this overnight culture and incubated with 
vigorous shaking (230rpm) at 37°C until the cell density equalled 5x10^ cells/ml (OD=0.5 
measured at 210nm). Following centrifugation of this culture (4000xg at 4"C in a Sorval 
centrifuge) the cell pellet was resuspended in half the original volume, 50ml, of ice-cold 
50mM CaClz/lOmM Tris/HCl (pH 8.0) and incubated for 15min at 4”C. Cells were then 
centrifuged (4000xg for 5min) and resuspended in 1/15‘^  the original volume of 
CaC^Tris/HCl (pH 8.0) and stored on ice until use (12-24hr).
’ LB broth: lO g N aC l, lO g tryptonc, 5 g  yeast extract in IL  d eion ised  H 2O w ith  pH 7.0
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2 .2 .4 .6  Tr a n s f o r m a t io n
The plasmid-containing insert was added to the competent E.coli (40ng of DNA per 
aliquot), and heat-shocked for 2min at 42°C. After adding 1ml of LB broth to each tube, 
this suspension was incubated at 37°C for 60min and inoculated onto Xgal (5-bromo-4- 
chloro-3-indolyl-p-D-galactopyranoside), IPTG (isopropyl-1 -thio-|3-D-galactopyranoside) 
and Ampicillin-treated LB^ agar plates and incubated overnight at 37”C.
Following selection of the colonies positive for insert (white), clones were picked off and 
spiked into 3ml LB/Amp broth (1/00 dilution of IM  Ampicillin) and incubated in a 
shaking incubator at 37”C (200rpm) for 24hr. The plasmid was extracted using the mini 
prep protocol (Qiagen) and ethanol precipitation of purified plasmid was carried out, as 
detailed above. Ethanol precipitation of the DNA achieved a five-fold concentration in the 
concentration of the plasmid DNA which was quantified using the A260 value.
2 .2 .4 .7  R e s t r ic t io n  e n z y m e  d ig e s t
A  MAPSORT analysis of the defensin sequence in UNIX established that the Not-1 and 
Eco-Rl enzymes cut the plasmid adjacent to the insert (on opposite sides), but not the 
defensin-specific sequence. Therefore 0.2pl of Not-1, 0.2pl of EcoRl, 2gl of 10 x buffer 
(all obtained from Gibco, Life Technologies, Paisley), 7.6gl of H2O and lOpl of purified 
plasmid (containing 2pg of DNA) was incubated for Ihr at 37*^ C. Ligation products were 
run on a 1% agarose gel, (70 volts for Ihr) to check size of insert and efficiency of ligation.
2 .2 .4 .S  Tr a n s c r ip t io n
Following the completion of ligation, 2pl of the linearised plasmid was added to 40pi T7 
polymerase, 20pl of 2.5pM rNTPs^ lOpl of lOOpM DTT, 8pi H2O and 20pl of 5 x
^LB agar: lOg NaCl, lOg tryptone, 5g yeast extract, 20 g agar in IL deionised H2O with pH7.0 
50pl of X-gal (0.25g of IM X-gal dissolved in dimethyl farmamide) + 100pi of IM IPTG was 
added per lOOpg of medium.
 ^Ribonucleotide triphosphates, ATP (adenine), GTP (guanine), CTP (cytosine) and UTP (uracil). 
10 pi of each rNTP (lOOmM) in 360 pi of RNAse free H2O gives a stock rNTP solution with 
2.5pM of each.
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transcription buffer (all obtained from Gibco Life Technologies, Paisley, Scotland, UK). 
This mixture was then incubated at 3 T C  for 90min. Following transcription, any remaining 
linear and circularised DNA was removed from the solution by the addition of DNAse, and 
DNA content was checked by PCR. The remaining solution was now composed of 
MIMIC-specific RNA, and could be used in a dilution series to determine the accuracy of 
the RT-PCR reaction both with and without the cellular RNA competitor.
2.2.4.9 C o m p e t i t i v e  RT-PCR
RT-PCR for HBD-2 /MIMIC competition was optimised by analysing the RT-PCR (SS 
one-step reaction, as detailed previously) at various time points, to determine the number of 
amplification cycles permitted before saturation of both products was achieved. The 
reaction details are as follows:
Reverse transcription: 30min 50°C, 94^C for 2min (1 cycle) and 32 cycles of 
Denature: 94°C, 15s
Anneal: 55-60°C, 30s
Extension: 70°C, Imin
2.2.4.10 G e l  ELECTROPHORESIS.
lOpl of each reaction was loaded onto 4% agarose (lxTBE^° buffer withlpg/ml ethidium 
bromide). Gels were run at 40 volts overnight (36hr) allowing separation and analysis of 
the defensin-specific and MIMIC-specific bands.
2.2.4.11 QUANTISCAN.
Densinometric analysis of the agarose gels was undertaken using Quantiscan software from 
Biosoft. In brief, Polaroid photographs of gels were scanned (at 400dpi’s) using a flatbed 
scanner. The image was saved as a TIF file and imported into Quantiscan where 
densinometric analysis of the bands was carried out, each sample being analysed three 
times. These values were then used to assess a ratio of amplification of MIMIC (known) to 
cellular (unknown) in the RT-PCR reaction and this was then expressed in terms of 
molecules/pg of RNA added to the reaction. PCR amplification was also performed
5x TBE buffer: 137g tris base, 68.75g boric acid, 50ml 0.5M EDTA (pH7.5) in 2.5L distilled 
H2O.
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directly on all RNA samples without the inclusion of the reverse transcriptase step, to 
confirm that the observed gel product was derived from RNA.
2.2.5 S t a t i s t i c a l  a n a l y s i s /  s a m p le  d e t a i l s
For each experiment 1 donor foreskin was used to make a batch of KC monolayers or 
LSEs. One batch of BRT was also used for each experiment and a range of donors were 
used as detailed in table 8-16^h The RNA from 3 skin models (either KC monolayers, LSE 
or BRT) was isolated at each timepoint, for each test condition. The value expressed in 
each table entry and graph is the mean measurement of these three samples^^. The between 
group differences (ie between control and organism treated samples) were measured using 
the students T-test, following application on the F-test to determine suitability of the 
standard deviations. The found value of T was expressed as a percentage probability (P) 
according to the appropriate tabulated values. A value of P<0.01 was determined to be 
significant and P<0.001 highly significant unless otherwise stated.
KC donors 1-17 did not correspond to the same KCs donors used to make LSE batch 1-17. 
In the Figures the mean is expressed +/- the SEM.
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2.3 R e s u l t s
2.3.1 V e r i f i c a t i o n  o f  MIMIC s p e c i f i c i t y
Initially a PCR competitor was created using the HBD-superprimer, with the same primer 
binding sites as HBD-2. However, as this would not give a directly quantitative value in 
RT-PCR, this DNA MIMIC (Figure 9) was inserted into a plasmid (Figure 10). Following 
reverse transcription and MAPSORT identification of those enzymes which would digest 
plasmid and not insert, a restriction enzyme digest of the plasmid showed that the plasmid 
RNA insert corresponds in expected size to the RT-PCR MIMIC product (Figure 11).
2 0 0 b p -
Lane 1 Lane 2 Lane 3 Lane 4
Figure 9: PCR compared to RT-PCR of MIMIC RNA.
Lane 1: lOObp marker
Lane 2: RT-PCR of RNA using HBD-25 and HBD-23 primers 
Lane 3: RT-PCR of RNA using superprimer and HBD-25 primer 
Lane 4: PCR of Lane 3 DNA amplified with HBD-23 and HBD-25
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Plasmid DNA MIMIC insert was converted to RNA by Not 1 digestion of the plasmid and 
T7 stimulated reverse transcription. Plasmid RNA was then isolated and DNAse treated. 
Purity of the RNA insert was determined by PCR of the RNA MIMIC produced, and a 
negative PCR reaction with the HBD-2 primers, which worked for RT-PCR, proved there 
was no DNA contamination.
Lane 1 Lane 2 Lane3 Lane4
Figure 10: Purified Plasmids containing MIMIC DNA insert.
Lane 1: lOObp ladder 
Lane 2: Recircularised plasmid 1 
Lane 2: Recircularised plasmid 2 
Lane 4; 1 Kbp marker
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3()()bp
-2.5Kb
Lane 1 Lane 2 Lane 3 Lane 4 Lane 5
Figure 11: HBD-2 and MIMIC DNA products; comparison of weights.
Lane 1: lOOBp Ladder.
Lane 2: Not 1-digested plasmid reverse transcribed 
Lane 3: Not 1-digested plasmid.
Lane 4: Undigested plasmid
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The sequence of MIMIC, HBD-2 competitor was determined via T7 promoted automated 
sequencing of the MIMIC PCR product in the plasmid vector (Appendix 1). To check that 
the sequence of the competitor was as expected, the plasmid was linearised with Not 1 (on 
the opposite side of the insert) and sequenced with T7 polymerase. The ASHBD-2 and 
SHBD-2 primer binding sites remained intact and aside from the ‘junk’ inserted sequence, 
the MIMIC sequence (sequence 1) was identical to the HBD-2 published sequence 
(sequence 2) which the ASHBD-2 and SHBD-2 oligonucleotides amplify (Accession no 
AF071216).
The RNA MIMIC was quantified using the Az^o/Aiso- The initial stock and a 1/10 dilution 
of the stock was quantified by this technique as the sensitivity was not valid with an 
absorbance of less than 0.001. The MIMIC stock was calculated to contain 599.26gg/ml of 
RNA. Having verified the MIMIC sequence, it was possible to determine the molecular 
weight (Mwt) of 1 molecule of MIMIC by the sequence information available and the 
quantity of RNA available in the stock (Table 6 & Table 7). By converting thymine to 
uracil it was possible to determine that the Mwt of MIMIC was 56163 daltons; hence the 
stock solution contained 3.88037 x 10^  ^molecules/pl (See Calculation 1).
Table 6: Quantitation of MIMIC RNA by A260/A280 ratio.
SAMPLE A 280 Blank A 280 RNA A260 RNA Ratio Quantity
([xg/ral)
Stock 0.119 0.168 0.071 1.448 599.26"’
1 X 10"^ 0.118 0.159 0.008 1.2796 35.352'“
A260 value x dilution factor (191) x 44.19 = RNAgg/ml 
A260 value x dilution factor (100) x 44.19 = RNA gg/ml
72
Sequence 1; MIMIC insert sequence
'"GGCGGCCGCT CTAGCCC'^GCC
ACCAGCTGTG
TCGTTCCTCT
TTGGTGGTAT
AGCCATATGT
CAAATTGGCA
AAAAGCCATG
GGATTCAGAA
TGAAAGTCGT
TCATATTCCT
AGGCGATCCT
CATCCAGTCT
CCTGTGGTCT
AGGAGGCCAA
AGGGCTCCGG
Sequence 2: HBD-2 amplicon sequence
’"GCC
TCGTTCCTCT
TTGGTGGTAT
AGCCATATGT
CAAATTGGCA
AAAAGCCATG
GGATTCAGAA
ATCAGCCATG
TCATATTCCT
AGGCGATCCT
CATCCAGTCT
CCTGTGGTCT
AGGAGGCCAA
AGGGCTCC
ATCAGCCATG
GCACCCTTGT
GATGCCTCTT
GTTACCTGCC
TTTGCCCTAG
CCCTGGAACA
GAAGCTGATG
AGGGTCTTGT
GATGCCTCTT
GTTACCTGCC
TTTGCCCTAG
CCCTGGAACA
GAAGCTGATG
AGGGT'TTGAA
ATCTCCCTTC
CCAGGTGTTT
TTAAGAGTGG
AAGGTATAAA
AAATGCTGCA
^TGGCTGATGC
ATCTCCCTTC
CCAGGTGTTT
TTAAGAGTGG
AAGGTATAAA
AAATGCTGCA
^GGCTGATGC
Not 1 Binding site of plamid 
SHBD2 Primer binding site 
”  Junk mimic sequence
ASHBD2 Primer binding site 
SHBD2 Primer binding site 
2°ASHBD2 binding site
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Table 7: Number of individual bases in the MIMIC DNA sequence.
BASE M o l e c u l a r
WEIGHT
No OF b a s e s  in  
INSERT
T o t a l  M wt 
(AMU)
A d e n in e 135.14 68 9189.52
U r a c il ’^ 112 79 8848
G u a n in e 151.13 71 10730.23
C y t o s in e 111.10 73 8110.3
Calculation 1: Determination of the number of MIMIC RNA molecules in the 
purified RNA stock.
Total Mwt of bases = 36878.05 atomic mass units (AMUs) for the 291 base product 
Total Mwt for the sugar phosphate backbone of the RNA molecule = 291 x (PO3 + Ribose; 
78 + 115 =193) = 56163 AMUs
To calculate the number of molecules in the RNA stock the following equation was 
utilised.
[Concentration of stock (in g/L) x MW (in g)] x Avogadro’s number = Molecules per litre
• Concentration of MIMIC stock = 599.26059pg/ml
• Total Mwt of RNA MIMIC = 93041.05 AMU’s
• Avogadro’s Number = 6.022 x 10 therefore:
[599.26059/ 93041.05 (xlOOO)] x 6.022 x 10 
= 3.877 X 10^  ^molecules/L 
= 3.877 xlO^  ^molecules/ ul
21 Uracil replaces Thymine in the RNA sequence
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By carrying out RT-PCR with a range of amplification cycles it was possible to determine 
the optimum RT-PCR reaction conditions, stopping the reaction before either the native 
HBD-2 mRNA or the MIMIC molecule reached its stationary phase of amplification. The 
optimum number of cycles was determined to be 32 as stated in the Methods (p67).
By densinometric analysis using Quantiscan it was possible to achieve a ratio for HBD-2 
amplification against MIMIC amplification. From this ratio it was possible to establish 
how many molecules of HBD-2 were in the starting RNA sample which could then be 
standardised against the total RNA value. This was tested by diluting KC cellular RNA and 
carrying out RT-PCR with a standard, known dilution of MIMIC (Figure 12). As can be 
seen from Figure 13 the observed and expected results obtained are comparable, with a 
similar amplification relationship obtained even when diluting the cellular RNA.
# #  # #
Lane 1 Lane 2 Lane 3 Lane 4 Lane 5 Lane 6 Lane 7
Figure 12: RT-PCR of RNA dilution series with standard MIMIC added.
Lane 1: lOObp marker
Lane 2: KC RNA, no MIMIC RNA
Lane 3: 1/10 dilution of KC RNA + Standard MIMIC
Lane 4: 1/8 dilution KC RNA+ Standard MIMIC
Lane 5: 1/6 dilution KC RNA+ Standard MIMIC
Lane 6: 1/4 dilution KC RNA + Standard MIMIC
Lane 7: 1/2 dilution KC RNA+ Standard MIMIC
Lane 8: No dilution KC RNA + Standard MIMIC
Lane 8
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Dilution of cellular RNA
Figure 13: HBD-2 production by KC monolayers determined by competitive RT-PCR 
(Run 1).
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To further reiterate the relationship of this RT-PCR reaction (Figure 13) a MIMIC dilution 
series with standard KC RNA was subjected to RT-PCR (Figure 14). As can be seen from 
Figure 15 there is some difference between the observed and expected results obtained. 
Although not overlying the expected results, the curve indicates a valid relationship 
between the dilution of the MIMIC and its ability to be measured by quiantiscan and RT- 
PCR. The loss of specificity of the MIMIC due to dilution did, however, indicate the 
sensitivity of this assay to dilution of MIMIC RNA; thus when carrying out quantitative 
RT-PCR a standard dilution of MIMC was included, with dilution of the target RNA 
occurring when necessary.
Having proven: 1. The purity of the MIMIC RNA stock,
2. The specificity of the ASHBD2 and SHBD2 primers for the 
MIMIC and cellular HBD-2 mRNA
3. The dynamics of the RT-PCR reaction and
4. The validity of the densinometric analysis
MIMIC stock was then used in RT-PCR reactions at a dilution determined by the target 
range of HBD-2 expression.
Lane 1 Lane 2 Lane 3 Lane4 Lane5 Lane6 Lane?
Figure 14: RT-PCR of MIMIC dilution series with standard KC RNA added.
Lane 1: lOObp marker
Lane 2: MIMIC RNA, no KC RNA
Lane 3: 1/2 dilution of MIMIC + Standard KC
Lane 4: 1/4 dilution of MIMIC + Standard KC
Lane 5: 1/6 dilution of MIMIC + Standard KC
Lane 6: 1/8 dilution of MIMIC + Standard KC
Lane 7: 1/10 dilution KC RNA+ Standard MIMIC
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Dilution of cellular RNA
Figure 15: HBD-2 production by KC monolayers determined by competitive RT-PCR 
(Run 2).
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2 .3 .2  C o n s t i t u t i v e  p r o d u c t i o n  o f  H B D - 2  i n  s k i n  m o d e l s
The three skin models, LSE, BRT, and KC monolayers were assayed for constitutive 
production of HBD-2. MEM was added as a control to the dorsal surface of both the LSE 
and BRT and the normal MEM medium was considered a control for KC monolayers. The 
basal levels of HBD-2 were assayed at 24, 48 and 72hr in all these models and as can be 
seen from Table 8, 9 and 10 a wide range in HBD-2 expression was detected between 
different KC donors. The pattern of constitutive HBD-2 expression by KCs can be seen in 
Figure 16 and it should be noted that these experiments were initiated when the cell 
population was considered to be confluent, normally following 11-14 days incubation. 
Donor differences in KC HBD-2 expression were detected at 24hr where the range of 
production was 3.16 x 10^-5.011 x 10^  ^ molecules of HBD-2/jLig KC RNA (Table 8)^. 
Hence constitutive expression of HBD-2 mRNA can be detected in KCs with a non­
significant decrease in HBD-2 expression, compared to the 24hr level of expression, 
observed following 72hr incubation.
Tune (lir)
Figure 16: Constitutive HBD-2 expression on KC monolayers (Average of 10 donors).
Each figure represents a single value of HBD-2 production for 1 KC monolayer.
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Table 8: Range of constitutive HBD-2 expression by KC monolayers from 10 donors 
(LoglO Molecules/pg RNA).
Time(hr)
Donor 24 48 72
1 11.690 12.020 11.290
2 12.758 12.735 11.773
3 12.086 12.044 11.914
4 10.326 9.920 9.0698
5 13.321 12.814 12.611
6 15.229 14.561 13.663
7 13.963 14.021 12.215
8 13.320 12.814 12.611
9 10.326 9.9206 10.007
10 13.145 13.282 13.433
Table 9: Range of constitutive HBD-2 expression by LSEs from 6 donors (LoglO 
Molecules/pg RNA).
Time (hr)
Donor 24 48 72
1 12.812 14.014 13.159
2 11.795 13.221 13.326
3 10.557 12.829 13.265
4 13.168 14.014 13.159
5 12.739 13.077 12.759
6 11.920 13.398 11.753
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The pattern of HBD-2 expression for BRT and LSE indicates a slight increase in 
expression at 48hr incubation, compared to 24hr, with a subsequent decline at 72hr for the 
LSE (Figure 17) and BRT (Figure 18). However as can be seen by comparing table 9 and 
10 with figure 17 and 18, this pattern is not consistently observed and was not statistically 
significant. The LSE at the ‘24hr incubation’ time point has been at the air/ liquid interface 
for in excess of 6 days (most commonly 10 days) prior to commencement of the 
experiments^. Hence the differences in KC viability and growth may affect the production 
of HBD-2. The BRT ‘24hr incubation’ time point is 24hr post-excision, or at most 24hr 
post-day of excision, a^ all tissue were collected and processed on the day of excision. Both 
the BRT and LSE exhibit donor differences in basal expression of HBD-2 with the LSEs 
ranging from 1.58 x 10^-1.26 x 10^  ^molecules/pg RNA (Table 9) and BRT ranging from 
7.94 xlO^°- 3.98 x 10^ "^  molecules/pg RNA (Table 10). Comparison of the models shows 
that LSE produces slightly more HBD-2 than both KCs and LSEs (Figure 19).
13.5
■3 12.5 -
12.0
10.5
T im e  (hr)
Figure 17: Constitutive HBD-2 expression on LSE (average of 6 donors).
A KC monolayer of each of the KC seeded on the LSE was used to approximate the growth of 
the KCs on the LSE.
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Time (lir)
Figure 18: Constitutive HBD-2 expression on BRT (average of 6 donors).
Table 10: Range of constitutive HBD-2 expression by BRT from 6 donors (LoglO 
Molecules/pg RNA).
Time (hr)
Donor 24 48 72
1 12.812 14.014 13.159
2 11.795 13.221 13.326
3 10.557 12.829 13.265
4 13.168 14.014 13.159
5 12.739 13.070 12.750
6 11.820 13.398 11.750
82
As can be seen from Figure 19 there was slight differences in the overall patterns of 
expression of HBD-2 in the three skin models. The only notable point is that HBD-2 
expression on BRT is lower at 24hr than all the other skin models at the same time and that 
the LSE and KC monolayers demonstrate a drop in HBD-2 production following 72hr 
incubation, compared to levels detected at 24hr.
Time (hr)
I.SK ■  
BRT [Z]
Figure 19: Constitutive HBD-2 expression on KC, LSE and BRT.
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2.3.3 HBD-2 EXPRESSION IN KC MONOLAYERS
To establish the inducibility of the KC monolayers to inflammatory mediators, the cells 
were washed and tested by the exogenous addition of TNFa (lOpg added per ml of MEM). 
Donor 11 KCs show increased, significant (P<().()()1) upregulation of HBD-2 expression in 
response to TNFa (Figure 20) and this magnitude of response increased with time. 
However donor differences in reaction to TNFa did exist and using donor 12 KCs TNFa 
did not stimulate HBD-2 production until 72hr incubation. (Figure 21). This difference in 
KC reaction to TNFa reiterated the fact that there appeared to be donor specific HBD-2 
production and this was observed in response to the addition of exogenous compounds. 
However as TNFa was only tested on 2 KC donors it is difficult to judge whether this 
difference was entirely donor specific.
^  12.2 -
( 'nn lro l
TN F (lO ^g/m l)
Time (hr)
Figure 20: HBD-2 production on KC monolayers, donor 11, in response to TNFa.
* Denotes significant difference compared to control (?<().() 1)
♦^Denotes highly significant difference compared to control (P<0.0()1)
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C ontrol
Time (hr)
Figure 21: HBD-2 production on KC monolayers, donor 12, in response to TNFa.
* S ig n if ic a n t  d iffe r e n c e  to  c o n tro l ( P < 0 .0 1 )
Table 11: HBD-2 expression in réponse to lOpg/ml of M. furfur cell wall (Log 10 
molecules/pg RNA). Range of expression between 3 donors.
Time (hr)
Donor 24 48 72
Control cell wall Control cell wall Control cell wall
13 13.098 12.695 13.239 12.991 13.121 12.796
14 13.531 13.278 13.152 12.922 13.182 12.711
15 13.044 12.944 13.115 12.199 13.161 13.165
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To investigate the possibility that M. furfur may interact with KCs to alter HBD-2 
expression M. furfur and M. furfur components were added to KC monolayers to determine 
if the organism altered the expression of HBD-2. Firstly donor 13 KCs were co-incubated 
with two dilutions of M  furfur cell wall suspension (lOOpg/ml + lOpg/ml in MEM). These 
KCs demonstrated a dose-dependent decrease in HBD-2 expression in response to the cell 
wall (Figure 22). This inhibition was achieved at 24hr with lOpg/ml on donor 14 KCs 
(Figure 23) and this was found to be borderline significant (P >0.01 <0.05). Comparison of 
these two figures (Figure 22 & Figure 23) indicate the difference in magnitude of 
expression between donors in response to M. furfur cell wall and demonstrate that this 
reaction was donor specific. In addition it should be noted as as can be seen in table 11, 
that this suppression while significant at 72hr for donors 12 & 13 was not consistently 
observed. Hence putative suppression of HBD-2 expression by M. furfur cell wall was in 
direct contrast to the effect seen in the response of donor 15’s KCs to C. albicans cell wall. 
This donor initiated an increase in HBD-2 transcription following 48 and 72hr incubation 
(Figure 24) with C. albicans cell wall (lOpg/ml). However again as this was only tested on 
1 batch of KC monolayers this effect cannot be verified.
8 6
rniilriil ■
cell wall to p^ml #
cell wall 100 jig/ml □
Figure 22: HBD-2 production on KC monolayers, donor 13, in response to M. furfur 
cell wall (O-lOOpg/ml).
* B o r d e r lin e  s ig n if ic a n t ly  d iffer en t to  co n tro l ( P > 0 .0 1 < 0 .0 5 )
Figure 23: HBD-2 production on KC monolayers, donor 14, in response to M. furfur 
cell wall (lOpg/ml).
* B o r d e r lin e  s ig n if ic a n t ly  d iffer en t to  co n tro l ( P > 0 .0 1 < 0 .0 5 )
Found value o f  T  w as so  c lo se  to the tabulated ‘s ig n ifca n t’ va lu e, w ith appropriate degrees o f  
freedom , as to warrant com m ent.
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To compare differences in cell wall and whole cells, viable M. furfur ( 10'^ cells/ml MEM) 
were added to the dorsal surface of KCs. In donor 16 M. furfur initiated a decrease in 
HBD-2 expression at 24hr followed by an increase (Figure 25). The differences in HBD-2 
expression between donors is best seen in Table 12 and although not always absolute there 
did appear to be a trend for M. furfur to increase HBD-2 transcription following 48hr 
incubation. This difference was not however measured as statistically significant. Out of 
the 5 KC donors tested, 3 demonstrated this pattern of slight inhibition with subsequent 
stimulation. Therefore bearing in mind the lack of statistical significance in the results all 
that could be noted is that a trend did exist which was subject to donor variation. The 
capacity of viable M. furfur to suppress and stimulate defensin production was examined 
further by the application of whole M. furfur cells, a killed whole cell suspension 
(lO'^cells/ml MEM), to KC monolayers” . These cells initiated inhibition of HBD-2 
expression by the KCs on donor 21 (Figure 26). However as this was only one donor no 
conclusions can be drawn from the data.
t '2>0
I 11%
Cell w all (10 |iR /m l)
Figure 24: HBD-2 production on KC monolayers, donor 15, in response to C. albicans 
cell wall.
* Significant difference from control (P<().01)
”  U n less otherw ise stated this ce ll num ber o f  k illed  w h ole  c e lls  w as a lw ays used.
8 8
Table 12: HBD-2 expression by KC monolayers over time in response to viable M.
furfur (Log 10 molecules/pg RNA). Range of expression between 5 donors.
Time (hr)
Donor 24 48 72
Control M.furfur Control M. furfur Control M.furfur
16 15.241 14.789 14.687 14.822 16.654 13.935
17 12.045 12.067 12.026 12.104 11.883 12.026
18 12.952 12.737 13.025 13.218 13.359 13.477
19 13.193 13.037 13.460 13.483 12.414 13.411
20 13.104 13.258 12.613 14.119 13.0449 13.316
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Time (hr)
Figure 25: HBD-2 production on KC monolayers, donor 16, in response to viable M. 
furfur .
O inlrol ■
M ^ur/ur(10* ceils/mi) §
<  14.75
g
I
Time (Mrs)
Figure 26: HBD-2 production on KC monolayers, donor 21, in response to killed M. 
furfur.
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2.3.4 HBD-2 EXPRESSION ON LSE
To establish whether HBD-2 expression could be induced on the LSE, three dilutions of 
TNFa (15 pi of 1, 10 or 100 pg/ml of TN Fa diluted in MEM) were added to the dorsal 
surface of LSE (donor 7). With this LSE, TNFa induced HBD-2 expression at 24hr. 
However statistical analysis could not be performed on these results due to lack of sample 
size (Figure 27)^ ,^ although it did appear that in this donor, in the first 24hr, TN Fa did 
increase HBD-2 production. To test the effect of fungal growth on the LSE, viable M. 
furfur was added to the dorsal surface of the LSE and the RNA analysed. There was a 
depression of HBD-2 production in response to the organism at 24hr on almost all donors, 
with a subsequent slight increase in defensin transcription (Figure 28) similar to the 
response seen with some KC monolayers. However as can be seen by comparing other 
donor values (Table 13) and in common with the KC response to viable M. furfur, no 
statistical significance was observed in these results. However all of the donors tested did 
exhibit a slight decrease in HBD-2 production at 24hr with a relative increase at 72hr 
(compared against time and donor matched controls). As these alterations were not 
significant at any time, and as with the KC data, these measurements merely indicated a 
trend in the HBD-2 production of the LSE in response to M. furfur.
”  Only tested on one batch of LSE’s from one donor. Duplicate samples taken at each timepoint 
for each test condition.
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Figure 27: HBD-2 production on LSE, donor 7, in response to TNFa.
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To examine this trend further cell wall and killed whole cells were added to the LSE 
surface and HBD-2 expression was measured. M. furfur killed whole cells initiated a dose- 
dependent suppression of HBD-2 production in donor 14 (Figure 29) whereas M. furfur 
cell wall (lOpg/ml) did not affect HBD-2 production in donor 15 (Figure 30). These results 
again were not statistically significant and merely indicate an individual LSE batch reaction 
to M. furfur components.
Control
V. furfur
4J6
XV
Time (hr)
Figure 28: HBD-2 production on LSE, donor 8, in response to viable M.furfur.
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Table 13: HBD-2 expression on LSEs in réponse to viable M, futfur (Log 10
molecules/pg RNA). Range of expression between 6 donors.
Time(hr)
Donor 24 48 72
Control M.furfur Control M.furfur Control M.furfur
8 15.511 15.289 15.328 15.587 14.988 15.244
9 13.449 13.168 14.014 13.786 13.159 13.321
10 12.9153 12.569 12.439 12.722 12.399 12.895
11 14.023 13.843 13.648 14.022 13.583 13.769
12 13.779 13.491 13.661 13.657 13.753 13.761
13 12.973 12.630 12.488 13.145 27
No 72 hr data available for this donor due to loss of RNA.
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Figure 29: HBD-2 production on LSE, donor 14, in response to killed M.furfur.
*Signifact difference from control (p<().()l)
Control H
CellwuII(iO pK/ml) gg
i
Figure 30: HBD-2 production on LSE, donor 15, in response to M. furfur wall.
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To determine whether the LSE would respond to yeast cells, C. albicans was added to the 
dorsal surface of the skin model. The addition of C. albicans stimulated defensin 
production by the LSE following 48hr incubation in donor 16 (Figure 31), Figure 31 
demonstrates that the ability of C. albicans to stimulate HBD-2 expression by the LSE is 
significant in donor 31 at 48hr. As can be seen from Table 14 this increased expression in 
response to C. albicans growth was identified on 2 LSE batches. However only one 
showed statistical significance- donor 16.
12 j  -
12.25 -
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C o n t r o l  0
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C .  albicarLS Q
Tim e (hr)
Figure 31: HBD-2 production by LSE, donor 16, in response to viable M .furfur and 
C. albicans growth.
* Significant difference from control (P<().()1)
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Table 15: HBD-2 expression on the LSE in réponse to viable M .furfur and viable C.
albicans (Log 10 raolecules/pg RNA). Range of expression between 2 donors.
Time (hr)
2 4 48 72
D onor Control M.furfur C. albicans Control M. furfur C. albicans Control M.furfur C.albicans
16 12.025 12.018 13.078 12.756 12.106 13.239 28
17 10.186 9.061 11.923 15.589 16.463 17.874 15.883 16.704 17.549
^  No 72hr data for this donor due to loss of RNA,
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2.3.5 HBD-2 EXPRESSION ON BRT
Inducibility of HBD-2 expression by BRT was examined by adding 15pl of a 1()pg/ml 
TNFa solution to the dorsal surface of the tissue no more than 24hr after excision. An 
increase in HBD-2 transcription was observed at 72hr, allthough the magnitude of the 
increase was less than that observed with the LSE and KC monolayers and was only 
statistically significant at 72hr (Figure 32).
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Figure 32: HBD-2 production on BRT, donor 7, in response to TNFa.
* Significant difference from control (P<0.01)
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Growth of M. furfur on the dorsal surface of BRT resulted in a pattern of HBD-2 
expression similar to that on LSE, with suppression of defensin expression at 24hr (Figure 
33). However as can be seen from Table 16 this effect is not seen in all BRT donors and 
the effect was not consistent as suppression of HBD-2 expression was deteceted in donor 8 
at 48hr. As with the LSE and KC data this effect was neither consistent or statistically 
significant. The BRT, as with the LSE, increased HBD-2 transcription at 24hr in response 
to C. albicans growth (Figure 34). This effect was generally observed in all donor BRT 
tissue tested (Table 17). Killed whole M. furfur and C. albicans cells did not greatly affect 
HBD-2 production on BRT donor 11 (Figure 35).
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Figure 33: HBD-2 production on BRT, donor 8, in response to M .furfur colonization.
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Table 16: HBD-2 expression on BRT in réponse to viable M. furfur (Log 10
molecules/pg RNA). Range of expression between 6 donors.
T im e  (hr)
D o n o r 2 4 48 72
Control M. furfur Control M. furfur Control M. furfur
8 13.449 13.168 14.014 13.786 13.159 13.321
9 12.691 12.909 12.099 12.265 13.183 13.274
10 11.307 11.566 11.966 12.619 11.044 10.802
11 12.821 12.4524 13.102 13.172 12.907 13.124
12 13.576 12.159 13.326 13.076
13 9.939 10.356 9.817 9.744
Table 17: HBD-2 expression on BRT in réponse to viable M. furfur and C. albicans 
(Log 10 moleeules/pg RNA). Range of expression between 3 donors.
Time (hr)
D onor 2 4 4 8 72
Control M.furfur C. albicans Control M  furfiir C. albicans Control M.furfur C.albicans
14 10.189 9.974 11.981 12.595 13.512 13.672 11.811 13.212 13.914
15 12.739 12.254 13.057 13.079 13.013 13.127 13.048 12.810 13.146
16 13.198 13.385 13.555 14.014 13.829 13.053 12.639 13.159 13.363
100
14.8 
14 J  
<  13.8
«  13.3
I
s  12.2
I
I I >-2
I  10.7
.5 10.2
(.'untnil
M.furfur
C. albicans \7\
I ime (hr)
Figure 34: HBD-2 production on BRT, donor 14, in response to M. furfur and C. 
albicans colonisation.
* Significant difference from control (P<0.01)
** Highly significant difference from control (P<0.001)
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Figure 35: HBD-2 production on BRT, donor 17, in response to killed M.furfur and 
C. albicans.
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2 .4  D is c u s s io n
The method developed here to assay HBD-2 transcription in the skin models has several 
advantages over other methods of quantitative RT-PCR analysis. The HBD-2-specific 
RNA competitor ‘MIMIC’ has two main advantages over semi-quantitative analysis using 
internal cellular standards, such as GAPDH (Bargon, 2000). Firstly, MIMIC was amplified 
with the same primers as the target. This negates the need to calculate any differences in 
primer binding efficiency, which would exist between, say GAPDH and HBD-2-specific 
primers. In addition, these cellular targets (GAPDH, actin, etc) change expression between 
cell populations making it impossible to obtain a comparative value for the measure of 
expression between cell populations. Only within group changes, those within the same 
population of cells can be assessed using internal competitors. By adding an external 
competitor it was possible to compare expression between groups of cells, and hence 
different models, as well as within groups. The experiments undertaken therefore had two 
main objectives: to establish the constitutive expression of HBD-2 in the three skin models, 
and to determine the alteration of HBD-2 expression in response to M. furfur and M. furfur 
cell walls.
Antimicrobial peptide expression has been demonstrated in normal skin where HBD-1 
mRNA was detected in situ, and was shown to be located in suprabasal KCs (Fulton et al.,
1997). HBD-2 expression has also been detected in punch biopsy samples of normal tissue, 
using anti-HBD-2 polyclonal antibody in immunohistochemistry (A i, 2000). A though no 
peptide has been directly isolated from normal skin as is the case with HBD-1 (Schroder 
and Harder, 1999), it would seem that samples like gingival epithelia (Krisanaprakornkit et 
al., 2000), ocular epithelia (Lehmann et al., 2000) and skin epithelia constitutively produce 
both HBD-1 and HBD-2. This hypothesis is supported by the analysis of freshly isolated 
BRT epidermal mRNA which showed, using competitive RT-PCR with MIMIC, that 
HBD-2 is expressed at a constitutive leveF® and that this basal level of expression differs 
greatly between donors. This corresponds with the data relating to HBD-2 expression in 
lung epithelia, where donor differences in the intensity of HBD-2 anti-sense probe binding
Results not shown: RT PCR was performed on freshly isolated RNA from 2 BRT donors. HBD-2 
expression was not quantified however crude expression was detected.
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were evident (Singh et al., 1998).
These results indicate that BRT expression of HBD-2 is slightly increased following 24hr 
incubation which may be due to inflammatory mediators that are produced in response to 
the trauma of excision. Excision, like wounding, will initiate the release a myriad of 
inflammatory mediators, some of which will induce iKBa activation and result in loss of 
NFkB inhibition. This will in turn initiate transcription of NFKB-dependent genes, one of 
which is thought to be that coding HBD-2, and therefore the physical act of excision may 
be responsible for the obseived rise in HBD-2 expression following incubation of the 
tissue. The inflammation related to trauma may also be responsible for the basal HBD-2 
expression, within 12hr of excision, as KCs in vitro have been shown to respond to TN Fa 
with increased HBD-2 expression within 2hr of exposure (Harder et al., 1997). The 
paradox of whether HBD-2 is constitutively expressed in skin is not easily solved. By snap 
freezing punch biopsy material the mRNA present could be amplified and hence measured; 
however, the speed at which cells could be induced to produce HBD-2 would have to be 
accounted for.
KC monolayers, BRT and LSE all demonstrate constitutive defensin mRNA expression, 
following 24hr incubation. With regard to KCs, the ‘constitutive’ expression of HBD-2 
may be due to culture conditions, with Ca^ "^  in the medium stimulating both differentiation 
and growth of the KCs. Culture conditions have been shown to stimulate defensin 
expression since medium from freshly isolated KCs does not contain detectable HBD-2 
peptide, but following culture, peptide can be detected in the culture medium (J.M. 
Schroder, personal communication). KCs do give positive RT-PCR for HBD-2 expression 
directly following excision but if functional peptide cannot be detected perhaps the 
message is not being effectively translated, or at least is not being translated into 
physiologically detectable values. Experiments with lung epithelia cell lines compared with 
in situ expression experiments (Singh et al., 1998) demonstrate that in vitro mRNA 
expression and protein expression cannot always be extrapolated back to in vivo models. 
Thus HBD-2 expression, in common with HBD-1, appears to be constitutively expressed in 
skin as it is in various other tissues (Bals et al., 1998).
Until this research, no measure of the alteration of constitutive HBD-2 expression in skin
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models had been undertaken. It is highly likely that the increases in BRT transcription of 
HBD-2 with time is due to post-surgery trauma of the KCs of the BRT. It has, however, 
been shown that HBD-2 expression is decreased in the area surrounding burn wounds 
(Milner and Ortega, 1999), a finding which does not correlate with the idea of a role for of 
HBD-2 as an essential factor in infection regulation. This down regulation of HBD-2 
production may be due to a loss of KCs from the tissue surrounding the burn wound, which 
is often depleted of KCs. A  striking difference in the constitutive HBD-2 expression 
studied is the range of donor differences of expression. KCs taken from juvenile foreskins 
show a large range of HBD-2 message expression. Donor differences in HBD-2 peptide 
expression have also been measured in lung epithelia (Hiratsuka, 1999) and may indicate 
the individuals predisposition to produce different levels of antimicrobial peptides. 
Consequently, all the alterations in expression measured in these experiments, in response 
to fungal infection, had to be compared to donor controls.
The stimulatory role of infection and inflammation on HBD-2 transcription has been 
widely examined. Bacterial pneumonia (Hiratsuka, 1999), cervical infection (Heine et al.,
1998) and psoriasis (Henseler and Christophers, 1995) have all been shown to increase the 
transcription of HBD-2. The skin models selected here also show increased transcription in 
response to viable M. furfur and C. albicans, following incubation and this is possibly due 
to the increase in colonization of the skin model. What is interesting is that epithelia are 
selective in their response to organisms. Helicobacter pylori will only stimulate human 
gastric cell line HBD-2 expression if it contains the cag pathogenicity island; this is a set of 
genes responsible for pathogenicity which initiate duodenitis, duodenal ulcers and gastric 
adenocarcinoma (Wada et al., 1999). In addition, the mucoid form of Pseudomonas 
aeroginosa which can cause infection in cystic fibrosis patients, induces HBD-2 expression 
in lung epithelial cells (Harder et al., 2000) whereas the non-mucoid, non-pathogenic form 
does not. It is possible that various sldn pathogens have pathogen associated triggers which 
may or may not effect HBD-2 transcription.
These experiments indicate that HBD-2 expression in response to organism challenge, and 
indeed TNFa exposure is not consistent in skin models, due in part to donor differences in 
basal HBD-2 expression and in response to inflammatory agents. While certain trends are 
suggested and some significant results were observed, the lack of correlation between all
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donors points to one of two things; either failure in the assay technique utilised to 
accurately measure alteration in HBD-2 transcription or the inconsistent response of donors 
to challenge. It is widely known that individual expression of inducible and constitutively 
produced defensins differs greatly between donors. The response of some sldn models to 
TNFa in these experiments would however indicate a loss of sensitivity of the assay. It is 
reasonable to assume that the sensitivity of this RT-PCR reaction, combined with donor 
differences in expression, both contributed to the erratic results obtained in these assays. 
The lack of general statistical significance in the results negates the possibility that any 
definitive answers may be found using this assay as to whether M. furfur or fungal growth 
affects HBD-2 production. However trends were observed and the results do suggest that 
M  furfur and C. albicans growth do stimulate HBD-2 production on the skin models.
It could be hypothesized that an increase in HBD-2 production, although not consistently 
observed in these experiments, could be due to growth of the organism. An increase in 
HBD-2 message could be stimulated by the mechanical disruption of corneocytes initiated 
by growth and, in some instances, hyphal transformation of the organism that has been 
observed in both LSE and BRT samples under SEM investigation (Figure 87 & Figure 94). 
M. furfur cell wall inactivation of HBD-2 transcription contrasts with the immunogenic 
capacity of C. albicans cell wall at the same concentration. C. albicans had previously been 
reported to have a stimulatory capacity on HBD-2 expression by KC monolayers (Harder et 
al., 1997), but this is the first time the initiation of HBD-2 transcription has been observed 
in skin models in response to growth of this organism. Two main hypotheses could explain 
how M  furfur and C. albicans could initiate HBD-2 transcription in response to growth in 
these skin models. Inflammation, as a result of fungal growth could trigger transcription of 
HBD-2 via a secondary pathway, i.e. via hyphal disruption of the cells which stimulate the 
cytokine network of the skin, resulting in NFkB activation and HBD-2 transcription. 
Aternatively, both M. furfur and C, albicans may possess pathogen patterns, that are 
recognised by PPRRs of the KC such as the IL-lot R l. No one has yet established a 
pathogen pattern that acts as a ligand for the IE-let R 1, but perhaps like other TLR4s, the 
IL -lR l can be directly induced by the specific antigen of some pathogens, thus directly 
stimulating NFkB activation. Hyphal production by both M. furfur and C. albicans would 
disrupt a wide range of KCs in both the BRT and LSE epidermis, and so release any stored 
HBD-2 from cells in the upper epidermis while initiating the primary immune response of
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the basal KCs. ÏL-1 a  and TNF a  secretion from KCs will also stimulate NFkB activation 
and thus HBD-2 transcription, therefore contributing to the rise in expression. Hyphal 
transformation would not account for the stimulation of HBD-2 expression on KC 
monolayers as M. furfur does not revert to hyphal transformation in MEM therefore the 
slight rise in HBD-2 production of the KC must be due to another factor associated with 
the viable organism. The organism did remain viable in MEM increasing slightly in cell 
numbers; therefore, the organism will be producing metabolites in this medium while not 
greatly proliferating. This growth was, however, only measured in the presence of plastic + 
MEM, not in the presence of KCs + MEM, so the inhibitory effect of any secreted defensin 
may have affected M. furfur growth in the co-incubated cultures. However as mentioned 
previously a consistent, statistically significant response to M. furfur could not be detected 
and this hypothesis is purely speculative. In addition these results are limited by the fact 
that only one strain of M. furfur and C. albicans was used, perhaps limiting the stimulatory 
capacity of the organism. While both strains were isolated from clinical samples, which 
would be assumed to be pathogenic, it would have interesting to examine the effect of 
various strains of the organism in altering HBD-2 production.
Perhaps the most obvious question to ask, when considering the inducibility of HBD-2, is 
whether it is active in killing M. furfurl Unfortunately purified HBD-2 was not available 
from other sources. In addition, due to monetary constraints, it was not possible to establish 
any kind of baculovirus expression system to express the gene transcribing HBD-2 and 
thereby obtain supplies of HBD-2. As a result the antifungal effect of HBD-2 on M. furfur 
growth in in vitro models was not investigated. It would have been interesting to carry out 
growth inhibition assays utilising the broth microdilution method (Nakamura et a l, 2000) 
to at least determine whether HBD-2 has a measurable effect on M. furfur growth. The 
growth of M. furfur in skin suggests that while the organism can revert to pathogenicity, 
the maintenance of the commensal on the skin must require some form of immune evasion 
by the organism. While these results do not exactly demonstrate immune evasion the trend 
for M. furfur to not stimulate HBD-2 production as quicldy as other yeast, namely C. 
albicans, indicates a possible lack of immunogenicity for the resting, non-proliferating M. 
furfur cell.
Aside from refining the quantitative analysis of HBD-2 production, by measuring either
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mRNA or peptide production, various research would be appropriate following this work. 
Firstly it would be necessary to repeat some of the singular donor experiments carried out 
to determine if the effects observed were a donor specific. In addition it would be useful to 
elucidate the exact pathways of HBD-2 transcription by KCs. It would be interesting to 
break down the initiating components of the cytokine network in controlling the rates of 
HBD-2 expression. The first candidate would of course be IL -la  and it would be easy to 
apply anti-IL -la antibody to KCs to measure their HBD-2 response while blocldng this 
ubiquitous inflammatory agent. In addition it would be interesting to utilise antisense 
HBD-2 in KC/LSE/ BRT to determine the effect of increased transcription on the 
organism’s viability in these skin models.
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3  M e l a n i n  s y n t h e s is  a n d  t h e  s k in  im m u n e  r e s p o n s e
3.1 In t r o d u c t io n
Some of the most interesting pathological effects of Malassezia infection manifest as 
pigmentory changes in the skin. PV, SD and folliculitis, initiated by M. furfur, can all 
present with alteration in the pigmentation of the affected skin and the surrounding areas 
(Faergemann, 1994). This hyper and hypo-pigmentation can be observed in the tissue 
affected by M. furfur and as yet no definitive evidence exists as to how the organism elicits 
these pigmentory changes. To elucidate a putative role for M. furfur in the alteration of 
melanin synthesis, the interaction of the organism with MCs must be examined.
3 .1 .1  M e l a n o c y t e s
MCs are the pigment-producing cells of the skin, derived from stem cell melanoblasts 
(Cramer, 1991). These neural crest-derived cells migrate during embryogenesis to the basal 
layer of the epidermis and hair follicles (Cramer, 1991). In the epidermis these cells 
associate at a ratio of 1:36 with KCs, forming a structural association commonly referred to 
as the ‘epidermal melanin unit’. MCs adopt a dendritic morphology in the basal epidermis 
contributing to the SIS (Le Poole et al., 1993) and in addition they are the source of the 
pigmentation organelles of the skin, melanosomes. Melanosomes develop from the 
endoplasmic reticulum of the MC and are membrane-bound organelles that manufacture 
melanin (Imokawa, 1989). The development of the melanosomes filamentous structures 
determines the type of melanin the melanosome will produce. There are two main types of 
melanin synthesised in mammals; eumelanins which are brown-black in colour and the 
phaeomelanins, associated with red or yellow pigmentation (Jimbow et al., 1979). As the 
pigment-producing organelle of the epidermis, melanosome distribution and activity is 
largely responsible for the general pigmentation of the skin. These organelles are 
distributed to surrounding KCs via the dendritic processes of the MC. When the 
melanosomes become filled with melanin they become tethered to myoxin filaments and 
are transported to KCs via a phagocytotic-like process (Okazaki et al., 1976). A though 
deposition of melanosomes contributes to the basal level of pigmentation in the skin 
several other factors can influence the rate of melanin production, as well as the movement 
of melanosomes.
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3J.1.1 P i g m e n t a t i o n
Pigmentation in humans can be influenced by several factors. These include:
Melanoblast migration and differentiation from neural crest cells. This process is 
genetically predetermined and can be affected by any neural tube defects and factors that 
interfere with the development of MC stem cells. Stem cell factor receptor is expressed in 
MCs at this time, following activation of the proto-oncogene, c-kit (Geissler et al., 1988). 
This results in melanoblast sensitivity to stem cell factor which induces the development 
and migration of the pre-MC (Nataf et al., 1995).
Melanosome formation. Pre-melanosome structural subunits are arranged in the MC and 
the subunits are further arranged into the melanosomal structure (Lambert et ah, 1999). The 
melanosome structure partly indicates the type of melanin which will be produced and 
deposited in the melanosome (Setaluri, 2000). Elliptical arrangement of the actin filaments 
indicates eumelanin synthesis while spherical, globular melanosomes with a granular 
appearance indicate pheomelanogenesis.
Melanin synthesis. The melanin synthesis mechanism of melanosomes is a complex 
metabolic pathway that can be influenced by countless molecules (Hearing and Tsukamoto, 
1991). The process, as detailed below (Figure 36), can be triggered by many metabolites 
including cytokines (Imokawa et al., 1992; Morelli and Norris, 1993), growth factors 
(Halaban, 1991) and UV irradiation (Birchall et ah, 1991).
Melanosome transfer. The phagocytic pathway of melanosome transfer is currently 
subject to much research (Okazaki et ah, 1976). It has been demonstrated recently that 
melanosome transfer to KCs is dependent upon a G protein coupled receptor on the MC 
membrane, termed PAR-2 (Sharlow et ah, 2000). PAR-2 is activated by serine proteases 
including trypsin and mast cell tryptase, and activation of PAR-2 in vivo results in 
increased pigmentation of the epidermis due to the increased uptake of melanosomes by 
KCs. In addition blockage of kinesin activity, which is a protein required for micro tubule 
movement of molecules, results in blockage of UV-induced melanosome transfer in MCs 
(Hirokawa, 1998). The exact pathway for melanosome transport has not yet, however, been 
fully elucidated.
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3 .1 .1 .2  M e l a n in  s y n t h e s is
The main factor in pigmentation is however the synthesis of melanin, a complex enzymatic 
process first elucidated by Raper and Mason (1965). In other animals, pigmentation serves 
several purposes ranging from sexual attraction to social interaction. In humans, however, 
the main function of melanin is to protect the epidermis and dermis from ionising radiation. 
Melanogenesis, as detailed in the Raper-Mason pathway, involves the oxidation of 
monophenol tyrosine or DOPA (3,4-dihydroxyphenylalanine) chrome catalysed by the 
integral enzyme tyrosinase (Figure 36).
3 .1 .1 .3  T y r o s in a s e
Central to melanin synthesis is the glycoprotein tyrosinase (del Marmol and Beermann, 
1996). Tyrosinase (monophenol dihydroxy-L-phenylalanine oxygen oxidoreductase) is a 
60-70kD, copper-containing enzyme, which catalyses both the hydroxylation of 
monophenols to o-diphenols and the oxidation of o-diphenols to o-quinones. The albino 
gene (Kwon et al., 1987), TYR in humans, is responsible for tyrosinase transcription and is 
a 35kbp gene located on chromosome l lq ,  14-21 (Kwon et ah, 1989). The TYR gene is 
transcriptionally spliced to remove introns and the 2.4kb mRNA is translated into the 
active tyrosinase molecule. The active enzyme is the rate-limiting molecule in melanin 
synthesis and it becomes incorporated into the melanosome during melanoblast 
development (Beermann et ah, 1990). Tyrosinase is transported to the melanosome in 
vesicles from the golgi apparatus of the MC (Halaban et ah, 2000), and although 
biologically active at this point, no melanogenesis occurs until the vesicle and enzyme 
reach the melanosome (Imokawa, 1989). Tyrosinase catalyses three stages in melanin 
synthesis. Firstly, it catalyses the hydroxylation of tyrosine to DOPA, which causes the pH 
of the cell to rise, initiating the oxidation of DOPA to DOPAquinone. In addition, 
tyrosinase also converts 5, 6-dihydroxyindole to indole-quinone. A though critical for 
melanin synthesis by its catalytic hydroxylation of tyrosine to DOPA, tyrosinase expression 
is not singularly responsible for melanin synthesis. By stimulating tyrosinase transcription, 
it is evident that upregulation of gene expression, and indeed increased translation, cannot 
completely account for the dramatic increase in melanin production in response to stimuli. 
This is due to two factors. Firstly, many molecules which are active in the melanin
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Figure 36: Diagrammatic representation of melanogenesis.
I l l
synthesis pathway are inactivated in the melanosome. In addition many other enzymes 
interact in melanin synthesis and these include the tyrosinase related proteins 1 and 2 
(TRP-1, 2) (Sanchez-Ferrer et al., 1995).
3 .1 .1 .4  TRPS
TRPs are essential specifically for eumelanin synthesis when, in the absence of thiols and 
cysteine, DOPAchrome is isomerised to DOPAchrome tautomerase or TRP-2 (del Marmol 
et al., 1996). The resultant compound is further oxidised by DHICA (5,6-dihydroxyindole) 
oxidase or TRP-1, to DHICA and this reaction is further catalysed to produce the 
eumelanins. TRP-1 and -2  genes, located in humans at 9p23 and 13q 31-32 loci 
respectively, are coordinately regulated with tyrosinase (Kuzumaki et al., 1993). Hence 
both the TRPs and tyrosinase are essential in melanin synthesis. It has been hypothesised 
that a plethora of melanogenic inhibitors exist intracellularly which may inhibit tyrosinase 
synthesis, expression and/or activity. It has been proven that an increase in tyrosinase 
transcription does not directly equate to an increase in melanin synthesis (del Marmol and 
Beermann, 1996) and many enzymes are thought to inactivate the already translated 
tyrosinase. Hence, stimulation of tyrosinase transcription is not fully responsible for 
melanin synthesis; however, it may induce tyrosinase activity via other important pathways 
such as increased acidity.
3.1.1.5 S  TIMULA TION OF MELANIN SYNTHESIS
As the main free radical scavenger of the skin, melanin and its production is largely 
controlled by epidermal exposure to UV irradiation (Johnson et al., 1972). However in 
addition, melanin synthesis is also affected by inflammatory stimuli and growth factors. 
These include:
bFGF. Basic fibroblast growth factor (bFGF) has long been recognised as a mitogenic 
stimulus for MCs (Matsumoto et al., 1991). Melanoma cells have a well documented 
increase in bFGF receptor expression coupled with increased bFGF intracellular levels 
(Halaban et al., 1991). In contrast to its induction of mitogenesis in MCs, bFGF does not 
always stimulate a concomitant increase in melanin synthesis.
IL - la .  KCs produce IL -la  in response to UV (Morelli et al., 1989). This stimulates
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expression of high affinity binding sites for a-melanocyte stimulating hormone and this 
manifests as enhanced cellular responsiveness to MSH with both increased tyrosinase 
activity and melanin content. Therefore it is possible that IL -la  production may control the 
reaction of MCs to inflammatory stimuli.
TNF-a. This inflammatory mediator is produced in response to exogenous stimuli from 
KCs (Stricldand et al., 1997) and it is found to inactivate NFkB inhibition. NFkB 
activation has been shown to down-regulate melanin synthesis in MCs (Englaro et al.,
1999) while stimulating the production of cytokines including IL -la  etc. TNFa expression 
therefore triggers a negative feedback control on melanin synthesis initiated by 
inflammation.
Endothelin 1, (ET-1) 10|^M of ET-1 induces an increase in tyrosinase transcription in MCs 
coupled with an increase in melanogenesis when secreted from endothelial cells (Imokawa 
et al., 1992). As ET-1 is secreted by KCs in response to IL -la , melanin production in the 
epidermis, particularly in relation to post-inflammatory pigmentation, may depend on 
secretion of this molecule (Yohn et ah, 1993).
a  M SH . a-Melanocyte stimulating hormone is a potent inducer of melanin synthesis (Hunt 
et ah, 1994a). Although primarily produced by the pituitary gland, it is also expressed by 
KCs in response to injury (Schauer et al., 1994), and as such a-M SH is probably the most 
influential hormone affecting melanin synthesis (Hunt et ah, 1994b).
Phospholipase. Secretory phospholipase A2 is the rate-limiting enzyme involved in 
arachidonic acid liberation from membrane phospholipids (Maeda and Naganuma, 1997). 
Arachidonic acid is a precursor molecule for many inflammatory mediators including 
platelet-activating factor and the eicosanoids (Wolf et ah, 1986) and it exerts an influence 
on the melanogenesis of MCs. As secretory phospholipase A2 is released from KCs in 
response to IL -la  (Birchall et ah, 1991) it is thought that this molecule may also be integral 
to the melanin stimulating cytokine network of the skin.
Histamine. Histamine is a ubiquitous inflammatory factor that induces morphologic
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changes and increases in tyrosinase activity in human MCs (Yoshida et ah, 2000), These 
stimulatory effects of histamine are completely inhibited by treatment of the MC with a 
histamine antagonist, indicating a role for this molecule in post-inflammatory altered 
pigmentation.
Leukotriene B4. Arachidonic acid and its metabolites (eicosanoids) are membrane-derived 
inflammatory mediators with a diverse set of biological properties affecting the skin. They 
have been implicated in the pathogenesis of inflammatory skin disease and post- 
inflammatory hyperpigmentation. Leukotriene C4 and D4 in particular may affect post- 
inflammatory MC hyperplasia as they are found to enhance MC growth and melanin 
synthesis in vivo (Morelli et ah, 1989).
3.1.2 I L - la
3.1.2.1 H i s t o r y
During the 1980s a KC-derived molecule which acted as an inflammatory agent was 
isolated. This molecule, termed epidermal cell-derived thymocyte activating factor was 
later identified as IL -la , a member of the interleukin family of inflammatory mediators. 
This 31kD factor is expressed constitutively in the basal epidermis, in the absence of 
exogenous stimuli and can be isolated preformed in the epidermis. In contrast, upregulation 
of IL -la  translation and biological activity in both the epidermis and KC monolayers is 
detected in response to trauma, antigen stimulation, UV irradiation, TNFa, TGFp, CSF and 
IL-6. The IL -la  content of the sldn is therefore controlled by both paracrine and autocrine 
factors and the regulation of IL -la  in the skin can be considered an axis.
3.1.2.2 I L - la  STRUCTURE
IL -la  is a pleiotropic proinGammatory cytokine secreted by a wide range of cells. The 2 
isoforms, a  and p, are encoded by two distinct genes on chromosome 2 and they are 
translated as two 31kD molecules in a range of epithelial, haematopoietic and senescent 
cells. Although possessing 23% homology, the range of activity and the levels of 
inducibility of these two cytokines are different. IL-1 a  is predominantly secreted, in active 
form, from epithelial cells while IL-lp is secreted by monocytes, macrophages and antigen-
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presenting cells including LCs and other dendritic cells. As IL-ip requires proteolytic 
cleavage, IL -la  is considered, along with TNFa, to be a primary cytokine in terms of skin 
immunity and with specific reference to the skin, IL -la  is the main inflammatory cytokine 
of the LL-1 family.
3.1.2.3 IL-1 AXIS
As mentioned above IL -la  is constitutively expressed by the ‘normal’ resting epidermis 
where it does not exhibit an inflammatory effect. The expression and activity of this 
cytokine is monitored in what has become known as the IL-1 axis (Figure 37)
Agonist Antagonist
IL -la  IL-lra
II-IP lU lR  (2)
iL i  R (1) ÆmNam
Figure 37: Factors involved in the IL -la  axis
IL -la  exerts its inflammatory effects via an 80kD membrane-spanning receptor termed the 
IL-IR (type 1). This Toll-like receptor 4 (TLR-4) is activated when its ligand binds to the 
extracellular portion of this molecule, and to the receptor-associated protein MYD88. This 
dual binding results in conformational changes in the 215 amino acid cytoplasmic domain 
and in turn activates the recruitment of a group of serine threonine kinases termed 
Interleukin receptor-associated kinases. This kinase cascade terminates in phosphorylation 
of iKBa, which is the ubiquitous NFkB inhibitor, resulting in NFKB-dependent gene 
expression. The effects of IL -la  and p are therefore monitored by this ligand-receptor 
binding relationship and two main molecules, the IL-IR (type 2) and IL-1 receptor- 
antagonist (IL-lra).
IL-lra is an 18kD molecule which bonds to IL-IR (1) without initiating signal 
transduction. It therefore exerts its influence on IL -la  activity by quenching any non-bound 
IL-IR (1) hence preventing activation of the receptor by IL -la  and p. The IL-1 R (2) works 
in a similar manner. This 68kD membrane-bound receptor binds IL -la , p and the MYD88
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receptor-associated molecule, and quenches the activity of these ligands by preventing 
activation of the true receptor. Both of these molecules therefore regulate the effects of IL- 
1 and indeed their transcription and expression is directly related to the transcription and 
secretion of IL-lot and p.
3.1.2,4 IL-1 ACTIVITY
IL -la  mediates activity in the skin by initiating a multitude of effects on the cellular 
components of both the epidermis and dermis. External and paracrine/autocrine stimuli 
induce release of preformed IL -la  and upregulation of IL -la  transcription. As the primary 
immune response agent of the skin, IL -la  initiates activation of both the specific and non­
specific immune response. For example, IL -la  stimulates IL-8 production from KCs and 
fibroblasts kick-starting the adaptive immune response, while it also stimulates 
complement components C3 and factor B release from KCs. IL -la  also induces a range of 
additional effects which include increased KC proliferation, possibly due to the 
concomitant increase in growth factor receptor expression; increased ICAM expression in 
endothelial cells; and chemotaxis of B and T-cells. The multipoietic capacity of IL -la  and 
the nature of its TLR make it an excellent paradigm of an innate immune response element 
of the skin.
3.1.3 IL-8
3.1.3.1 I n t r o d u c t io n
IL-8 is a potent neutrophil chemoattractant, classified as a chemokine, which is produced 
by a variety of cell types upon stimulation. The role of IL-8 in skin disease often focuses 
upon its involvement in psoriasis and its function, if any, in the innate skin immune 
response has yet to be defined.
3.1.3.2 IL-8 HISTORY
IL-8 was initially identified in 1988 as an agent involved in controlling leukocyte 
migration, initially named monocyte chemotactic factor. The family of chemokines that 
was later identified share common structural and functional homology with IL-8, and 
currently the human chemokine family numbers in excess of 40 molecules. Chemokines
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are small 8-lOkD molecules sharing sequence homology based on conserved cysteine 
residues. They all contain four cysteines that form 2 disulphide bonds and the family is 
grouped depending on the spacing of the shared cysteine motif (CC, CxC Cx3C). 
Chemokines exert their influence via the five CxC and eight CC chemoldne receptors 
which exist, primarily on T lymphocytes. The chemokines cross react with each receptor 
and receptor binding results in activation of cellular immune responses. Chemokine release 
and binding has been implicated in a wide variety of diseases including HIV infection, 
where a chemokine receptor functions as a binding site on the T-cell for the virus. In 
addition, recurrent urinary tract infection associated with dysregulation of IL-8 receptor 
expression has been identified. In relation to the skin, chemokine expression of IL-8 is 
shown to be upregulated in psoriasis and is thought to contribute to the T-cell infiltration 
seen in psoriasis pathology.
3 .1 .3 .3  S t r u c t u r e  I ACTIVITY
Human IL-8 is a dimeric 16kD chemokine of the CxC grouping which is produced by 
monocytes, epithelial cells and leukocytes. While involved in the regulation of leukocyte 
maturation and circulation, IL-8 is mainly associated with cellular migration in response to 
injury and inflammation. As a member of the growth-related superfamily, it shares 
functional and structural homology with melanoma growth stimulatory activity, GRO-a, p 
and Y- IL-8 creates a chemoattractant gradient at sites of release and it activates neutrophils, 
in particular via the CxCR2 receptor on the neutrophil. This results in an increase in 
cystolic free Ca^’*’ which initiates phagocytosis and superoxide release from the neutrophil. 
As IL-8 is produced by both KCs and fibroblasts in response to IL -la  (Boxman et al., 
1996) and TN Fa (Newby et al., 2000) it is thought to be a major component of the 
cytokine regulatory network of the skin, and it is therefore hypothesized that IL-8 plays an 
integral role in skin homeostasis and disease pathogenesis.
3.1.4 E n d o t h e l i n
3 .1 .4 .1  I n t r o d u c t io n
ETs are a group of three peptides involved mainly in the alteration of endothelial cell 
adhesion molecule expression and vasoconstriction. ET-1 has been implicated particularly 
in the dermatological setting, possessing an immunoregulatory function.
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3 .1 A .2  H is t o r y
ET-1 was first recognized in 1988 as the vasoconstrictive component of enriched porcine 
endothelial cell medium. Subsequently its production has been identified in cancer cell 
lines, smooth muscle cells, endometrial cells and epithelial cells. In relation to skin cells 
ET-1 is produced by KCs, FBs and MCs and it effects epidermal cell proliferation in an 
autocrine and paracrine manner.
3 ,1 .4 .3  S t r u c t u r e  I ACTIVITY
ET-1 exerts its influence via binding to the ET-A and ET-B G protein coupled receptors. 
Binding results in activation of a cellular-specific MAP kinase cascade which stimulates 
proliferation, and in the case of MCs, melanogenesis. IL -lp, TNFa, TGFp, UVB and 
insulin stimulate ET-1 secretion. Secretion of ET-1 from KCs also activates a negative 
feedback mechanism of ET-1 secretion, via the ET-B receptor.
3.1.5 I n f e c t i o n  a n d  p i g m e n t a t i o n
It has long been established that inflammation, most commonly resulting from wounding, 
initiates melanin synthesis in the repaired areas. The role of infectious agents in the 
alteration of skin pigmentation has not however been examined. While M. furfur infection 
has long been clinically associated with altered pigmentation, little evidence exists as to the 
mechanism by which the organism elicits an alteration in the normal rate of melanin 
synthesis. Clinically, PV, an M. furfur-initiated infection, presents with scaling and altered 
areas of pigmentation on the chest and trunk, which has also been identified in penile 
infection (Smith, 1978). Moderate cellular infiltrates are observed in PV with the majority 
of infiltrating perivascular cells belonging to the mature T-cell phenotype (Scheynius et al., 
1984). Epidemiologically, PV affects 3.1% of the general population (Martins et al., 1989) 
and M. furfur serovar A  was found to be the predominant isolate on the chest and back of 
PV sufferers with no difference in the total population density of M. furfur in disease 
(Ashbee et ah, 1993). While no altered levels of overall humoral immunity are detected in 
PV (Ashbee et ah, 1994) 84% of the PV patients' sera recognises a 70 kD component of the 
oval M. furfur exoantigen (Silva et ah, 1997). SEM and transmission electron microscopy 
have been performed on skin material of patients with PV and this has revealed M. furfur 
predominantly in its mycelial phase, inside KCs in this infection. Lipid-like molecules are
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detected on the stratum corneum, and inside KCs, which may contribute to the 
hypopigmentation of some PV lesions, as they may constitute an ultraviolet light block 
(Borgers et ah, 1987).
Gas chromatography-mass spectrometry analyses of M. furfur growth on enriched medium 
demonstrate the generation of linoleic acid hydroperoxides (De Luca et ah, 1996). These 
oxidative agents may utilise skin lipids for ergosterol biosynthesis and as the oxidation of 
unsaturated fatty acids gives rise to dicarboxylic acids which behave, in vitro, as 
competitive inhibitors of tyrosinase, the lipid metabolism of M  furfur may affect normal 
melanin synthesis in this manner. Malassezia-dexived lipase also stimulates arachidonic 
acid release, a precursor for various pro-inflammatory agents from epithelial cell culture 
(Plotkin et ah, 1988), and this cytokine stimulation may be responsible for alteration in 
melanin synthesis of affected areas. M. furfur produces a melanin-like pigmentation when 
faced with altered nitrogen metabolism (Mayser et ah, 1998b); however, the relevance of 
this study is brought into question by the persistence of pigmented lesions, despite the 
resolution of infection. It has been shown that M. furfur does not directly affect tyrosine 
metabolism (El-Gothamy, 1981). Hence, the exact mechanism by which M. furfur alters 
melanin synthesis in PV is still unknown. Additional evidence for fungal involvement in 
melanin production exists, distinct from PV. Anti-MC antibodies are present in the sera of 
29% of patients with chronic mucocutaneous candidiasis suggesting that complement- 
fixing antibodies to MCs are associated with the establishment of chronic mucocutaneous 
candidiasis (Howanitz et ah, 1981).
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3.1.6 OBJECTIVES
The purpose of this work was twofold:
• To determine the levels of melanin and tyrosinase expression in skin models, mouse 
melanoma cells and BRT in response to M. furfur and M. /wr/wr-derived components.
• To determine the cytokine stimulatory capacity of M, furfur and to establish whether 
there is any difference in donor response to the organism.
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3.2 M e t h o d s
3.2.1 Tissue culture
3.2.1.1 M e l a n o m a  c e l l s
B16 F I mouse melanoma cells (low metastatic rate) were obtained from Dr L R, Hart, 
ICRF, London, UK. Cells were seeded at 3xl0^cells/cm^ into 35mm petri dishes and 
incubated in MEM supplemented with penicillin (100 units/ml), streptomycin (lOOug/ml), 
and L- glutamine (2mM) in 5% CO2 in air for approximately 4 days until confluent. At this 
time the cells were washed in PBS (3ml) and incubated with 2ml of fungal test suspension 
(organism, cell wall or cell extract, as detailed previously 2.2.3). Following incubation, 
cells were washed (2x, 3ml PBS) and trypsinised (0.25% (w/v) trypsin in PBS) for 30s and 
resuspended in PBS (5ml). Total cell number was obtained by adding 0.5ml of the cell 
suspension to electrolytic fluid (Isoton 2) for counting using a Coulter counter (Coulter 
Multisizer 2) thus obtaining the number of cells in the total sample. The cell suspension 
was then centrifuged (400xg, lOmin) and the pellet isolated and assayed for total melanin 
content.
3.2.1.2 KC MONOLA YERS
KCs were isolated and incubated as previously described (2.2.2.1). When cells reached 
confluence, monolayers were incubated with serum-free MEM at 37°C in 5% CO2 in air for 
24hr prior to inoculation with 10p.g/ml of M. furfur and C. albicans cell walls (suspended 
in serum-free MEM as previously described). KCs and cell walls were incubated for 24, 48 
and 72hr and following incubation, cell medium was harvested and aliquoted into 300pil 
samples and stored at -20^C until ELISA could be carried out. Matched KC RNA was 
isolated as previously described, and estimated by measuring the A280/A 280 ratio of each 
sample. RNA was then stored at -70^C till used in semi- quantitative RT-PCR.
3.2.1.3 B R T
BRT tissue was processed, inoculated and incubated as previously described (2.2.1.2). 
BRT epidermis was isolated by cutting the tissue into 5 x 2mm strips. These strips were 
then floated on to 0.5% (w/v) dispase in PBS and incubated overnight at 4°C. The tissue
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was then placed in a pre-weighed RNAse-free Eppendorf tube and freeze-dried overnight 
(12hr). Following freeze drying the tissue was weighed and melanin production assayed.
3.2.1.4 B R T  RN A ISOLATION
Freeze-dried BRT epidermis was treated as previously described to isolate RNA (2.2.4.1) 
and RNA integrity and quantity was determined as previously detailed in 2.2.4.1 and 
2.2.4.10 respectively.
3 .2 .2  M e l a n i n  A SSA Y
Melanin content was measured by a colorimetric method on a per cell basis. Cells were 
resuspended in 0.5ml distilled H2O and following two cycles of freeze/thawing, 0.5ml of 
IM perchloric acid was added to the mixture which was then incubated on ice for lOmin. 
Following centrifugation, (300xg, 5min) the pellet was washed twice in 0.5M perchloric 
acid, 3:1 v/v ethanol : ether and finally with ether. The pellet was dried overnight, 1ml of 
0.85M KOH was added, and the mixture was heated for lOmin at 100°C. The absorbance 
of the dissolved melanin was then measured at 400nm and compared against a known 
standard (Figure 38).
3.2.3 C y t o k i n e  S e m i - Q u a n t i t a t i v e  RT-PCR
3 .2 .3 .1  C y t o k in e  PRIMERS
Primers for IL -la , IL-8, ET-1 and GAPDH were synthesised by Gibco, Life technologies 
(UK) as detailed in Table 18.
3.2.3.2 Op t im is a t io n  o f  RT-PCR
The optimum amplification cycle number for each of the primer sets was established by 
determining when the amplification curve in the RT-PCR reaction reaches its optimum 
phase. This was achieved by making a 100p,l reaction mixture with each primer set and a 
constant sample of RNA and analysis of the RT-PCR products (i.e. when cycle number is 
at an optimum for amplification). Following determination of RT-PCR optimum, 2\xl of 
template KC RNA was subjected to RT-PCR using a Gibco BRL SS-one step reaction as 
previously described. Following cDNA synthesis (initial incubation of 50°C for 30min and 
94°C for 2min) each reaction mixture was amplified by a primer-specific amplification
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protocol of: 
Denature: 
Anneal: 
Extension:
94°C, 15s 
55~60°C, 30s 
7G°C, Imin
This cycle was repeated for 33 cycles for IL -la , 38 cycles for IL-8, 35 cycles for ET-1 and 
32cycles for GAPDH to give comparable PCR products.
Table 18: Primers for RT-PCR of cytokines.
Target PCR
Product
Sense primer Antisense primer Ref
IL -la 450 bp GTA AGC TAT GGC 
CCA CTC CAT
TGA CTT ATA AGC 
ACC CAT GTC
(Kondo et 
al., 1994)
IL-8 250 bp ATT TCT GCA GCT 
CTG TGT GAA
TGA ATT CTC AGC 
CCT CTT CAA
(Redondo et 
ah, 1997)30
ET-1 410 bp TTC CCA CAA AGG 
CAA CAG ACC G
GAC AGG CCC CGA 
AGT CTG TCA
(Teraki et 
ah, 1996)
GAPDH 180 bp TCT GGT AAA AGT 
GG A TATTGT TG
GAT GGT GAT GGG 
ATTTCC
3.2.3.3 A n a l y s i s  o f  c y t o k in e  mRNA e x p r e s s i o n
Having isolated each KC monolayer RNA, mRNA was amplified using IL-8, IL -la  ET-1 
and GAPDH primers. lOp.1 of each separate PCR reaction product was then loaded onto a 
1% agarose gel, run at 70 volts for 60min, and was densinometrically analysed using 
Quantiscan programme as previously described (2.2.4.11). Each cytokine was compared 
against the intensity of GAPDH-amplified matched RNA, thus allowing a relative measure 
of expression.
On analysis of genebank data, IL-8 primer proved to be incorrect in paper, ie published as ATT 
TCA, whereas the mRNA sequence requires ATT TCP for amplification. Author was unaware 
of the published mistake until this was pointed out.
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3.2.4 T Y R O SIN A SE  Q U A N T IT A T IV E  RT-PCR
A tyrosinase-specific RNA MIMIC was kindly supplied by Dr Geoff Brownbridge from the 
Department of Dermatology, University of Glasgow. In brief, the tyrosinase MIMIC 
(TYRMIMIC) was created by PCR. A segment of neutral DNA (from the pORSVICAT 
vector) was amplified using composite primers HTYRIM and HTYR2M. During this 
amplification the HTYRl and HTYR2 primers were incorporated onto the flagging ends of 
a 280bp long fragment. The product was then purified using Qiaquick PCR columns 
(Qiagen) and the concentration determined by the A260/A280 ratio.
T y r o s i n a s e  p r i m e r s
Human tyrosinase mRNA sense primer; HTYRl : TTG G C A G A T T G T C TG TA G C C  
Human tyrosinase mRNA antisense primer; HTYR2 : A G G C A T T G T G C A T G C T G C T I’
TYR MIMIC PR IM ER S
Human tyrosinase mimic primer sense:
HTYRl-Ml; T T G G C A G A T T G T C T G T A G C C T G A T A T A T C C C A A -T G G C A T C G T A A A G  
Human tyrosinase mimic primer antisense:
HTYR-M2 : a g g c a t t g t g c a t g c t g c t t t a a g g g t g a a c a c t - a t c c c a t a t c a c c a g
Cellular RNA was isolated from BRT epidermis and 2p,l of template RNA was subjected to 
RT-PCR using a Gibco BRL SS-one step reaction. In brief, 25 p.1 of 2x reaction buffer, Ipil 
of a 10|iM primer mixture (HBD-23 and HBD-25), Ipil RT-Taq polymerase, 2p,l template 
and 21 \il RNAse-free H2O was added to 2|il template RNA. cDNA was initially 
synthesised by incubating this reaction at 50°C for 30min in a Perkin- Elmer thermal 
cycler. cDNA was then denatured at 94°C for 30s and optimum amplification was achieved 
by 36 cycles of
Denature: 94°C, 15 s
Anneal: 55-60°C, 30s
Extension: 70“C, Imin
Control PCR, to determine the absence of primer-specific DNA in the RT-PCR reaction, 
was carried out using a Qiagen PCR as detailed previously (2.Z.4.9).
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3 .2 .4 .1  Ge l  ELECTROPHORESIS.
lOfxl of each reaction was loaded onto 2% agarose (IxTBE buffer withl[xg/ml ethidium 
bromide, as previously detailed, 2.2.4.10). Gels were run at 40 volts for 12hr allowing 
separation and analysis of the tyrosinase-specific and TYRMIMIC-specific bands which 
were analysed using Quantiscan as previously described (2.2.4.11).
3 .2 .4 .2  S t a t is t ic a l  a n a l y s is ! s a m p l e  d e t a il s
For the BRT melanin assay at each timepoint three samples were taken for each test 
substance with half of the tissue used to determine melanin content and the other half used 
for tyrosinase mRNA assay. The figures are expressed as the mean +/- the SEM. For B16 
monolayers each experiment was repeated 3x unless otherwise stated and the mean of these 
three experiments were expressed as above. Cytokine peptide expression experiments were 
carried out on 2 KC donors (triplicate samples/test substance/timepoint) while the cytokine 
RT-PCR assay was tested on 1 KC donor (diplicate samples/test substance/timepoint). 
Statistical analysis was carried out as previously described (2.2.5).
3.2.5 ELISA
Commercial ELISAs for human IL -la , IL-8 and ET-1 were obtained from R&D systems, 
(Oxon, UK) and cytokine measurements obtained as per manufacturers instructions.
3.2.5.1 IL-1 a
In brief, for IL -la  assay, cell culture supernatant samples were centrifuged to remove any 
particulate matter. 200p.l of the cell supernatant was added to the anti-cytokine antibody 
coated wells. Samples were incubated for 2hr at room temperature, aspirated and washed 
three times with wash buffer. Wells were then incubated with 200pil of IL -la  conjugate for 
Ihr, aspirated, washed three times with wash buffer and blot dried. Wells were then 
subjected to colour development by adding 200|il substrate and incubating at room 
temperature for 20min. Following incubation, SOjil of stop solution was added to each well 
and the OD of each well measured (3x) at 450nm using a Dynex spectophotometer (Dynex 
info). When running each sample an IL -la  standard, ranging in concentration from 3.9-250 
pg/ml was also measured and regression analysis, using FigP data package, allowed 
correlation between sample values and standard. The IL -la  assay was repeated three times
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and the values were expressed as pg/|ig KC RNA^h
3 .2 .5 .2  IL -8
For the IL-8 assay, 50[xl of KC supernatant was added to lOOpil of assay diluent and lOOfil 
of IL-8 conjugate and incubated for 2.5hr at room temperature. Wells were then aspirated, 
and washed six times with wash buffer. Following blot drying, 200p.l of substrate solution 
was added to each well and incubated for 30min at room temperature. 500p,l of stop 
solution was then added and the OD measure at 450nm as above. An IL-8 standard with a 
concentration range of 31.2-2000 pg/ml was measured during each test and regression 
analysis, using FigP data package, allowed correlation between sample values and 
standard. IL-8 measurements were done in triplicate and the values were expressed as 
pg/|Ag KC RNA.
3 .2 .5 .3  E n d o t h e l in -1
In brief, lOOfxl of assay diluent and lOOjil of sample or standard was added to each well and 
incubated at room temperature on a horizontal microplate shaker set at 500rpm for 90min. 
Following incubation, wells were washed four times with wash buffer and 200|a,l of ET-1 
conjugate was added to each well and incubated at room temperature for 3hr on the 
microplate shaker. Following incubation, wells were aspirated washed four times with 
buffer. 200p,l of substrate solution was added to each well and incubated at room 
temperature for a further 30min. The relative light units (RLU) of each sample was 
determined using a luminometer (Dynex technologies, MLX model luminometer). An ET- 
1 standard with concentration range of 0.32-5000 pg/ml was measured during each test and 
ET-1 measurements were assessed in triplicate and sample values expressed as pg/ml.
3.2.6 O r g a n is m  PREPARATION
3 .2 .6 .1  M . FURFUR
M. furfur was grown and viable cell suspensions were prepared as previously described 
(2.2.3.1). Crude cell extracts were obtained by inoculating 10ml PBS with a loopful of M.
31 200pg/ml of KC RNA = 1 xlO cells
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furfur (Hook) and emulsifying in a glass universal. This suspension was autoclaved (121‘^ C 
12min) and then centrifuged resultant solution centrifuged (400xg, lOmin) to remove the 
cell pellet. The supernatant (10ml) was diluted in MEM and added directly to the cell 
surface of MCs. Diluted MEM acted as the negative control medium.
3.2.6.2 M . FURFUR CELL WALL
M. furfur cell wall was isolated as previously described (2.2.3.3). Cell walls were diluted in 
MEM and added directly to the cell surface of MCs or dorsal surface of the BRT.
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3.3  R e s u l t s
3 J . l  MELANIN PRODUCTION BY B16 MELANOMA CELLS
A Standard curve of melanin absorption was generated for each experiment. From the 
standard curve obtained (Figure 38), the measure of melanin synthesis from each sample of 
cells was obtained via regression analysis of the OD value. Melanin production/ cell in 
‘normal’ untreated B16 cell populations reached a constant level following 72hr incubation 
after seeding onto 35mm dishes (Figure 39). It was therefore at this time that all 
experiments were initiated, to negate any possible influence of the fluctuation in melanin 
synthesis that accompanies growth of the B16 cells.
B16 cells responded to viable M. furfur in a dose-dependent manner with a significant 
increase in melanin production at 72hr (Figure 40). This contrasted sharply with the effect 
exerted by killed whole M. furfur which demonstrated a non significant suppression of 
melanin synthesis (Figure 41).
0.62 -1
0.52 -
0.41 -
S'
I 0.31
0
0.21 -
0.10  -
0 20 8040 60 100
Melanin
Figure 38: Standard curve of melanin absorbance measured at 400nm.
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Figure 39: Growth and melanin production by B16 mouse melanoma cells.
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Figure 40: Melanin production by B16 mouse melanoma cells in response to viable M. 
furfur.
*  Significant (iifference from control P<0.01
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In a separate experiment the cell wall component of M. furfur did not demonstrate 
inhibition of the melanin synthesis of the B16 mouse melanoma cells (Figure 42) and little 
difference between the M. furfur and C. albicans cell wall was observed. The only 
conclusion which could be drawn from thess data is that M. furfur cell wall did not 
stimulate melanin synthesis of the B16 cells in the same way as viable M. furfur did 
(Figure 40).
To determine which component of the viable cells stimulated melanin synthesis, B16 cells 
were co-incubated with two dilutions of a crude M. furfur cytoplasmic extract (Figure 43). 
In this experiment the B16 mouse melanoma cell controls exhibited lower levels of 
melanin synthesis, due to the need to dilute the MEM in PBS to obtain a reasonable control 
for the extracts. Even though the cells exhibited an overall decrease in melanin synthesis in 
response to this diluted MEM, it was evident that the concentrated M. furfur cytoplasmic 
extract stimulated melanin synthesis significantly at 48hr as illustrated in Figure 43.
Tim e (hr)
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Figure 41: Melanin production by B16 mouse melanoma cells in response to M. furfur 
cell wall (lOpg/ml) and killed whole cells (10  ^cells/ml)/^
* Significantly different to control P<0.()1
T h is figure represents a sin g le  assay o f  8 1 6  m elanin syn th esis.
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Figure 42: Melanin production by B16 mouse melanoma cells in response to M. furfur 
cell wall (lOpg/ml) and C. albicans cell wall (lOpg/ml)
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Figure 43: Melanin production by B16 mouse melanoma cells in response to M. 
furfur cytoplasmic extract.
* B o r d e r lin e  s ig n if ic a n c e  P > 0 .0 1 < 0 .0 5  
** S ig n if ic a n t  P <  0 .0 1
33 This figure represents a single assay of B16 melanin synthesis.
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This increase in melanin synthesis in the presence of cytoplasmic extract correlated with 
the increase observed when B16 cells were co-incubated with viable M. furfur. However, 
this was not a M. furfur-specific effect as viable C. albicans exhibited a similar pattern of 
stimulation when co-incubated with B16 cells (Figure 44); and indeed, C. albicans was 
more stimulatory than the viable M furfur. As the intensity of stimulation was greater with 
C. albicans than M furfur, a yeast-associated stimulation of melanin synthesis could be 
hypothesised. C. albicans growth in MEM was rapid compared to M. furfur thus the 
comparison of viable M. furfur and C  albicans has to be questioned. Although melanin 
synthesis was expressed as concentration (pg/ml)/10  ^ cells, there was an increased death 
rate of the B16 melanoma cells in response to rapid C. albicans growth and the resulting 
cell death may directly affect the surrounding B16 cell melanin synthesis.
%
Significant P<0.01 
Highly significant P<0.001
Time (hr)
Control H  
MJurfur ^
C. albicans [2 ]
%
72
Figure 44: Melanin production by B16 mouse melanoma ceils in response to viable M.
furfur and C. albicans (10 cells/ml of each).34
T h is figure represents a sin g le  assay o f  B 16  m elanin syn th esis.
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To determine the source of melanin stimulation by C. albicans, crude cytoplasmic extract 
was co-incubated with B16 cells. Figure 45 does not demonstrate any ‘C. albicans extract 
specific’ stimulation of melanin synthesis. By comparing the magnitude of melanin 
expression by B16 cells in response to viable C. albicans (Figure 44) and C. albicans 
cytoplasmic extract (Figure 45), it was evident that melanin expression was much higher in 
response to viable C. albicans than it was to C. albicans cytoplasmic extract (no difference 
observed in Figure 45). There was however a correlation between the B16 cell response to 
viable M. furfur and M. furfur cytoplasmic extract indicating that viable C. albicans may 
initiate an increase in melanin synthesis, not because of a metabolic by-product 
(cytoplasmic extract), but because of its direct toxicity as a result of its increased growth 
rate in MEM, on the B16 cell monolayers. Thus the increase in B16 melanin synthesis in 
response to viable C. albicans may be due to the surrounding cell death while M. furfur 
stimulation could be due to the organism’s metabolism.
Cootrul IH  
ExtriHl l/KKI ■  
Extiw l 1/10 \Z]
Time (hr)
Figure 45: Melanin production by B16 mouse melanoma cells in response to C. 
albicans cytoplasmic extract.
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3.3.2 M e l a n i n  p r o d u c t i o n  o n  t h e  BRT
Having established that viable M. furfur did stimulate melanin synthesis by B16 cells, it 
was desirable to examine this finding in a skin model system, namely excised BRT. Firstly, 
on examination of basal levels of melanin synthesis in BRT it was apparent that there were 
wide donor differences, as indicated by the large error bars in Figure 46. In addition, an 
increase in melanin production by the BRT was measured over incubation. Thus any 
increase or decrease in melanin synthesis had to be measured directly against time and 
donor matched controls.
&
1.50
1.28
1.06
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Figure 46: Melanin production by the BRT in response to time, average of 4 donors.
134
BRT was inoculated with viable M. furfur and C. albicans and donor differences in the 
response of the BRT to this experimental infection were detected. Occasionally an increase 
in melanin production was observed when viable M. furfur and C. albicans were applied to 
the dorsal surface of the tissue. As can be seen with donor 18 (Figure 47), there was not a 
constant increase in melanin synthesis in response to colonisation, since at 48hr a decrease 
in melanin synthesis was detected in response to both organisms. By contrast, with donor 
19 (Figure 48) there was increased melanin synthesis until 72hr when a suppressive effect 
became apparent. More surprisingly with donor 20, M. furfur initiated a larger increase in 
melanin production than C. albicans at 24hr indicating possible ‘donor sensitivity’ to M. 
furfur growth. With donor 20 (Figure 49), there was an unusual response to M. furfur 
growth at 72hr, with apparent inhibition of melanin synthesis.
A
C'nntnil ■  
M. fu rfu r  ^
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T im e (hr)
Figure 47: Melanin production by BRT, donor 18, in response to M. fu r fu r  and C. 
albicans growth.
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Table 19: Melanin production [melanin concentration (pg/ml) /pg epidermal tissue] 
by BRT in response to viable M, furfur and C. albicans. Range of expression between 
3 donors.
Time (hr)
2 4 48 72
Donor Control M.furfur C. albicans Control M. furfur C. albicans Control M.furfur C. albicans
18 0.664 0.789 0.656 0.786 0.765 0.694 1.114 1.302 1.382
19 1.121 2.079 1.631 0.937 1.609 1.988 1.635 1.141 1.283
2 0 0.877 1.373 1.839 0.863 0.955 1.550 2.322 1.008 2.097
Table 20: Tyrosinase production by BRT in respons to viable M. furfur and C. 
albicans (Log 10 molecules/pg RNA). Range of expression between 3 donors.
Time (hr)
2 4 48 72
Donor Control M.furfur C.albicans Control M. furfur C. albicans Control M.furfur C.albicans
18 11.976 12.305 12.923 12.943 13.695 13.928 13.957 12.961 13.507
19 16.268 16.692 16.968 16.679 16.597 16.987 16.591 15.972 15.577
2 0 10.818 11.149 11.149 10.896 11,442 11.325 10.957 10.751 10.708
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Figure 48: Melanin production by BRT, donor 19, in response to M. furfur and C. 
albicans growth.
(o n tn d
M .furfur
C. albicans [ 7 j
Time (hr)
Figure 49: Melanin production by BRT, donor 20, in response to M. furfur and C. 
albicans growth.
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By examining and comparing these results in Table 19 it was evident that melanin 
synthesis in response to C. albicans and M. furfur was not consistently measured in this 
assay. In addition none of these results demonstrated statistical significance, hence the 
effectiveness of this assay to measure melanin production on the BRT was questioned. 
Melanin production was largely unchanged by the addition of yeast cell walls to the BRT 
(Figure 50). In conclusion little difference in the production of melanin between inoculated 
and control tissue was observed.
Time (hr)
Conlrol H  
M.furfur W  
C. alhicaiK ( 3
Figure 50: Melanin production by the BRT, donor 21, in response to M .fu r fu r  and C. 
albicans cell wall (lOpg/ml)
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3.3.3 Tyrosinase production by BRT
After verifying the amplification profiles of tyrosinase and the TYRMIMIC in RT-PCR, 
tissue from 4 donors (which was ‘control’ incubated over 72hr) was assayed for melanin 
synthesis and tyrosinase production. From this matched tissue, tyrosinase expression was 
observed to increase roughly in line with melanin production. However as can be seen in 
Figure 51, 48hr value, tyrosinase synthesis did not always match up to melanin synthesis.
Ë
Î
1
2  10.75
24
T im e  (h r)
Figure 51: Tyrosinase mRNA and melanin production by the BRT in response to 
incubation (average of 4 donors).
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In g en er a l ty r o s in a se  tra n scr ip tio n  d id  n o t eq u a te  to  the m ea su re d  m e la n in  s y n th e s is  w h e n  
c o m p a r in g  th e tw o  m o d e ls  and  a s ca n  b e  se e n  b y  c o m a r in g  th e se  m a tc h e d  t is su e , o n ly  
rarely  w a s  a d irect c o r re la tio n  o b se r v e d . A s  can  b e  se e n  from  F ig u re  5 2  and F ig u re  4 7  n o  
co r re la tio n  b e tw e e n  ty r o s in a se  tra n scr ip tio n  and m e la n in  s y n th e s is  can  b e d e te c te d . A g a in  
w ith  d o n o r  19 (F ig u r e  4 8 ) ,  it w a s  n o t p o s s ib le  to  d ir e c tly  c o r re la te  ty r o s in a se  tran scr ip tion  
to  m e la n in  s y n th e s is ,  in  p articu lar  w ith  re fe r e n c e  to  th e r e s p o n s e  at 2 4 h r  to  M. furfur 
g ro w th  (F ig u r e  5 3 ) .  A g a in  litt le  co r re la tio n  b e tw e e n  m e la n in  s y n th e s is  and ty r o s in a se  
tra n scr ip tio n  ca n  b e  o b se r v e d  w ith  d o n o r  2 0  t is su e  (F ig u r e  4 9  &  F ig u re  5 4 )  and d o n o r  
t is su e  21 (F ig u r e  5 0  an d  F ig u re  5 5 ) .
CniKnil
M. furfur ^
C. albicans (71
Figure 52: Tyrosinase production by BRT, donor 18, in response to M .furfur and C . 
albicans  growth.
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Figure 53: Tyrosinase production by the BRT, donor 19, in response to M .furfur and 
C. albicans growth.
Control ■  
M. fu r fu r  g g
C. albicans (71
Figure 54: Tyrosinase production by the BRT, donor 20, in response to M.furfur and 
C. albicans growth.
In c o n c lu s io n  litt le  e v id e n c e  o f  e ith er  in crea sed  m e la n in  p ro d u c tio n  (T a b le  1 9 ) or
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ty r o s in a se  tra n scr ip tio n  (T a b le  2 0 ) ,  in r e sp o n se  to M. furfur and  C . albicans g r o w th , can  b e  
g a in e d  from  th e se  e x p e r im e n ts .
%%
Control
M .fu r fu r  ^  
C. albicans [ 2
Figure 55: Tyrosinase production by the BRT, donor 21, in response to M .fu rfu r  and 
C . albicans cell walls (10 pg/ml).
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3.3.4 S e m i - q u a n t i t a t i v e  RT-PCR
A m p lif ic a t io n  o f  K C  R N A  w ith  ap p rop r ia te  p r im ers a l lo w s  an e s t im a t io n  o f  I L - l a ,  IL - 8  
and E T -1  m R N A  p ro d u c tio n . T h e  o p tim u m  a m p lif ic a t io n  c y c le  r a n g e  fo r  e a c h  target h a d  to  
b e  d e te r m in e d  w ith  th e  o p tim u m  n u m b e r  o f  c y c le s  d e te r m in e d  b y  a n a ly s is  o f  th e R T -P C R  
re a c tio n . F ig u r e  5 6  illu s tr a te s  th e  a n a ly s is  o f  th e R T -P C R  a m p lif ic a t io n  o f  K C  R N A  fo r  IL - 
l a ,  w h ic h  a llo w e d  d e te r m in a tio n  o f  th e  o p tim u m  c y c le  n u m b e r  fo r  I L - l a  to  b e  3 3 .  C u r v es  
fo r  e a c h  s e t  o f  p r im er in  th e  R T -P C R  r e a c t io n  w e r e  a lso  fo r m u la te d  an d  th e  o p tim u m  c y c le  
n u m b er  w a s  c a lc u la te d  fo r  IL -8 , E T -1  and  G A P D H .
Z.2S -1
ÈS
2.00  -
I 1.75 -s
1
■3
I
1.25 -I
30 34 35 3631 32 33 37
N u m b e r o f  cycles (P C Il ex tscnsiun  cycle)
Figure 56: Amplification of IL-a by RT-PCR. Self-limitation of the reaction and the 
relationship between amplification cycle numbers.
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K C  m o n o la y e r s  from  1 d o n o r  w a s  in cu b a ted  and te sted  at 2 4 ,  4 8  and 2 7 h r in te rv a ls  w ith  
the R N A  iso la te d  for  u se  in  R T -P C R . S ta t is t ic a l a n a ly s is  c o u ld  n o t b e  carried  o u t o n  the  
R T -P C R  d ata  d u e  to  lo s s  o f  R N A  h e n c e  th e a v e r a g e  v a lu e  o f  2  
sa m p le s /t im e p o in t/tr e a tm e n t  is  e x p r e s se d  in F ig u re  5 7 -F ig u r e  5 9 . A s  can  b e  se e n  from  
F ig u re  5 7 , th ere w a s  a g en er a l in c r e a se  in  c o n s t itu t iv e  I L - l a  m R N A  e x p r e s s io n  b y  K C  
m o n o la y e r s  w ith  cu ltu re  t im e  and a s lig h t  in cr ea se  in I L - l a  m R N A  e x p r e s s io n  in  r e sp o n se  
to  T N F a  an d  M. furfur/C. albicans c e ll  w a lls  w a s  m ea su re d . In h ib it io n  o f  I L - l a  e x p r e s s io n  
ap p eared  to  b e  a s so c ia te d  w ith  T N F a  e x p o su r e  in  th is  e x p e r im e n t  at 7 2 h r  h o w e v e r  a s  th is  
e x p e r im e n t w a s  carried  ou t o n  o n e  d o n o r  K C  so u r c e , w ith  o n ly  d u p lic a te  s a m p le s  for  
m e a su r e m e n t, it w a s  im p o s s ib le  to  d e ter m in e  i f  th is  e f f e c t  w a s  s ig n if in c a n t . K C  m o n o la y e r  
c o n s t itu t iv e  IL - 8  m R N A  p ro d u c tio n  c o u ld  b e  d e tec te d  u s in g  th is  P C R , w ith  a d e c r e a s e  in 
IL - 8  p ro d u c tio n  w ith  t im e  (F ig u r e  5 8 ) .  T N F a  w a s  p a rticu la r ly  p o te n t at s t im u la t in g  K C  IL- 
8  p ro d u c tio n  at 2 4 h r . H o w e v e r  th is  s t im u la to ry  a b ility  d e c r e a se d  w ith  t im e . M . furfur and  
C. albicans d id  ap p ear to  s t im u la te  a s lig h t  in cr ea se  in IL - 8  p r o d u c tio n  at 2 4  and 4 8 h r  c o ­
in cu b a tio n ; h o w e v e r  n o  d if fe r e n c e  in  e x p r e s s io n  w a s  d e te c te d  at 72h r.
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Figure 57: IL -la  mRNA production in response to M .furfur and C. albicans cell walls 
(lOpg/ml) and TNFa. Semi quantitative RT-PCR amplification of Donor 1 KC RNA.
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Figure 58: IL-8 mRNA production in response to M. furfur and C. albicans cell walls 
(lOpg/ml) and TNFa. Semi quantitative RT-PCR amplification of Donor 1 KC RNA.
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Constitutive ET-1 production by KC monolayers decreased with incubation time (Figure 
59). M. furfur and C. albicans cell-wall-treated monolayers showed a marked rise in ET-1 
secretion at 24hr. No alteration in ET-1 expression could be detected at 48hr and 72hr as a 
result of exposure to TNFa, C. albicans or M. furfur cell walls. Comparison of mRNA 
levels and secreted peptides from IL -la, IL-8 and ET-1 revealed little correlation. Firstly 
IL -la  mRNA (Figure 57) and peptide levels (Figure 63) were similar until 72hr. IL-8 
mRNA and peptide production (Figure 58, Figure 64) also showed little correlation with 
some results exhibiting complete disparity i.e. cell wall and TNFa do not stimulate the 
same increase in message production as they did in peptide production at 48 and 72hr. ET- 
1 peptide production did not also appear to correlate to message production, with TNFa 
eliciting a sharp rise in ET-1 peptide production at 24, 48 and 72hr, which was not 
supported by an increase in ET-1 mRNA synthesis. Due to the sample size (1 donor) and 
lack of sample repetition this RT-PCR assay proved inconclusive in measuring cytokine 
mRNA production by KCs.
t
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Figure 59: ET-1 mRNA production in response to M .furfur and C. albicans cell walls 
(lOpg/ml) and TNFa. Semi quantitative RT-PCR amplification of Donor IKC RNA.
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3.3.5 ELISA
Because there was no access to a multi-filtered spectrophotometer, the OD of both the IL- 
l a  (Figure 60) and the IL-8 (Figure 61) samples for ELISA had to be measured without 
the wavelength correction of 540 and 570nm. The standard curves plotted therefore do not 
completely correlate to the expected data, as detailed in manufacturers instructions. In 
addition these ELISAs only maximally achieve 96% recovery of target, however as 
manufacturers instructions did not comment on the need for correction, the results were not 
corrected for the additional 4%. ET-1 standard curve was measured usilng a luminometer 
(Figure 62). Samples were standardized against the total RNA content of each monolayer.
S t a n d a r d  c u r v e  o f  I L - h  a b s o r b a n c e
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Figure 60: Standard curve of IL -la  absorption at 450nm.
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Figure 61: Standard curve of IL-8 absorption at 450nm.
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Figure 62: Standard curve of ET-1 luminescence (RLU).
148
To assay IL -la  levels, 2 KC monolayers were treated with both M. furfur and C. albicans 
cell walls (Figure 63- Average of the 2 donors). TNFa was also used as a positive control. 
No difference in IL -la  production could be detected until 48hr had elapsed. Only then did 
TNF-a initiate stimulation of IL -la  production, and they coincided with stimulation by M. 
furfur cell wall. At 48hr C. albicans cell wall did not elicit an increase in IL -la  production. 
After 72hr, KC monolayers had produced a significant increase in IL -la  in response to M. 
furfur cell wall, while TN Fa had stimulated an even greater increase in IL -la  production at 
this time. Two interesting points to note regarding IL -la  synthesis are that first constitutive 
production of IL -la  increases with time in untreated controls. Secondly, C. albicans cell 
wall stimulates an increase in IL -la  production after 72hr.
0.2 —
C ontro l
M alassezia  cell wall 
CandidaceW  wall [ 2 ]
T N F a  CD
Tim e (hr)
Figure 63: IL -la  secretion by KCs in response to M. fu r fu r  and C. albicans cell walls 
(lOpg/ml) and TNFa.
* Significant difference (P<0.01)
** Highly significant difference (P<().0()1)
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IL-8 secretion by KCs was also measured in response to co-incubation with M. furfur and 
C. albicans cell wall (Figure 64). Constitutive expression of IL-8 by KC monolayers 
showed an increase in expression with culture time. Positive control TNFa, a potent 
stimulator of IL-8 secretion, produced a dramatic increase in IL-8 production which 
dwarfed any change induced by either C. albicans or M. furfur cell wall; hence these data 
with TNFa was not shown Again, M. furfur cell wall initiated an increase in lL-8 
secretion by KCs at 48hr, while C. albicans showed no real increase. This situation was 
somewhat reversed at 72hr with M. furfur cell wall stimulating a further increase in lL-8 
production, while C. albicans cell wall stimulated a dramatic increase. Again two donors 
were tested for IL-8 production and comparable results were obtained.
B l o J  -
c »•»
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Figure 64: IL-8 secretion by KCs in response to M. furfur and C. albicans cell walls 
(lOpg/ml).
* Significant difference (P<().()1) ** Highly significant difference (P<0.()()1)
KC secretion  o f  IL- 8  in resp onse to T N F a  w as h ighly sign ifican t (P< 0.()01) at all tim es. M ean  
production at 24hr w as 19 .5p g /m l, 48hr 18.6pg/m l and at 72hr 8 pg/m l.
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The same populations of KCs exhibited a similar pattern of ET-1 expression similar to that 
for IL -la, while M. furfur and C. albicans cell wall did not appear to affect ET-1 synthesis 
after 48hr (Figure 59). Following incubation for 72hr, M. furfur stimulated a rise in 
detectable ET-1; however statistical analysis revealed that the difference was of borderline 
significance. What was interesting is that ET-1 production was constitutive and increased 
with time; moreover TNFcx stimulated ET-1 production at every timepoint, without 
reaching a saturation of stimulation.
C ontrol
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Figure 65: ET-1 secretion by KCs in response to M. furfur and C. albicans cell walls 
(lOpg/ml) and TNFa.
* Significant difference (P<0.01)
** Borderline significant difference (P>0.01<0.05)
*** Highly significant difference (P<().()()1)
Found value o f  T  w as so  c lo se  to the tabulated ‘s ig n ifica n t’ va lu e, w ith  appropriate d egrees o f  
freedom , as to warrant com m ent
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3 .4  D i s c u s s i o n
3.4.1 M elanin  SYNTHESIS
Melanogenesis in the epidermis is a complex biosynthetic process that centres on the 
interaction of the epidermal melanin unit, KCs and MCs, with the external environment. 
Clinically, M. furjur infection often presents with altered pigmentation, and following the 
experimental observation of altered pigmentation in M. yhr/hr-inoculated BRT, attempts 
were made to quantitate the capacity of M. furfur to alter melanin synthesis. During growth 
experiments with M. furfur on BRT, changes in the pigmentation of the inoculated tissue 
were observed. As excised tissue is traumatised and acts very much like wounded skin, an 
increase in post-excision melanin synthesis would be expected; however inoculated tissue, 
as compared with donor and time matched control tissue, did demonstrate a trend in 
increased pigmentation. As M. furfur infection often presents clinically with altered 
melanin synthesis it was decided to investigate the possible pathogen-associated factors 
which may alter melanin synthesis. The B16 melanoma data suggest that viable M. furfur 
cells could actively upregulate the melanin production in these mouse melanoma cells. It 
could be argued that these cells of murine origin are not the equivalent of human cells; 
moreover, the very fact that they are melanoma cells, oncogenic in origin, would point 
towards their unsuitability in assaying the stimulatory and inhibitory capacity of M. furfur 
in melanin synthesis. However, B16 melanoma cells have been used extensively in 
assaying the changes in melanin synthesis in response to many chemical and 
immunomodulatory molecules; this is largely due to their ease of culture and similar 
melanin metabolism, albeit greatly increased in B16 cells. During these experiments a 
trend did emerge indicating that M. furfur cell walls do not stimulate melanin synthesis 
whereas viable M  furfur cells and cytoplasmic extract appears to have a stimulatory 
capacity. To determine if M. furfur metabolism does alter melanin synthesis these 
experiments would have to be expanded to investigate the effect of cell wall fractions and 
metabolites on the HBD-2 production of the cells. The BRT data unfortunately proved 
inconclusive, and this assay method proved inaccurate in measuring melanin synthesis. As 
with the HBD-2 assay either the inconsistent nature of BRT donor melanin synthesis or the 
inaccuracy of the assay itself could be at fault. In this instance 1 feel that the assay was 
difficult to perform on BRT with large amounts of tissue required to give a measure of
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melanin production. In addition the tyrosinase assay, due to the sensitivity of RT-PCR, was 
subject to much variation in the results and could not be used to measure melanin 
synthesis.
Many M. furfur agents have been proposed to stimulate melanin synthesis including the 
cell-associated lipase, which becomes active at pH 7.5 (Plotkin et al., 1996; Ran et al., 
1993). Urease, alkaline phosphatase and hydrolase production by M. furjur (Dworecka- 
Kaszak et al., 1994; Mayser et al., 1996), may also contribute to the capacity of the 
organism to directly affect melanin synthesis. Hence it would be useful to develop a more 
accurate and reproducible assay to determine which component of the organism contribute 
to the effect on melanin synthesis see in vivo.
3 .4 .2  C y t o k i n e  r e s p o n s e
The stimulation of the epidermal immune response by M. furfur, or the lack of stimulation, 
is indeed a paradox. While remaining a skin commensal on the majority of the population 
this lipophilic yeast has been implicated in a wide range of cutaneous infections. Clues as 
to how the organism elicits hyperproliferation, mild inflammation and altered pigmentation 
in some individuals may exist in the cytokine immune response of the skin KCs to M. 
furfur. The upregulation of IL -la  in response to M. furfur is the first experimental 
indication that this organism should elicit an innate immune response in the skin. The IL- 
IR l is a TLR-4 and these receptors usually only recognize Gram-negative organisms, 
thereore it is unlikely that yeast would stimulate IL -la  production via the IL -lR l. The 
induction of IL -la  secretion and transcription may be due to IL -lR l recognition of lipid 
moieties of the M. furfur cell wall as pathogen-associated molecular patterns and 
transduces the signal accordingly. Some of the consequences of IL -la  release in vivo 
would account for some of the pathology associated with M. furfur infection, including 
both the hyper- and hypo-pigmentation seen in PV and the increased desquamation 
observed in SD. In addition to its mitogenic effects on KCs, which could account for this 
increase in epidermal proliferation, IL -la  also stimulates KC a-M SH release and receptor 
expression, which could contribute to any increase in pigmentation observed.
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As increased IL -la  expression stimulates further cytokine release from the surrounding 
KCs and epidermal cells, the effect of any initial IL -la  release could stimulate the immune 
response of these cells, increasing antigen presentation by LCs, stimulating adhesion 
molecule expression from endothelial cells and amplifying cytokine production via FBs. 
One of the most interesting results is that despite the stimulatory capacity of C. albicans 
cell wall on HBD-2 production, there appears to be a moderate increase in IL -la  in 
response to C. albicans. As another member of the commensal yeast population, C. 
albicans carriage is common, and the organism often becomes pathogenic only in severe 
cases of neutropenia and T-cell depletion. Thus the difference between the ability of M. 
furfur and C. albicans to initiate disease in ‘normal’ individuals may lie in the individual’s 
capacity to produce an innate immune response to M. furfur. While no donor variation was 
seen in the trend of the KC response to M. furfur cell wall (increase in a time-dependent 
manner), donor differences in the magnitude of responses was observed. This raises the 
possibility that some people may experience a more marked response to M. furfur, pushing 
the individual’s lL-1 axis over its ‘threshold’ into action. IL -la  expression will induce ET- 
1 secretion and the increase in ET-1 expression at 72hr indicates an accumulative effect of 
IL -la  synthesis on ET-1 expression. ET-1 production is normally associated with 
endothelial cell vasoconstriction in response to injury; however, KC production may be 
implicated in both KC mitogenesis and MC melanogenesis. ET-1 stimulates the MC- 
associated MAP kinases and this phosphorylation cascade terminates in increased 
tyrosinase production with concomitant increase in melanin synthesis. ET-1 production 
appears to be stimulated significantly (borderline) at 72hr by M. furfur compared to a 
relative lack of effect by C. albicans. This therefore indicates a specific stimulation of ET- 
1 by M. furfur and as such is a possible organism derived mechanism for melanin 
synthesis. Thus, the rise in ET-1 secretion in response to M. furfur cell wall may account 
for a putative pathway for M. furfur-specific induction of melanogenesis.
lL-8 production has been detected in direct response to microbial challenge (Huang et al., 
1998). IL-8 is a potent chemokine produced by a wide variety of cells and induced 
classically by LPS-stimulated monocytes. lL-8 is produced by KCs in response to M. furfur 
cell wall and this result has implications for the pathogenesis of two skin diseases. M. 
furfur has been implicated as an allergen/irritant for both atopic dermatitis and psoriasis. 
Thus M. furfur could act as a primary stimulant in establishing and exacerbating the
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dysregulated immune response in psoriasis. The creation of a chemotactic gradient by M. 
furfur could be responsible for the neutrophil and cellular accumulation observed in 
psoriatic plaques, or it could exacerbate existing plaques. Again, in atopic dermatitis, a 
positive correlation between head and neck dermatitis and positive patch test for M. furfur 
exists (Kim et al., 1999). The possible lL-8 stimulation in AD in response to M. furjur 
would exacerbate the cellular infiltration observed in AD. It is possible that IL-8 is induced 
in response to IL -la  induction directly or via the effect of IL -la  on a-M SH stimulation, 
and its capacity to upregulate IL-8 production. M. furjur and C. albicans do not necessarily 
equate to each other in terms of immunomodulating capacity (Huang et al., 1995) and the 
increase in IL -la  and ET-1 production by KC in response to M. furfur cell wall may trigger 
melanin synthesis in BRT by activating a range of co-factors. Other microbial by-products 
have been shown to interact in melanin biosynthesis. Staphylococcal exfoliative toxins 
cleave a-M SH, a potent initiator of MC melanogenesis, and this creates a possible pathway 
for post- inflammatory hypo-pigmentation following staphylococcal scalded skin syndrome 
other than the action of its exfoliative toxins.
While only 1 KC donor was used it was evident that cytoldne mRNA expression could not 
be equated to cytokine peptide synthesis using this assay. Little correlation between the 
mRNA and peptide production, was observed using this particular RT-PCR assay, however 
as several groups have shown good correlation between peptide and message production 
then increasing the donor size should allow for correlation of the message and peptide 
production^^.
37 Lack of KC donor material prevented repetition of this experiment.
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3.4.3 L im it a t io n s  o f  t h e  m o d e l s
There was wide variation in the results obtained from BRT, both in the tyrosinase assay 
and the melanin assay. This is due to two factors. Firstly, the two assays employed in the 
tissue assay of tyrosinase transcription and melanin synthesis are very sensitive. RT-PCR, 
in particular, is extremely sensitive to contamination and can be subject to great variation. 
In addition, donor differences in the tissue response to the organism exist. BRT, unlike B16 
melanoma cells, is not homogenous.
As the method employed previously in this study (Chapter 2) creates a LSE virtually 
devoid of MCs, this model was not used for any of the melanin synthesis experiments. 
Recent studies have attempted to standardise the addition of MCs to the LSE so this model 
could be used for melanin synthesis assays. Adding MCs to the model would allow greater 
standardisation in the assay techniques employed. For future studies it would be interesting 
to determine how in a model system more representative of conditions in vivo, the 
cytokines interact in melanin synthesis. This question can only be answered in a co-culture 
system. It is important, however, to recognise the different KC donor reactions of cytokine 
production which will still exist on the LSE.
In addition it is evident that there are some limitations to the detection of peptide 
production by using RT-PCR assays. Firstly trying to assay any alteration in melanin 
synthesis by measuring tyrosinase transcription indicates the problems in correlating 
tyrosinase transcription and melanin synthesis. This could be due to several factors, the 
main one being melanin synthesis does not directly correlate to MC tyrosinase 
transcription. TRP production, acidity of the melanosome etc all contribute to melanin 
content, thus tyrosinase transcription is not a direct indication of melanin synthesis.
In summary M. furfur appears to have little effect on the melanin synthesis of the skin 
models examined. While B16 cells exhibit increased melanin production in response to 
viable M. furfur, wide variation in the BRT response was measured. More in vfw-like 
models must be developed to establish if M. furfur growth or its cellular components have 
any effect on melanin synthesis. M. furfur and C. albicans cell walls did however stimulate 
IL-la, lL-8 and ET-1 secretion from KCs as measured by ELISA. This peptide secretion 
could not be correlated back to transcription using the PCR method employed.
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4  G r o w t h  o f  M a l a s s e z ia  o n  s k in  m o d e l s
4 .1  I n t r o d u c t i o n
The likely involvement of M. furfur in cutaneous infections has intensified the 
investigation and experimentation into the growth of this organism. Research has clearly 
established the dynamics of M. furfur growth both in vivo and in vitro and has enhanced 
our understanding of the metabolism and distribution of this lipophilic, dimorphic 
organism.
4 .1 .1  MALASSEZIA POPULATION DYNAMICS
M. furjur can be isolated from the majority of the population following puberty 
(Faergemann and Fredriksson, 1980). The back and chest are most frequently colonised 
while areas such as the arms and hands yield fewer organisms (Faergemann et al., 1983c). 
Between individuals of 30-80 years, there is a declining frequency of colonisation thought 
to be associated with decreased lipid production (Bergbrant and Faergemann, 1988), which 
is supported by the yearly decline in colonisation following puberty (Noble and Midgley, 
1978). In HIV-positive individuals, some studies indicate a higher density colonisation, 
however, these increased rates of colonisation do not correlate with increased cutaneous 
pathogenesis (Pechere et al., 1995). Conflicting reports exist surrounding the role of the 
declining T-cell population in this increased colonisation rate, with some groups 
identifying no significant correlation between CD4+ cells (Hakansson et al., 1988) while 
others express the belief in a connection (Schechtman et al., 1995b). Interestingly, serovar 
A predominates in the colonisation of the back area; however, no link between serovar type 
and infection rate exists (Ashbee et ak, 1993). Recent studies suggest that it is in fact M. 
sympodialis which is isolated from the back (Aspiroz et al., 1999) while M. furfur is 
isolated from the scalp, possibly due to its lipid preference.
4 .1 .2  M a la s s e z ia  g r o w t h
4.1.2.1 m e t a b o l i s m  ! a c t i v i t y
M, furfur is an obligatory lipophile requiring lipid for growth (Bond and Anthony, 1995), 
and this is supported in vivo where declining lipid isolation from skin correlates with
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declining colonisation (Bergbrant, 1991). In vitro acid and alkaline phosphatases, 
phosphohydrolase, leucine arylamidase, beta-glucosidase and lipase production can be 
detected during growth (Dworecka-Kaszak et ak, 1994). As mentioned previously, the 
production of lipoperoxidase required for ergosterol biosynthesis is essential for growth of 
M. furfur growth (De Luca et ak, 1996), and may account for some of the immunological 
influence of M. furfur on skin. Linked to this prerequisite for lipid, M. furfur is often 
isolated from the lipid-rich sites of the host and is frequently implicated in septicemia 
originating from IV lipid emulsion therapy (Halpin and Dahms, 1983). Unsaturated fatty 
acids promote growth of M. furfur in vitro (Mayser et ak, 1995) and another factor which 
promotes growth of M. furfur in vitro and in vivo is increased humidity. Occlusion of M. 
/wr/hr-infected sites results in an increased rate of growth of the organism, directly relating 
to higher levels of trans epidermal water loss, and increased re-infection is observed in 
geographical areas of high humidity (Faergemann et ak, 1983d). Cell wall hydrolase and a 
hydrolase produced by the metabolizing cell population are thought to be essential in the 
degradation of skin lipids (Mayser et ak, 1996). The skin pH of 5.0 also seems to be the 
optimum value at which the M. furfur lipase is enzymatically active (Ran et ak, 1993) and 
lipase activity is directly related to clinically isolated strains (Riciputo et ak, 1996). In 
systemic infection, M. furjur activates the blood coagulation system where the beta-glucan 
portion of the organism is implicated in clot formation (Suzuki et ak, 2000a). M. furfur 
also activates the complement cascade alternatively stimulating production of C5a 
anaphylatoxin (Terui et ak, 1989).
4.1.2.2 M o r p h o l o g y
M, furfur is a dimorphic yeast which exists in oval and hyphal form. In vitro cholesterol 
stearates induce hyphal transformation (Porro et ak, 1977) and in situ PV +ve specimens 
exhibit the characteristic ‘spaghetti and meatball’ hyphae and yeast on KOH digestion of 
skin scrapings (Abou-Gabal and Fagerland, 1979). Freeze-fracture investigations of PV 
+ve skin scrapings support the hyphal/yeast morphology in the pathogenesis of PV 
(Breathnach et ak, 1976; Mittag, 1995). Treatment of M. furfur with antifungals elicits 
alterations in the cell wall (McDaniel and Welton, 1984; Moulin-Traffort et ak, 1990; 
Faergemann and Bratel, 1996) due to inhibition of ergosterol biosynthesis by the 
antifungak With reference to colony morphology, 3 types prevail, again associated with the 
areas from which the organism can be isolated (Pechere et ak, 1999).
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4.1.3 SKIN MODELS
Although skin models are a good representation of sldn there are limitations placed upon 
the uses of such models, because of the morphology of the tissue. The LSE is a three 
dimensional model of viable stratified epidermis supported upon a FB-contracted collagen 
matrix. In brief, our protocol utilised collagen obtained from rat-tail tendons seeded with 
FBs obtained from breast reduction skin. The FBs attach to collagen fibrils and contract 
down the gel by drawing the fibrils together via contraction of their podia. KCs, obtained 
from the foresldns of 3-5 year olds, are then seeded onto a submerged collagen matrix, 
allowed to adhere and form monolayers. When raised to the air/ liquid interface, 
stimulation of KC differentiation occurs with the formation of distinct basal, spinous, 
granular and stratum corneum layers. In addition, expression of the appropriate keratin 
markers is found to be equivalent to in vivo levels, and laminin, type IV collagen and (34 
integrin are all deposited at the epidermal/dermal junction (Coulomb et al., 1998; Sugihara 
et al., 1991).
4.1.4 P r o l if e r a t io n  o f  e p id e r m is
Hyperproliferation of the epidermis is a characteristic of trauma to the skin, particularly in 
relation to the immune response. Many factors act as mitogens for KCs; UV, bFGF, IL-8 
and ET-1 all stimulate KC proliferation. M. furfur infections present with 
hyperproliferation, ranging from mild in the case of PV, to extreme in SD. Psoriasis, one of 
the most disturbing hyperproliferative disorders, is a direct response to the abnormal 
accumulation of immunological factors in the epidermis. Although the disease is genetic in 
origin, some investigators postulate an abnormal inflammatory response to the normal skin 
commensal organisms (Bunse and Mahrle, 1996; Elewski, 1990; Squiquera et al., 1994; Xu 
et al., 1991). AD is also a hyperproliferative disorder of the skin which is linked to M. 
furfur exposure (Broberg and Faergemann, 1995; Broberg et al., 1992; Kieffer et al., 1990; 
Svejgaard et al., 1989; Waersted and Hjorth, 1985; Wessels et al., 1991). Differential rates 
of microbial adherence to KCs are not implicated in Malassezia infections in the normal 
host (Bergbrant and Faergemann, 1994) or in the HIV positive population (Schechtman et 
al., 1995a).
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4 . 1 .5  O B JE C T IV E S
The purpose of this work was twofold;
• To determine the different patterns and rate of growth M. furfur and C. albicans on the 
two skin models (BRT and LSE).
• To measure epidermal proliferation in the skin models in response to yeast growth.
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42  M e t h o d s
4.2.1 TISSUE CULTURE
4 .2 .1 .1  B r e a s t  r e d u c t io n  t is su e
BRT was isolated and prepared as previously described (2.2.1.2).
4 .2 .1 .2  LSE
LSE was prepared as previously described (2.2.1.1).
4.2.2 O r g a n is m  PREPARATION
4 .2 .2 .1  M . FURFUR
M. furfur and C. albicans were prepared for inoculation onto the BRT and LSE tissue as 
previously described (2.2.3.1).
4.2.3 G r o w t h  a n a l y s is
4 .2 .3 .1  Q u a n t it a  t iv e  m e a s u r e m e n t s
Microorganisms were removed from the BRT and LSE surface, following incubation, by 
washing the tissue in a sterile universal containing 5ml PBS (230rpm for Ihr). Viability 
and growth of the organisms were assayed by centrifugation of 4ml of each wash fluid 
sample (1300xg, lOmin) and resuspension of the cell pellet in 400pil of sterile FBS. lOOp.1 
of serial dilutions of this concentrated cell pellet were plated onto Dixon’s agar, incubated 
at 37°C for 72hr and a CFU/ml value for the wash fluid was obtained.
4.2.5.2 SE M
Tissues were fixed for SEM staining by staff at IBLS, Univeersity of Glasgow. In brief 
tissue was fixed in 2.5% glutaraldehyde in IM  Sorrenson buffer^^ for Ihr then washed 
twice with 0.5M PO4 buffer. Samples were then postfixed in 1% sodium tetroxide, rinsed
Sorrenson buffer: 9.45g Na2HP0 4  and 9.07g KH 2 PO4  in IL distilled H 2 O, pH 5.6
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once with 0.5M P O 4  buffer and serially dehydrated in graded ethanol (25-100%). 
Thereafter samples were dried in a critical point dryer, mounted on aluminium stubs, 
sputter coated with gold and viewed in a Philips 500 scanning electron microscope. 
Matched tissue was fixed overnight in formalin, stained with PAS and H&E, as detailed in
4.2.4.2 and 4.2.4.3, and a visual observation as to extent of growth obtained.
4.2.4 H i s t o l o g y  
4.2A.1 S e c t i o n i n g
Following incubation, BRT and LSE tissue was fixed in 4% (v/v) formaldehyde in TBS^^ 
for 24hr. Tissue was then processed by staff at the Department of Dermatology 
(Dermatopathology), University of Glasgow, Glasgow. In brief the tissue was dehydrated 
in graded ethanol, embeding in paraffin wax and cut into 4p,m sections using a microtome.
4 .2 A .2  H is t o l o g ic a l  s t a in in g
H&E staining was carried out on slides by rehydration of the samples in xylene for 5min, 
ethanol for 3min and H2O for Imin. Samples were then stained with haematoxylin for 
5min, washed in H2O and alcohol for 5s and in Scott's tap water for 30-60s, Following 
washing, samples were stained in eosin for 5min, washed, dehydrated and covered with a 
glass cover slip. Slides were viewed using a Nikon 350 model microscope.
4 .2  A 3  F u n g a l  s t a in in g
PAS staining was carried out by rehydrating samples as above, and incubating slides in 
0.5% dispase, in PBS, for Ihr at 37°C. Samples were then washed in H2O for 5-lOmin, 
incubated at room temperature in periodic acid for lOmin and washed in H2O. Samples 
were further incubated in Schiffs reagent for 20min, washed in H2O and then nuclear 
staining was carried out by incubating in haematoxylin for Imin. Samples were then 
washed, rehydrated and covered with a glass slip.
4.2.4A iMMUNOmSTOCHEMISTRY
39 Tris buffered  saline; 900m l sa lin e (8 .5gN aC l/L ), 1 0 0 m l tris buffer pH  7.6 .
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For immunohistochemistry, 4 micron thick paraffin sections were placed on silane-coated 
slides and fixed by heating overnight at 37°C. Sections were hydrated as detailed above. 
High-pressure antigen retrieval was then carried out by microwaving the slides on full 
power (650W) for 25min in 1 litre of 0.25M Tris HCl (pH 7.6), in a pressure cooker. After 
cooling, slides were left in the buffer for 20min, and then washed in H2O. Endogenous 
peroxidase was blocked by adding 0.3% H2O2 to each sample and leaving for 15min. 
Samples were then washed in tap H2O, left in TBS for 5min, then incubated with 20% 
normal rabbit serum for 20 min after which the blocking serum was drained off. The 
sections were then covered with 1/100 dilution of mouse monoclonal primary antibody to 
Ki-67 in TBS (Ki-67-specific antibody from DAKO Ltd, Angel grove, Ely, 
Cambridgeshire, UK) and incubated for 60 min at room temperature. Following incubation, 
samples were washed 3x for lOmin in TBS. Samples were then incubated with secondary 
antibody (biotinylated rabbit anti-mouse,) for 30min, washed in TBS (3x lOmin) and 
incubated with extra-avidin - peroxidase conjugate for 30min. Samples were then washed 
in TBS (3x over 6min), stained using VIP chromagen Idt SK4600 (Vectastain, Vector 
Laboratories Ltd, Accent Park, Orton, Southgate, Peterborough, UK) and washed in H2O. 
Slides were then counterstained in haematoxylin for 2min, H2O for Imin, acid/alcohol for 
30s, Scott's tap water for Imin, H2 O for 5min, methylated spirit for 2min, alcohol for 3min 
and xylene for 5min and mounted in DPX mountant.
4.2 A .5 PROLIFERA TIVE INDEX
A measure of the proliferation of the epidermis was obtained by counting the number of 
Ki-67-positive cells/ 1000{xm of basal epidermis. As Ki-67 is a measure of active cellular 
proliferation it allowed a comparative estimaion of the proliferation of the skin models 
epidermis.
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43  R e s u l t s
4.3.1 SEM OBSERVATIONS OF SKIN MODELS
The two skin models, LSE (Figure 66 & Figure 67) and BRT (Figure 69), showed similar 
properties on SEM investigation. The stratum corneum of both models, the main area of 
colonisation for Malassezia species, displayed similar dorsal surfaces. The stratum 
corneum of LSE however had a slightly higher rate of desquamation as indicated by the 
increased number of loosened corneocytes observed in SEM (Figure 67). Despite identical 
methods of treatment during preparation for microscopy, the LSE showed distinct 
corneocyte shedding following 24hr incubation, whereas the BRT desquamation rate was 
only comparable with the LSE following 96hr post-excision incubation (Figure 69).
Figure 66: Scanning electron micrograph of transverse section of LSE (x400)
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Figure 67: Scanning electron micrograph of the dorsal surface of the LSE following 
24hr incubation. Desquamation of epidermis evident (x800).
Figure 68: Scanning electron micrograph of the individual corneocytes on the dorsal 
surface of the LSE (xl200).
166
Overall the surfaces of both the BRT and LSE and specifically the dorsal surfaces, 
resembled each other sufficiently well to allow SEM comparison of the growth of M. furfur 
on each. One of the more obvious differences in microscopic evaluation of the tissues was 
the presence of hair follicles in the BRT (Figure 70). The tissue fixed was approximately 
lcm “ and hair follicles were commonplace over the dorsal surface.
Figure 69: Scanning electron micrograph of the BRT dorsal surface following 96hr 
incubation. Individual corneocytes evident (xl200).
Figure 70: Scanning electron micrograph of BRT with hair follicle (xl200).
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4.3.2 SEM OBSERVATIONS OF FUNGAL GROWTH ON LSE
4.3.2.1 GROWTH OF M. FURFUR ON LSE
A lth o u g h  d istr ib u ted  in  an id e n tic a l fa sh io n , M . furfur and  C. albicans had v e r y  d is t in c t  
p attern s o f  c o lo n is a t io n  o n  the L S E . F o llo w in g  24h r in c u b a tio n , M. furfur w a s  d istr ib u ted  
in d is t in c t  c o lo n ie s  or  c lu s te r s  (F ig u r e  7 1 ) . W ith in  th e se  c lu s te r s , b u d d in g  o f  th e o r g a n ism  
w a s  lim ite d  and  th ere w a s  a d isc r e te  b ord er to ea c h  c o lo n y  w ith  large  areas u n -c o lo n is e d  
b e tw e e n  th e se  c o lo n ie s .  F ig u re  71 d isp la y s  b u d d in g  c e l l s  lo c a te d  o n  th e L S E  fo l lo w in g  
2 4 h r  in c u b a tio n  w ith  M. furfur at d iffer en t s ta g e s  in th e o r g a n is m ’s l i f e  c y c le  e v id e n t . T h e  
larger c e l ls  are th o se  w h ic h  are p r e d o m in a n tly  b u d d in g  w ith  th e  se p e r a te d  sm a lle r  d a u g h ter  
c e l ls ,  su rr o u n d in g  th e se  large c e l l s  h a v in g  b e c o m e  sep a ra ted  p r e v io u s ly . B u d d in g  w a s  
o b se r v e d  fre q u en tly  at th is  s ta g e  in  th e se  iso la te d  c o lo n ie s .  H y p h a l p r o d u c tio n  w a s  n ot  
o b se r v e d  u n til 4 8 h r  in c u b a tio n  (F ig u r e  7 2 );  w h e n  the ch a r a c te r is tic  irregu lar h y p h a e  o f  M. 
furfur c o u ld  b e  se e n  o n  th e L S E  at 4 8 h r  (F ig u r e  7 3 ) . T h e  h y p h a e  p ro d u c ed  b y  M. furfur are 
w id e  co m p a r e d  to  the m o th er  c e ll  d ia m e te r  and b o th  F ig u re  7 3  and F ig u re  7 4  d em o n stra te  
th is .
CA
4
Figure 71: Scanning electron micrograph of M. furfur on LSE following 24hr
incubation at 37^C. Cavitation of the epidermis (CA) and budding evident (xl200).
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Figure 72: Scanning electron micrograph of M. furfur on LSE following 48hr 
incubation. Hyphal transformation observed (x4000).
Figure 73: Scanning electron micrograph of M. furfur on LSE following 72hr 
incubation. Philaospore extrusion (P) and hyphal invasion (HI) into stratum corneum 
observed (x8000).
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F ig u re  7 3  illu s tr a te s  th e p r e se n c e  o f  a su r fa ce  c o a t in g  on  the o r g a n ism . T h e  c o a t in g  i t s e l f  is  
n ot u n ifo rm  an d  c o u ld  b e  a g ly c o c a ly x - l ik e  m ateria l. F ig u re  7 3  and  F ig u re  7 4  s h o w s  h o w  
the M. furfur h y p h a e  b rea ch  th e stratum  c o r n e u m , w ith  in ser tio n  th rou gh  a c o r n e o c y te  
b e in g  e v id e n t . T h is  m icro g ra p h  su p p o rts  the n o tio n  that M. furfur p r o d u c e s  a k era tin o ly t ic  
e n z y m e  that a id s  its  in v a s io n  an d  a l lo w s  it to  p en etra te  the stratum  c o r n e u m . F ig u re  7 4  
s h o w s  the m o r e  w id e sp r e a d  p ro d u c tio n  o f  h y p h a e f o l lo w in g  7 2 h r  in c u b a tio n  on  the L S E ,  
and a g a in  illu s tr a te s  th e  in ser tio n  o f  the h y p h a e in to  the stratum  c o r n e u m .
Figure 74: Scanning electron micrograph of M. furfur on LSE at 72hr. Hyphal 
extension and budding evident with hyphal invasion into the stratum corneum 
(xl200).
170
4.3.2.2 C. ALBICANS GROWTH ON LSE
W id e sp r e a d  h yp h a l tra n sfo r m a tio n  o f  C. albicans w a s  o b se r v e d  o n  the L S E  fo l lo w in g  
in c u b a tio n  fo r  2 4 h r  in c u b a tio n  (F ig u r e  7 5 )  or 4 8 h r  (F ig u r e  7 7 ) . L arge areas o f  th e  t is su e  
w e r e  c o v e r e d  w ith  n u m e r o u s  h y p h a e  and b la s to c o n id ia  fo r m in g  a ty p ica l biofilm'^'* o n  the  
t is s u e  su r fa c e  (F ig u r e  7 6 ) .
B
Figure 75: Scanning electron micrograph of C. albicans growth on LSE following 
24hr incubation. Spherical yeast cells with true hyphae (H) and blastoconidia (B) 
present (x4000).
For the con text o f  th is d scu ssion  a b io film  shall be d efined  as a co llec tio n  o f  yeast/hyphal 
c o lo n ie s  assoc ia ted  together and attached to the skin surface. T h is shall include those w ith  or 
w ithout any extracellu lar matrix m aterial d eposition .
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Figure 76: Scanning electron micrograph C. albicans on LSE following 48hr 
incubation (x4000).
F o llo w in g  in cu b a tio n  for  4 8 h r  h y p h a e  w e r e  freq u en tly  o b se r v e d  o n  th e p er im e te r  o f  th e C. 
albicans b io f i lm  (F ig u r e  7 7  and F ig u re  7 8 ) . T h e s e  h y p h a e  o f te n  in ser ted  in to  th e stratum  
co r n e u m  o f  the e p id e r m is  (F ig u r e  7 8 ) , s o m e t im e s  re su ltin g  in  w id e sp r e a d  d estru c tio n  o f  the  
L S E  su r fa c e  a fter  72h r. C lo se r  in v e s t ig a t io n  r e v e a ls  that true h y p h a e  are p ro d u c ed  b y  th e C. 
albicans at 4 8 h r  (F ig u r e  7 9 ) . A s  ca n  b e  se e n  from  F ig u re  8 0  an d  F ig u re  7 6  h y p h a e  
p ro d u c tio n  an d  b ra n ch in g  w e r e  s o  w id e sp r e a d  as to crea te  a b io f i lm  e f fe c t  o v e r  th e d orsa l 
su r fa ce  o f  the t is su e .
Figure 77: Scanning electron micrograph of C. albicans on LSE following 48hr 
incubation. Evidence of hyphal invasion into the stratum corneum (x8000).
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Figure 78: Scanning electron micrograph of C. albicans on LSE following 48hr 
incubation. Conidiophores observed with hyphae and invasion into epidermis 
(x4000).
Figure 79: Scanning electron micrograph of C. albicans on LSE following 48hr
incubation. True hyphal production with clusters of yeast cells (x8000).
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Figure 80: Scanning electron micrograph of C. albicans on LSE 72hr incubation. 
Spherical yeast cells with yeast cells, branched pseudohyphae and true hyphae 
observed. Generalised invasion of the epidermis was detected (xl200).
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4.3.3 SEM OBSERVATIONS OF FUNGAL GROWTH ON BRT 
4.3.3.1 M. FURFUR ON BRT
A s  m e n tio n e d  p r e v io u s ly , th e d orsa l su r fa c e  o f  B R T  is  s im ila r  in stru ctu re and c o m p o s it io n  
to  that o f  L S E . S im ila r  p a ttern s o f  g r o w th  for b o th  C. albicans an d  M. furfur w e r e  o b se r v e d  
on  B R T , w ith  c lu s te r s  o f  c e l ls  b e c o m in g  w id e sp r e a d . B u d d in g  o f  M. furfur w a s  rarely  
o b se r v e d  at 2 4 h r  (F ig u r e  81 and F ig u re  8 2 )  but large d is t in c t  c o lo n ie s  w e r e  d e tec te d . 
B u d d in g  o n  B R T  b e c a m e  m o re  c o m m o n  after  4 8 h r  in c u b a tio n  (F ig u r e  8 3  and F ig u re  8 4 ) .  
W id esp re a d  b u d d in g  o f  the m a jo r ity  o f  c e l l s  in the c o lo n y  w a s  o b se r v e d  but th ere w a s  no  
h yp h al tra n sfo r m a tio n  at that tim e .
Figure 81: Scanning electron micrograph of M. furfur on BRT following 24hr 
incubation. Ellipsoidal, ovoid and spherical yeast cells observed in clusters with some 
cells exhibiting unipolar budding (xl200).
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B e c a u se  o f  the n o n -h o m o g e n e o u s  n ature o f  B R T , d iffer en t rates and p attern s o f  
c o lo n is a t io n  w e r e  se e n  in th e t is su e s . T h e  p r e se n c e  o f  hair f o l l ic le s  on  s o m e  o f  th e B R T  
a c c o u n te d  for th e a c c u m u la tio n  o f  M. furfur on  b oth  th e h air sh a ft  and  fo l l ic le ,  w h ic h  are 
k n o w n  to b e  a c o m m o n  areas o f  c o lo n is a t io n  for the o r g a n ism  (F ig u r e  8 4  and F ig u re  8 5 ) .
Figure 82: Scanning electron micrograph of M. furfur on BRT following 24hr 
incubation. Budding rarely observed (x3200).
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Figure 83: Scanning electron micrograph of M. furfur on BRT following 48hr
incubation. Extensive budding observed with a distinct collarette (C) (x4000).
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Figure 84: Scanning electron micrograph of M. furfur on BRT following 48hr 
incubation. Clumps of ovoid cells in distinct colonies with budding visible (xl200)
Figure 85: Scanning electron micrograph of M. furfur on hair follicle following 48hr 
incubation on BRT. Accumulation of organism on the hair follicle and exposed shaft 
with fibrin-like structures connecting yeast-yeast and yeast-hair shaft (x3200).
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G r o w th  o f  M. furfur o n  th e hair sh a ft  w a s  a s so c ia te d  w ith  f ib r o u s  stru ctu res that ap p eared  
to  c o n n e c t  th e sep a ra te  M. furfur c e l ls  to  ea c h  o th er, b ut a lso  a n ch o red  M. furfur to  th e  hair  
sh a ft (F ig u r e  8 6 ) .  E x te n s iv e  b u d d in g  b y  M. furfur w a s  o b se r v e d  o n  the hair sh a ft  in  all 
d o n o r s  in d ic a t in g  a p o s it iv e  n u trien t e n v ir o n m e n t in th is  area  in  a ll o f  the d o n o r s  te sted .  
B u d d in g  c o n t in u e d  at 7 2 h r  in c u b a tio n  and th is  w a s  a s so c ia te d  w ith  d isc r e te  c lu m p s  o f  M. 
furfur. H y p h a l tra n sfo r m a tio n  w a s  n o t d e tec te d  in an y  s a m p le s  u ntil 7 2 h r  in cu b a tio n  
(F ig u r e  8 7 )  and  w a s  s t il l  l im ite d  at th is  t im e .
Figure 86: Scanning electron micrograph of M. furfur on a hair follicle after 72hr. 
Showing a mixed population of spherical and ellipsoidal cells with evidence of 
budding. Fibrous structures (F) associated with cells (x8000).
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XFigure 87: Scanning electron micrograph of M. furfur on BRT following 72hr 
incubation. Clumps of mixed cells with hyphal extension (H) and budding (B) 
observed (x8000).
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43 .3 .2  C. ALBICANS GROWTH ON BRT
G ro w th  o f  C. albicans o n  BRT w a s  s lo w e r  than  o n  L S E . C. albicans h yp h a l tra n sfo rm a tio n  
w a s  h o w e v e r  d e te c te d  o n  th e BRT s a m p le s  fo l lo w in g  4 8 h r  in c u b a tio n . A lth o u g h  it w a s  n ot 
as w id e sp r e a d  a s  that o b se r v e d  in L S E , C. albicans d id  s h o w  c o n tin u e d  p ro d u c tio n  o f  
h y p h a e  from  4 8 h r  o n w a r d s . C lu m p s  o f  c e l ls  w e r e  a lso  fr e q u e n tly  o b se r v e d , o fte n  in the  
sk in  fo ld s  o f  BRT, w ith  n o  h yp h a l e x te n s io n  (F ig u r e  8 8 ) .
Figure 88: Scanning electron micrograph of C. albicans in skin fold of B R T  after 48hr 
incubation (xl200).
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H y p h a l e x te n s io n  from  th e  p er im iter  o f  th e C. albicans c lu s te r s  w a s  o b se r v e d . A s  F ig u re  8 9  
s h o w s , d is t in c t  z o n e s  o f  c o lo n is a t io n  w ith  o u tr e a c h in g  h y p h a e  w e r e  o b se r v e d . T h e  
tra n sfo rm a tio n  o f  C. albicans o n  B R T  o c c u r e d  ear lier  than  th e tra n sfo rm a tio n  o f  M. furfur 
on  th e sa m e  t im e  m a tc h e d  d o n o r s . F ig u re  9 0  d e m o n str a te s  th e  p r e se n c e  o f  C. albicans 
h yh al p ro d u c tio n  o n  the t is su e  at 72h r.
Figure 89: Scanning electron micrograph of C. albicans on BRT after 48hr showing 
clumping of spherical cells with limited hyphal production (xl200).
Figure 90: Scanning electron micrograph of C. albicans  on BRT after 72hr. Single 
yeast cells, distinct clusters and clusters of yeast cells along the hyphae are apparent 
(x4000).
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4.3.4 Histology of skin models
C o m p a ra tiv e  h is to lo g y  o f  B R T  sh o w e d  n orm al ep id er m a l m o r p h o lo g y  in  th e e x c is e d  sk in , 
w h e n  e x a m in e d  f o l lo w in g  H & E  s ta in in g  (F ig u r e  9 1 ) . A fte r  2 4 h r  in c u b a tio n , the co n tro l 
e x c is e d  t is su e  s t ill  re ta in ed  its  n orm al m o r p h o lo g y  (F ig u r e  9 2 );  h o w e v e r , the v ia b il ity  
d e c lin e d  w ith  in c u b a tio n  t im e , a s  can  b e  se e n  b y  the K C  v a c u o la t io n  in th e t is su e  (F ig u r e  
9 3 ) . F o l lo w in g  9 6 h r  in c u b a tio n , co n tro l B R T  sh o w e d  a n e c r o t ic  m o r p h o lo g y  w ith  large  
v a c u o la te d  c e l ls  in m a in ly  the g ra n u lo su m  layer  o f  the e p id e r m is ;  th is  w a s  o b se r v e d  u s in g  
b oth  H & E  s ta in in g  (F ig u r e  9 3 )  an d  P A S  s ta in in g  (F ig u r e  9 4 ) .
Figure 91: Histological observation of BRT on day of excision (H&E xlOO).
Figure 92: Histological observation of control BRT 24hr post-excision (H&E x400).
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Figure 93: Histological observation of control BRT 96hr post-excision (H&E x400).
Figure 94: Histological observation of control BRT 96hr post-excision (PAS x400).
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T h e  p r o to co l u sed  for  fo r m u la tio n  o f  L S E s resu lted  in v ia b le  e p id e r m a l- lik e  t is su e  (F ig u r e  
9 5 )  that re m a in e d  v ia b le  in  e x c e s s  o f  9 6 h r  (data  n ot s h o w n ) . It is  im p ortan t to  re m em b e r  
that the L S E s  b e c a m e  read y  for e x p e r im e n t c o m e n c e m e n t  f o l lo w in g  10  d a y s  in c u b a tio n  at 
the air liq u id  in te r fa c e . T h er e fo re  t im e  z e r o  e q u a lle d  10  d a y s  in c u b a tio n  at th e air liq u id  
in ter fa ce . T h e  a d d it io n  o f  a sc o r b ic  a c id , a s  d e ta ile d  p r e v io u s ly , sh o u ld  h a v e  im p r o v e d  the  
lip id  c o n te n t  o f  th e t is su e , w h ic h  w a s  n ot a n a ly sed , b ut h s to lo g ic a lly  th is  t is su e  p o s s e s s e d  
an in vitro  lik e  s tra tif ic a t io n  w ith  d is t in c t  b a sa l, gran u lar and h orn y  la y ers  (F ig u r e  9 6 ) .
Figure 95: Histological observation of control LSE following 11 days of incubation at 
air liquid interface; 24hr control (H&E x400).
Figure 96: Histological observation of control LSE following 48hr incubation (H&E 
x250).
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D u e  to  the w e a k  n ature o f  the b a se m e n t m e m b r a n e /h e m i-d e s m o so m a l lin k a g e , the  
ep id er m a l layer  o f  th e L S E  w a s  p o o r ly  an ch o red  to  the u n d e r ly in g  d erm al c o m p o n e n t  and  
fre q u en tly  d e ta c h e d  d u r in g  p r o c e s s in g  (F ig u r e  9 6 ) . T h e  stratum  co r n e u m  o f  th e L S E  w a s  
p articu lar ly  w e ll  d e v e lo p e d , d u e  to the h y p e rp ro life ra tiv e  nature o f  the K C s w ith in  the  
e p id e r m is  (F ig u r e  9 7 ) . In a d d it io n , th e  stratum  co rn eu m  th ic k e n e d  in r e sp o n se  to  cu ltu re  
t im e  f o l lo w in g  in c u b a tio n  at the a ir / liq u id  in ter fa ce  as can  b e  se e n  b y  co m p a r in g  F igu re  
9 5 , F ig u re  9 6  an d  F ig u re  9 7 . T h is  w a s  d u e  to  in cr ea se d  d iffe r e n tia tio n  o f  L S E  K C s and th e  
a b se b c e  o f  sh e d d in g  in th e h u m id if ie d  p r o te c tiv e  a tm o sp h e re .
Figure 97: Histological observation of control LSE following 72hr incubation (H&E 
x250).
185
4.3.5 Histological observations of fungal growth on LSE
G r o w th  o f  b o th  C. albicans and  M . furfur o n  the sk in  m o d e ls  a p p ea red  to  p r o ce ed  m ore  
ra p id ly  o n  L S E  than  o n  B R T . D is t in c t  c lu m p in g  o f  M. furfur w a s  o b se r v e d  in  the stratum  
co r n e u m  o f  th e L S E  f o l lo w in g  4 8 , 7 2  and 9 6 h r  in cu b a tio n  (F ig u r e  9 8 , F ig u re  9 9  and F igu re  
1 0 0 ) . T h is  c lu m p in g  w a s  in co n tra st to  th e h yp h al tra n sfo r m a tio n  o f  C. albicans in the  
u pp er stratum  co r n e u m  o f  th e L S E  at 4 8 h r  (F ig u r e  1 0 1 ) . H y p h a l p ro d u c tio n  b y  C. albicans 
w a s  restr ic ted  to  th e u p p er stratu m  co r n e u m  o f  th e L S E  and w a s  c o m m o n ly  o b se r v e d  in the  
t is su e  at th is  t im e . M . furfur o n ly  b eg a n  to  u n d erg o  h yp h a l tra n sfo r m a tio n  fo l lo w in g  7 2 h r  
in c u b a tio n , w ith  in term itten t h yp h a l e le m e n ts  p ro d u ced  (F ig u r e  1 0 2 ) . T h e s e  c e l ls  w e r e , lik e  
C. albicans at 4 8 h r , c o n f in e d  to  th e stratum  co r n e u m  o f  th e L S E  b ut m o st  c o m m o n ly  M. 
furfur ca n  s t ill  b e  se e n  in  u n tra n sfo rm ed  c lu m p s , a g a in  in  th e stratum  co r n e u m  (F ig u r e  
100).
Figure 98: Histological observation of LSE following 48hr co-incubation with M. 
furfur. Clumps of M. furfur in the stratum corneum are apparent (H&E x400).
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M o re  w id e sp r e a d  h yp h a l p ro d u c tio n  b y  C. albicans c o u ld  b e  o b se r v e d  at 9 6 h r  (F ig u r e  1 0 3 ). 
D e str u c t io n  o f  t is su e  b y  th e C. albicans h y p h a e rea ch ed  th e d e r m is . T h is  d estru c tio n  w a s  
c o m m o n ly  o b se r v e d , and the r e m a in in g  L S E  t is su e  w a s  e x tr e m e ly  d a m a g e d  and  th u s c o u ld  
n ot b e  c o n s id e r e d  v ia b le . If the in cu b a tio n  w a s  c o n tin u e d  p ast 9 6 h r , the stratum  co r n e u m  o f  
the L S E  w a s  n o t d e te c te d  b y  h is to lo g y . M . furfur, h o w e v e r , d id  n o t s h o w  a n a lo g o u s  
w id e sp r e a d  p r o d u c tio n  o f  h y p h a e , and o n ly  a fe w  h y p h a e c o u ld  b e  d e te c te d  in d esq u a m a te d  
la y ers  o f  th e stratum  co r n e u m  o f  L S E  (F ig u r e  1 0 2 ). M o r e  w id e sp r e a d  c lu m p in g  o f  M. 
furfur w a s  o b se r v e d  at 9 6 h r  (F ig u r e  1 0 0 ) , su p p o rtin g  the th e o ry  that the o r g a n ism  d o e s  
su sta in  g r o w th  o n  the t is su e .
Figure 99: Histological observation of LSE following 72hr co-incubation with M. 
furfur. Yeast budding in the stratum corneum can be seen (H&E x400).
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Figure 100: Histological observation of LSE following 96hr co-incubation with M. 
furfur. Clumps of M. furfur in the stratum corneum can be seen (H&E x400).
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Figure 101: Histological observation of LSE following 48hr co-incubation with C.
albicans. Clumps of C. albicans in the stratum corneum can be seen (PAS x400).
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Figure 102: Histological observation of LSE following 72hr co-incubation with M. 
furfur. Clumps of M. furfur and hyphal production in the stratum corneum observed 
(PAS x450).
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Figure 103: Histological observation of LSE following 96hr co-incubation with C. 
albicans. C. albicans hyphae can be seen in the epidermis, spreading down to the LSE 
dermis (H&E x250).
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4.3.6 Histological observations of fungal growth on BRT
Histological examination of BRT co-incubated with M. furfur demonstrated clumping of 
the organism in the stratum corneum of the excised tissue epidermis following 48hr 
incubation (Figure 104). Tissue co-incubated with C. albicans also exhibited clusters of 
cells in the upper epidermis, and attachment of C. albicans to the desquamated layers of the 
stratum corneum was widely observed (Figure 105) BRT samples co-incubated with either 
M. furfur or C. albicans for 24hr had no organisms in the stratum corneum, and no hyphae 
were detected. At 72hr clumping of both M. furfur (Figure 106) and C. albicans became 
more widespread. In all experiments the organisms were still confined to the stratum 
corneum of the BRT.
Figure 104: Histological observation of BRT following 48hr co-incubation with M. 
furfur. Clumps of M. furfur in the stratum corneum can be seen (FAS x400).
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Figure 105: Histological observation of BRT following 48hr co-incubation with C. 
albicans. Clumps of C. albicans can be seen (PAS x400).
I
Figure 106: Histological observation of BRT following 72hr co-incubation with M. 
furfur. Clumps of M. furfur in the stratum corneum observed (PAS x400).
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In some time samples the hyphal production resulted in widespread epidermal damage. 
Hyphal growth on BRT became extensive at 72hr for M. furfur (Figure 107). In general 
hyphal transformation by C. albicans always occurred at 72hr, if not before; however, M. 
furfur did not produce hyphae at all experiments. Tissue from some donors appeared to 
stimulate little M. furfur hyphal transformation (Figure 108), while some donors stimulated 
extensive hyphae production widespread destruction of the stratum corneum Figure 109). 
Other inoculated tissue samples showed only limited hyphal transformation of M. furfur, 
and in these cases the transformation was restricted to the upper layers of the stratum 
corneum (Figure 108). C. albicans displayed hyphal transformation repeatedly in tissue 
incubated for 72hr or less (Figure 110). Extensive destruction of the stratum corneum, as 
seen in Figure 110, was commonplace with the C. albicans hyphae reaching into the 
dermis of the BRT.
%  ^
Figure 107: Histological observation of BRT following 72hr co-incubation with M. 
furfur. M. furfur hyphae can be seen in the stratum corneum (PAS x450).
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Figure 108: Histological observation of BRT (donor 22) following 96hr co-incubation 
with M. furfur. Hyphal extension into stratum corneum can be seen (PAS x400).
%
Figure 109: Histological observation of BRT (donor 23) following 96hr co-incubation 
with M. furfur. Destruction of the epidermis by hyphae can be seen (H&E x400).
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Figure 110: Histological observation of BRT following 72hr co-incubation with C. 
albicans. Extension of C. albicans hyphae into the dermis can be seen (PAS x400).
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4 .3 .7  G r o w t h  o f  f u n g i  in  s k in  m o d e l s
Growth curves for both C. albicans and M. furfur on the LSE revealed that C  albicans had 
a much higher growth rate on this tissue. Moreover, there was a detectable difference in the 
growth of both fungi when ICCs from different donors were used as a component of the 
LSE (Figure 111 and Figure 112). The significance of donor differences was highlighted by 
the very different patterns of growth obtained in BRT from two donors (Figure 113 and 
Figure 114). While donor 24 appeared to allow a rapid and substantial increase in C. 
albicans cell numbers, there was limited growth on BRT from donor 25. Growth of both 
was better on LSE than on BRT, as can be seen by comparing Figure 111 & Figure 112 
with Figure 113 & Figure 114. The rate and magnitude of growth of C. albicans and M. 
furfur was greatly increased on the LSE tissue. This finding is consistent with the 
histological and SEM data obtained in sections 4.3.5 and 4.3.6.
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Figure 111: Growth of M. furfur and C. albicans on LSE, donor 1.
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Figure 112: Growth of M. furfur and C. albicans on LSE, donor 2.
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Figure 113: Growth of M. furfur and C. albicans on BRT, donor 24.
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Figure 114: Growth oiM , furfur and C. albicans on BRT, donor 25.
4.3.8 P r o l if e r a t iv e  in d e x  o f  s k in  m o d e l s
As can be seen from Figure 115 and Figure 116, there was clear Ki-67 staining of both 
BRT and LSE. Ki-67 antigen is expressed during active cellular proliferation (G1 stage of 
cell cycle) thus its expression in a cell indicates active proliferation. Therefore by counting 
the number of positive cells/1000pm of the basal epidermis, a measure of the proliferation 
of the tissue could be obtained. Examination of BRT from two donors showed that growth 
of M. furfur and C. albicans stimulates an increase in proliferation of the breast tissue 
epidermis. While C. albicans produced a rise in the proliferation of the breast tissue 
epidermis, M. furfur appeared to overtake the C. albicans ‘stimulation’ at 72hr (Figure 
117), at a time when the previous data (Figure 113 and Figure 114) indicated growth of C. 
albicans was far greater than that of M. furfur. Ki-67 staining was not restricted to the basal 
epidermis in LSE, but was in BRT. This indicated the increased proliferative index of LSE 
while in resting phase.
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Figure 115: Ki-67 staining of BRT 72hr control
Figure 116: Ki-67 staining of LSE 48hr control.
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D u e  to  th e rap id  g ro w th  o f  C. albicans on  L S E  (F ig u r e  1 1 1 , F ig u re  1 1 2 )  it w a s  im p o s s ib le  
to  o b ta in  a tr ip lic a te  co u n t  o f  th e  K i-6 7  p ro life r a t iv e  in d e x  o f  the L S E  in  r e sp o n se  to  C. 
albicans c o lo n is a t io n  s in c e  the e p id e r m is  w a s  o fte n  c o m p le te ly  d e str o y e d  and c o u ld  n ot  
w ith sta n d  im m u n o h is to c h e m ic a l p r o c e s s in g . A s  F ig u re  1 1 8  d e m o n str a te s , M. furfur d o e s  
in d u c e  a s ig n if ic a n t  in c r e a se  in  L S E  p ro life ra tio n  in r e sp o n se  to  in itia l c o lo n is a t io n  at 24h r .
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Figure 117: Proliferation of BRT in response to M. furfur and C . albicans 
colonisation.
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Figure 118: Proliferation of LSE in response to M./wr/i/r colonisation.
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4 4  D i s c u s s i o n
The colonisation of normal human skin by M. furfur has long been recognised and studies 
of the metabolic requirements of M. furfur have established an absolute requirement for an 
exogenous lipid source. The growth of M. furfur has been demonstrated in vitro, in animal 
models (guinea pigs) and in skin models; however, little evidence exists as to the 
morphology of the organism in model systems. The SEM and quantitative growth 
measurements carried out in this study attempted to clarify the growth rates and patterns of 
M. furfur and C. albicans on BRT and LSEs.
Previous studies have established the role of LSE in investigating fungal infections 
(Battacharyya et al., 1998). While studies on M. furfur infection of LSE revealed the ability 
of the organism to sustain growth, no evidence was present concerning the differences in 
donor KCs, and their antimicrobial activity, to inhibit or promote growth. As this study has 
pointed out, not only do different excised tissues yield different growth patterns of M. 
furfur and C. albicans, but the LSE, an apparently homogenous skin model, also affects 
fungal growth due to the differences in KCs from different donors. As can be seen from 
both the histological data and SEM observations, fungal morphology varies greatly on 
different host tissue. While C. albicans produced hyphae when grown on BRT from some 
donors, BRT from other donors sustained only limited growth with little hyphal 
production. As nutrient stress is often a triggr for hyphal production in C. albicans it is 
possible that the nutrient lacking environment of the LSE did promote hyphal production 
by the organisms. M. furfur also exhibited donor differences in its growth rates and patterns 
on BRT, with some tissue initiating extreme growth and destruction of the entire 
epidermis, due to hyphal formation. Other tissue only supported limited cluster-type 
growth with no hyphal formation observed, however in these models clustering was often 
widespread over the tissue. It is possible that different strains of organism, had they been 
used, may have exhibited different colonisation patters however as the strains used were 
from clinical isolates it is assumed that they would be most likely to act and adhere as 
pathogens. A  putative explanation for differences in LSE growth patterns may be the lipd 
concentration of the skin equivalent. The LSE, which having been raised to the air/liquid 
interface 10 days previously never formulates a appropriate barrier function due to its 
altered lipid profile. The percutaneous penetration of the LSE, which is very high 
compared to skin, indicates the dysregulation in both the LSEs barrier function and its lipid
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profile and it is probable that this irregular lipid concentration greatly effect the lipd 
sensitive M.furfur.
The reverse should be true for BRT where a lipid profile more closely resembling that in 
vivo should exist. This would stimulate growth and differences in host lipid levels in the 
BRT may contribute to the differences in C. albicans and M. furfur growth. In addition to 
this 'donor-difference'; there is also the possibility that the KCs of both LSE and BRT may 
have varying rates and quantities of HBD-2 production. As demonstrated previously, both 
BRT, ICC and LSE produce different levels of HBD-2 mRNA. Thus, the production of this 
antimicrobial peptide would directly affect the growth of the organisms on these tissues.
One of the most interesting results obtained in this study is the increase in the proliferative 
index of KCs measured in these skin models in response to infection. This appears to be 
the first time that any skin model has been assayed for a direct effect on the proliferation of 
the epidermal KCs. It would be useful to obtain the proliferative index of biopsied, infected 
skin, and biopsied normal skin in those individuals suffering from M. furfur infections, 
particularly SD which manifests clinically mainly as epidermal hyperproliferation. As 
mentioned previously, the rise in IL -la  transcription and secretion in response to M. furfur- 
associated compounds could be responsible for this rise in epidermal proliferation since IL- 
l a  directly acts as a mitogen for KCs. The difference in Ki-67 staining patterns between 
BRT tissue and the LSE should be noted. As a naturally occurring tissue, BRT exhibits the 
limited Ki-67 staining of the basal KCs expected of ‘normal’ skin. LSE, with its 
hyperproliferative epidermis, reveals Ki-67 staining in the higher layers of the epidermis. 
This supports the conclusion that LSE is not completely equivalent to in vivo skin. 
However, as long as these limitations are recognised, LSE can still be used successfully in 
various areas of skin research, and in particular for further studies into M. furfur infection.
One of the other points raised in this study highlights the danger of only undertaking 
histological observation of the growth and extrapolating this to in vitro growth. Little 
growth can often be observed by histological analysis of the tissues while the viability 
studies (Figure 111, Figure 112, Figure 113 & Figure 114) all indicate that growth occurs 
on both models, albeit slow in the case of M  furfur. Pehaps a better indication of growth 
and indeed the patterns of growth obtained, comes from studying the SEM data. SEM 
allows an overall view of the dorsal surface of both tissues, allowing the examination of the
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patterns and extent of both M  furfur and C. albicans growth on these tissues. I believe 
SEM therefore allows a more detailed examination of the nature of the organisms growth 
on these tissue and thus I believe it should be used in preference to histology in such 
studies.
Hence what is the validity of using these skin models as directly comparable to M. furfur 
infection in vivol Firstly to employ these models it is essential to use several donors, both 
for the formation of the LSE (KC donors) and for BRT (use a wide range of tissue donors). 
By measuring the ability of M. furfur and C. albicans to grow on various donor-derived 
tissues, a pattern of M. furfur and C. albicans growth may be revealed which is dependent 
upon site of isolation of tissue or KCs. The lipid content of the skin is determined by KC 
and sebum production from the sebaceous glands, therefore it is possible that the BRT in 
particular would have large variations in the lipid content of the epiderms as any sebaceous 
glands are still intact in the tissue.
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5  G e n e r a l  d i s c u s s i o n
The question around which most M. furfur research, and indeed this thesis is based upon, 
relates to how M. furfur initiates cutaneous infections. While remaining a commensal for 
the majority of the population, M. furfur is known to cause a myriad of dermatological 
disorders that have a range of manifestations. It is generally accepted that commensals 
remain commensal because of their weakly pathogenic nature and the effectiveness of host 
defences in maintaining a limited population. If this is true, two hypotheses present 
themselves as the most logical explanation for the establishment and progression of these 
diseases. Either some component of the organism is altered, resulting in its increased 
pathogenicity, or some aspect of the host environment is altered, initiating the pathology of 
disease. Several investigators have attempted to address this question by studying 
colonisation patterns in M. furfur-associatQd disease and the differences in host response 
between infected and non-infected individuals''\ The results obtained are inconclusive, for 
reasons that will be discussed. However it seems likely that differences in host reactions 
predominate in the transition from M. furfur colonisation to M  furfur infection.
5.1  O r g a n is m  FACTORS
Firstly focusing on the organism, it is reasonable to assume that the reversion from 
commensal to pathogen in M. furfur-associated disease could be due to differences in the 
organism. Many pathogenic organisms possess virulence characteristics that are in addition 
to their species classification (eg. E.coli 0157). Despite the innocuous nature of M  furfur, 
it is possible that certain strains of the organism may contain pathogen-associated factors 
that contribute to its infectivity.
5 .1 .1  T y p i n g  o f  M ,  f u r f u r
Typing of M. furfur on skin indicates the presence of three serovars that specifically react 
with anti-M. furfur antiserum, and hence are able to elicit an immune response. While no 
differences in colonisation rates between these serovars exist in FV and SD infection, the
For the purpose of this discussion, infected individuals are those suffering from PV, SD 
folliculitis etc, while non-infected individuals are those who are colonised but do not suffer 
from any recognisable disease.
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serovar types can be isolated from distinct areas of the body. Some immunological 
differences in the host reaction to these organisms can be identified in infected individuals 
where serovar A stimulates a significant increase in IgG and a decrease in IgA in SD and 
PV respectively (Ashbee et al., 1994). The difference in the immunological reaction by 
infected individuals indicates that a difference in host response to the organism is 
responsible for the transition to infection since no difference in organism density or overall 
numbers could be detected. Thus, induction of the immune response as described in this 
study, is an organism-independent phenomenon, based on the fact that uninfected controls 
had the same type and quantity of organisms as infected individuals.
5.1.2 M . FURFUR CLASSIFICATION
One of the main problems in identifying pathogenic M. furfur strains has been the difficulty 
in classifying the Malassezia species and the problems with nomenclature. Until recently 
the identification of Malassezia species has relied upon classical microbiological, 
morphological and metabolic identification mechanisms which are methods open to errors 
due to the similar characteristics of all the organisms in the Malassezia species Using 
microscopy and biochemical analysis, a mixed population of M. furfur, M. globosa and M. 
sympodialis has been identified on normal human skin (Aspiroz et al., 1999). This is 
contrary to the historical evidence that only M. furfur, while under the nomenclature 
Pityrosporum orbiculare, colonises human skin with an increase in organism density on 
the chest and back (Faergemann et al., 1983c). The identification of a mixed population on 
human skin has also indicated that M. furfur predominates in both PV and SD while M. 
sympodialis is mostly isolated from normal skin (Makimura et al., 2000). Perhaps this is 
the problem in clarifying the pathogenicity of M. furfur: that M. sympodialis is isolated as a 
commensal on normal skin while M. furfur is the pathogenic Malassezia species. If this is 
the case, then a study of the differences in metabolism of these organisms would be 
appropriate, to determine the pathogenic factors which may initiate disease. One study has 
compared the growth of M. furfur and M  sympodialis, indicating very different metabolic 
pathways and patterns whereby M. sympodialis produces significant ammount of free fatty 
acids and ethyl esters, while M. furfur produces only small amounts of both metabolites 
(Mayser et al., 1998a). The contribution of these metabolites to the initiation of infection
' M. furfur alone can exist in spherical, globose and hyphal forms.
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has never been established, as they have not been tested on any kind of skin model; hence, 
the exact relevance of the differences in metabolism between these two organisms cannot 
be clarified. The confusion surrounding both nomenclature and classification of Malassezia 
species must be resolved in order to establish M. furfuî' as the human Malassezia pathogen. 
A retrospective study, utilising the novel molecular typing methods (Maldmura et al., 
2000) needs to be carried out on a large dataset of clinically isolated M. furfur. In addition, 
the metabolic profiles of both M. furfur and M. sympodialis would have to be analysed, and 
different metabolites tested on skin models, to determine whether a pathogenic strain of M. 
furfur exists.
5.1.3 F u n g a l  c o l o n is a t io n
Putting aside the possibility that M. furfur is the primary pathogen of Malassezia species, 
there are several other M. /wr/wr-associated factors that may contribute to disease. One of 
the most obvious possibilities is that increased carriage of the organism, whatever 
Malassezia species it might be, would result in an organism overload whereby the host 
defence is over-whelmed, resulting in disease. M. furfur colonisation begins in infancy with 
the organism detected during the first 12 weeks of life. In infantile seborrheic dermatitis, 
the infant equivalent of SD, M. furfur is cultured from 90% of infected children, compared 
with 20% of the non-infected population (Broberg and Faergemann, 1989). This study 
directly conflicts with more recent data obtained on ISD and M. furfur colonisation 
(Broberg, 1995) and indeed it is the only study which supports a link between increased 
colonisation with M. /hr/hr-associated disease in the normal (non-HIV positive) 
population. The rate of M. furfur colonisation does increase with age, peaking at puberty, 
directly relating to the peak in sebum production by the host. Hence the rise in colonisation 
rates is not due to an increase in the organism’s pathogenicity, or the growth of a 
pathogenic strain of Malassezia; rather, this is a host-derived alteration of the habitat of the 
resident M. furfur population. M. jurjur colonisation is greater in the Caucasian population, 
compared to the black population (Noble and Midgley, 1978), and if M. furfur load was 
responsible for infection a correlation with increased colonisation and increased infection 
might be expected in these populations. No detectable difference in infections between the 
races exists in the epidemiological data, thus supporting the theory that fungal density does 
not increase pathogenicity.
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Direct examination of SD and non-infected individuals yields conflicting results on 
whether M. furfur carriage is increased in infection. Bergbrant and Faergemann (1990) 
investigated quantitative differences in M  furfur carriage between SD and non-infected 
individuals, and reported that there was no significant difference in numbers of organisms 
between the two groups (Bergbrant and Faergemann, 1990). This finding contrasts greatly 
with the data of Heng et al (1990) which revealed a relationship between M. furfur carriage 
and SD severity. The variation in results may be due to differences in the quantitative 
methods used by these two groups. Some studies which examined the HIV-positive 
population, support the conclusions of Heng et al. For example a greater density of M  
furfur carriage could be detected on HIV-positive individuals, without M  furfur disease, 
than non-HIV positive individuals (Pechere et al., 1995). A  weak trend between organism 
load and increased severity of SD in the HIV positive population has been identified by 
two groups (Ross et al., 1994; Schechtman et al., 1995b). Thus there appears to be a 
relationship between increased density of M  furfur in the non-infected HIV-positive 
population and limited evidence of an increase in SD severity with increased M. furfur 
colonisation in this populationA possible explanation for this is that in the HIV-positive 
individual the normal immunosurveillance, which protects the skin and all other lymphoid- 
associated tissues, is depleted and unable to keep in check the proliferation of its 
commensals. This is supported by data relating to the colonisation of the mucosa in HIV- 
positive individuals, with organisms previously considered as commensals such as 
Candida species reverting to pathogenicity. Regarding FV infection, only one study by 
Faergemann (1984) has suggested the possibility of a slight correlation between PV andM  
furfur colonisation. However, recent studies indicate that no difference in either the 
serotype or density o f Malassezia species exists in PV (Ashbee et al., 1993).
Differences in the ability of the organism to adhere to the stratum corneum would account 
for any increased colonisation. However, no differences in the ability of M. furfur to bind 
to epithelial cells from different areas or differences using Malassezia species has been 
detected (Faergemann et al., 1983a). In addition, no difference in the ability of organisms 
isolated from SD to bind to stratum corneum cells has been reported (Schechtman et al., 
1995a). All of these reults are consistent with the theory that an altered host response to the 
organism is responsible for infection. As no conclusive evidence exists for a difference in 
the rate of colonisation between infected and non-infected individuals, the data regarding
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HIV infection also support the theory that host factors are responsible for reversion to 
infection and this is further strengthened by the situation observed in AD. AD presents on 
the skin as a chronic eczematous eruption which often exhibits elevated Staphylococcus 
aureus infections and elevated IgE serum levels. While there is major alteration of the host 
skin of an AD sufferer, there is also a significant increase in M. furfur colonisation in 
patients with AD (Hiruma et al., 1999). However the difference however in colonisation in 
AD, like that observed in HIV, should be considered a difference in the host as opposed to 
the organism, and as such it will be discussed later.
5.1.4 M e t a b o l it e  p r o d u c t io n
One final organism-related factor which could affect its pathogenicity is fungal metabolism 
and specifically whether clinical isolates of M. furfur have metabolic properties different to 
that of non-pathogenic strains. While many metabolic products and putative by-products, 
like dicarboxylic acid and lipase, would account for some of the pathology in cutaneous M. 
furfur infections, no study directly comparing clinically isolated M. furfur and laboratory 
subcultured M. furfur has been carried out.
Previous studies have indicated that the antigenicity of M. furfur changes according to 
culture time and growth phase of the organism. Antigenic components isolated from M. 
furfur varied with culture time in their ability to bind IgE in an ELISA, with a rapid decline 
in antigenicity detected at 4 days (Zargari et al., 1995). Declining antigenicity may be due 
to the decreased protein concentration in these extracts. It is possible that a nutrient rich 
environment would encourage the establishment of an exponential population on the skin, 
resulting in the production of more antigen and thus initiation of disease. In contrast a 
slow-growing M. furfur that would be maintained as a transient population would remain 
largely inert due to its low production of antigen. This theory is supported by the difference 
in rates of growth observed in M. furfur and M. sympodialis (Mayser et al., 1998a), 
however, no definitive studies have been performed to determine if this is the case in 
infection.
5.2 H o s t - d e p e n d e n t  p a t h o l o g y
Based on the currently available data, little difference in the distribution, metabolism or
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density of M. furfur can be identified; thus the hypothesis that disease is in fact an 
abnormal host response to this normal commensal prevails. To determine what host factors 
are responsible for disease pathology, it is necessary to examine differences in the host 
environment and host immune response which may alter the antigenicity of the organism.
5.2.1 L ip id  DIFFERENCES
Individual differences in host sebum levels would be the most obvious variation which 
could affect M. furfur infection. As an obligatory lipophile M. furfur has a fastidious 
requirement for long chain fatty acids, as is indicated by its predilection for the sebaceous 
areas of the body (Porro et al., 1976). It is reasonable to assume that an optimum host lipid 
profile may be present which, while not increasing density of the organism, may increase 
the pathogenicity of the organism by switching its metabolism in some way. Studies on PV 
and SD-positive individuals indicate a higher lipid content of the skin of infected 
individuals, as compared to controls (Bergbrant and Faergemann, 1989). In addition, 
treatment which reduces the levels of lipid secretion initiates resolution of SD in some 
individuals (Bergbrant, 1995). As declining lipid levels correlate to declining M. furfur 
colonisation a concomitant rise in M. furfur levels in infected individuals might be 
expected but as discussed previously, only tenuous data link infection with high M. furfur 
numbers. Because of the postulated differences in lipid metabolism between M. furfur and 
M. sympodialis, the altered lipid profile of a host might encourage growth of one species 
over the other, eliciting disease. Despite the possibility that the lipid profile does contribute 
to the pathology of infection, the question remains as to how M. furfur initiates the 
symptoms associated with disease. For reasons that will be discussed it seems that the host- 
immune response, or lack of it, is the primary host-factor responsible for M. furfur 
induction of infection.
5.2.2 General  hum oral  im m unity
To establish if the host immune response is integral to M. furfur infections, it is necessary 
to compare the immune response of infected and non-infected individuals to elucidate 
possible pathways of activation. Much of the recent published research has invstigated the 
humoral immune response of the host to M. jurfur. Firstly anti-M. furfur antibodies become 
detectable in the population at approximately llyears of age (Faggi et al., 1998), with a 
maximum immunoprécipitation formed at age 40. Hence, while the organism can be
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detected and cultured from subjects under llyears old, it is not until the onset of puberty 
that the organism manages to elicit a detectable immune response. It is of course possible 
that the increase in sebum concentration of the skin at puberty stimulates the putative M. 
furfur and M. sympodialis growth axis, allowing the stimulation of the immune response. 
While an age-dependent increase in the Malassezia-speciiic immune response is observed, 
this does not explain the initiation of disease by M. furfur.
5.2.3 H o s t  im m u n e  r e s p o n s e  in  SD
In SD there is a myriad of conflicting data regarding the cellular and humoral immune 
response of the diseased host to the organism. One of the first studies demonstrated that 
there was no difference in M. furfur-specific IgG levels between healthy controls and SD 
infected individuals (Bergbrant and Faergemann, 1989). Using a different protein 
component of M. furfur this same group later measured a significant decrease in anti-M 
furfur IgG in SD sufferers (Bergbrant et al., 1991a). Because of the selection of a different 
antigenic component these two studies cannot be directly compared and this problem 
prevails throughout all the M. furfur infection/ immune reaction studies which have been 
published. As a standard antigen has not been used throughout, and because the protein 
component is thought to be more antigenic, these results may indicate an 
immunosuppressive effect, initiated by M. furfur. Despite the lack of standardization it is 
fair to point out that this same group detected significantly increased IgG levels in SD 
(Bergbrant et al., 1991b). In this study T lymphocytes from SD sufferers exhibited 
subnormal stimulation by M. furfur antigen, with overall higher levels of circulating T-cells 
and decreased peripheral blood mononuclear cell proliferation in response to M. furfur 
detected in the SD patients. These studies combined would indicate that an altered cellular 
response to M. furfur is responsible for infection but this theory has recently been 
challenged by Bergebrant et al (1999) who, on testing the lymphocyte transformation 
response of SD patients, could not find any difference between controls and patients. In 
addition, the previous studies by Bergebrant et al, which suggested the significance of the 
humoral immune response in SD, have recently been refuted by Parry and Sharpe (1998). 
They demonstrated that there was no detectable difference in the IgA, IgG and IgM M. 
furfur-specific response between controls and SD, so whether SD is a result of a T-cell 
immune dysregulation or an altered humoral immune response is still unclear.
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Evidence from the HIV+ population does distinctly point towards a T-cell dependent 
dysregulation in SD and this is the most powerful evidence available regarding the host 
reaction in M. furfur infections. The main problem with these studies is the non­
standardisation of antigen components and this situation should be resolved by the recent 
cloning, characterization and expression of a group of M. furfur antigens, Malf 1-10. I the 
present study, M. furfur cell wall, whole cells and cytoplasmic extracts were used, and 
these to were obviously not standardised antigen preparations. The Malf 1 antigen is 
thought to be cell wall-associated. Thus allthough purified Malf components were not 
available these antigens used were probably adequate to gauge the stimulatory capacity of 
M. furfur for the innate immune response of the skin models. However, it would be 
interesting to utilise these characterized antigens in any future experiments. Such studies 
should allow a more definitive conclusion to be drawn.
5.2.4 H o s t  im m u n e  r e s p o n s e  in  PV
While PV displays similarities in its pathogenesis to SD, with mild hyperproliferation of 
the epidermis, the distinct pigmentory changes in PV indicate a unique pathology. Recent 
studies have demonstrated the capacity of M. furfur to significantly decrease the 
lymphocyte transformation response of patients with PV and some differences in this 
response were detected using different antigen types. For exampl increased reactivity of 
PV lymphocytes to M. furfur serovar B as compared with ither serovars, has been reported 
(Ashbee et al., 1994). This substantiates and supports the oval exoantigen study of Silva et 
al. (1997) which suggests that there is no difference in the host immune response in PV, 
just a stimulation of the normal immune response due to a switching of the dominant 
species in the mixed colonizing Malassezia population.
Histological observations in patients with PV illustrate dilated blood vessels with moderate 
B and T-cell infiltration. However, few studies have investigated the significance of the 
cellular immune response in PV, allthough some evidence points towards a dysregulated T- 
cell response. A  study of changes melanin synthesis might help to clarify the situation. 
Because melanin synthesis is particularly sensitive to trauma, and the resulting cytoldne 
stimulation, this would be a logical candidate for an investigation of the origin of altered 
immune response in PV.
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5.2.5 A t o p ic  DERMATITIS
While AD is a disease not caused by M. furfur the organism has been shown to exacerbate 
the condition in certain individuals. Hence the atopic individual is a prime example of how 
a pre-altered host immune response is partially responsible for the ability of M. furfur to 
elicit disease. By examining the immune response of AD patients to M. furfur, a potential 
mechanism for M. furfur activation or evasion of the ‘normal hosts’ immune response may 
be revealed. This is exactly what several investigators have attempted by examining the 
different cellular and humoral responses to M. furfur in the AD patient, as compared to 
controls. AD is a multi factorial disease which presents as inflammation of the respiratory 
tract, epithelia and skin when they come into contact with allergens. Overall increased IgE 
responses to a range of environmental allergens result in disrupted respiratory tract and 
skin functioning, with hypersenstitivity to these aero allergens and contact allergens. In the 
skin an underlying skin abnormality is thought to be responsible for the delayed type 
contact hypersensitivity mounted in response to allergen contact. Th2 cells and IgE 
accumulate at the site of allergen contact, with IgE stimulating mast cell histamine release 
and the stimulation of the cytokine cascade which follows, manifests as red erythematous 
skin often with underlying puritis. While aeroallergens like the dust mites are known to 
exacerbate the atopic rhinitis condition, skin commensals have only recently been 
considered to exacerbate inflammation in AD. The first major study implicating M. furfur 
in AD was carried out in 1985 (Waersted and Hjorth, 1985). It was shown that 
ketoconazole treatment of individuals with head and neck dermatitis resulted in disease 
resolution with declining severity of the inflamed areas. Hence a role for M. furfur in 
stimulating AD was hypothesized. This was further supported by work which demonstrated 
that 80% of AD sufferers had a positive skin reaction to M. furfur (Jensen-Jarolim et al., 
1992) and more recently it has been shown that the addition of M. furfur to the skin of head 
and neck AD patients can elicit an eczematous reaction with CD4+ T-cell and eosinophil 
infiltration (Tengvall Linder et al., 2000). Compared to healthy controls and SD patients 
the host’s SIS response to M. furfur in AD exacerbates disease.
Investigators have tried to establish how M. Jurfur alters the immune system in AD, or 
more precisely how M. furfur further interacts with the altered abnormal immune response 
of the AD patient. As IgE accumulation is observed in biopsied AD affected skin, it comes 
as no surprise to detect elevated overall IgE antibodies in the serum of AD patients. High
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levels of anti-M. /wr/hr-specific IgE antibodies are detected almost exclusively in AD 
patients and it has been postulated that a T-cell dysregulation is responsible for this 
hyperstimulation of the IgE response. Although admittedly tenuous, T-cell depletion 
(CD8+ in AD patients) is a common theme in the ability of M. furfur to elicit disease 
(HIV+ve CD4 cell depletion). It is thought that CD8+ cell regulation of B-lymphocyte IgE 
production is depleted in AD resulting in the abnormal response of the AD skin to M. 
furfur. One study gives support to this theory of T-cell depletion, when peripheral blood 
mononuclear cells from AD patients showed increased production of IL-4 and IE-10 in 
response to M. furfur stimulation (Kroger et al., 1995). IL-4 is secreted by CD4+ Th2 cells 
and it stimulates B-cell secretion of IgE and eosinophil and mast cell proliferation. IL-10 is 
an 18kD protein produced by Th2 cells, CD8 T-cells and KCs. The most important activity 
of IL-10 is that it inhibits the production of cytokines by activated T-lymphocytes, 
inhibiting the T h l cell response, tipping the immune balance in favour of the humoral 
immune response and hence stimulating IgE response. This may mean that in the normal 
host a T-cell response, specifically the T hl response is integral in regulating the infectious 
capacity of M. furfur. The state of the M. furfur population, and the axis between M. furfur 
and M. sympodialis may be significant so perhaps M. furfur growth is encouraged by the 
lack of the Th2 response in AD. There is a significantly higher T-cell response of the Th2 
variety in AD, (Tengvall Linder et al., 1996) and a distinct Th2 stimulatory cytokine profile 
is induced by the organism (Tengvall Linder et al., 1998). Hence the significance of the 
Th2 response appears to be relevant in the regulation of the immune privilege that exists 
for M. furfur. It is interesting to note that HIV infection, while directly affecting CD4 + T- 
cells also infects LCs; hence the ability of M. furfur to be presented as antigen to the 
efferent lymph nodes. If a dysregulation in the T-cell response results in infection, there 
should be a detectable difference in the humoral immune response of the normal infected 
population in AD and PV, which is not the case. Hence the abnormal AD patient may have 
a distinct novel immune response to M. furfur.
5.2.6 P s o r ia s is
Psoriasis is an inflammatory scaly dermatosis which affects approximately 2% of the 
population. Abnormalities in several genes have been detected, many involving the HI A  
loci, indicating abnormalities in the host immune system for disease pathogenesis. The 
psoriatic patient can therefore be considered an immune abnormal host, hence the reaction
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of the psoriatic skin to M  furfur is curious. Firstly the addition of heat-killed M. furfur to 
the psoriatic skin results in the initiation of a psoriatic-like lesion (Lober et al., 1982), 
indicating the ability of heat-killed organisms to exacerbate the abnormal skin. Some 
correlation between M. furfur and head and face psoriasis has been detected (Rosenberg et 
al., 1989) and while the hypothesis that microorganisms interact in psoriasis is not novel 
(Noah, 1990) the interaction of M. jurfur is fairly new. A M  furfur-specific IgG response is 
detected in 73% of psoriatics (Squiquera et al., 1994) and this response is directed against 
the N-acetylglucosamine component of the fungal cell wall (Mathov et al., 1996). This 
agrees with the Malf 2 and Malf 3 proteins, which react with serum-specific IgE isolated 
from AD patients (Schmidt et al., 1997). These proteins have sequence homology with two 
Candida biodini membrane proteins, and while not cell wall-associated these proteins may 
come into contact with the host during replication. The Malf 4 protein however is known to 
be homologous to mitichondrial malate dehydrogenase, and the relevance of this homology 
is unknown.
While the humoral response is significant in the clearance of any infection, neutrophil 
migration and the T-cell response is perhaps more significant in psoriasis. The protein 
component of M. furfur significantly enhances polymorphonuclear neutrophil migration 
and this effect is specific for M. furfur, as opposed to other skin commensals like S. 
epidermidis (Bunse and Mahrle, 1996). T-cells from individuals with psoriasis of the head 
initiate a Th2 CD4 + T-cell response which is dependent on HLA-DR binding, with no 
difference between cytoplasmic or cell wall extracts of M. furfur in stimulating the immune 
response. All T-cells respond more significantly to the cytoplasmic extracts of M. furfur; 
however this response was not different to the normal scalp-derived T-cell lymphocytes 
and psoriatic scalp derived T-cells (Baker et al., 1997). Hence little evidence as to how M. 
furfur interacts with the psoriatic immune system exists. It does appear however that M. 
jurfur possesses the ability to stimulate neutrophil migration and the KC studies indicate 
that KC may be the source of IL-8; however the actual interaction of M. jurjur with the 
psoriatic inflammatory mechanism is unknown.
In summary, there is no conclusive evidence which pinpoints either an organism or host- 
derived cator which may predominate in M. jurjur infection, either in normal infected 
individuals and psoriatics/ AD patients. One area that has received little experimental
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investigation is host differences in the innate immune response of the skin to M. furfur. 
Due to the immense cytokine production profile of KCs, it is not unreasonable to assume 
that alteration of an individual’s innate SIS homeostasis may affect the pathology of M. 
furfur infection in the ‘normal’ (non-AD/psoriatic) infected host.
5-3 I n n a t e  im m u n e  r e s p o n s e
The capacity of M. furfur to interact with the innate component of the SIS has received 
little attention. However, it is reasonable to hypothesise that differences in host innate 
immunity to M. furfur may be responsible for disease pathology. It is possible that innate 
immune dysregulation could directly activate the pathology seen in M. furfur infections. 
The pathology associated with both PV and SD are perhaps the two most widely studied of 
the infections and despite their common origin, the pathology of the diseases is different. 
Enhanced pigmentation, increased sebum production, mild cellular infiltrate, and 
hyperproliferation are all symptoms of these infections and could be directly linked to an 
alteration of the skin’s innate immune response. To consider the SIS as an axis, particularly 
in relation to IL -la  is relevant. The skin, in particular the epidermis, like any other organ 
maintains a homeostasis which is controlled by the differentiation of its cellular 
components and its interaction with the outside world. Differentiation of KCs is controlled 
by a myriad of factors including cytokines, with IL -la  in particular controlling terminal 
cornification of KCs. Disruption of the biological status of the skin results in disruption of 
the differentiation of the skin, and much of the pathology associated with M. furfur 
infections is associated with a disturbance of the homeostasis of the skin by the organism, 
or organism-derived components. Hyperproliferation, neutrophil migration and 
vasoconstriction are all associated with fungal infections; hence knowledge of the 
interaction of M. jurfur with components of the innate SIS should clarify whether the 
organism can push the homeostatic balance of the skin from normal to diseased pathology.
5.3.1 C O M P L E M E N T  F IX A T IO N
M. jurjur is able to fix complement via C3 and factor B, and as KCs produce both C3 and 
factor B M. jurjur could theoretically stimulate the immune system via the alternative 
pathway of complement fixation. This could initiate the inflammatory response of the skin, 
and additional injury of the skin by complement activation could exacerbate diseases
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already present, such as AD and psoriasis. This complement fixing activity is common to 
other yeast species, including Candida, and dermatophytes have also exhibited the ability 
to initiate the complement fixing immune response. While the efficacy of complement 
activation in clearing cutaneous fungal infections is questionable, the inflammation caused 
by lysis of yeast, albeit limited, may push the SIS axis over the homeostatic edge. Further 
studies into the potential of complement fixation to alter the skin homeostasis should be 
undertaken to elucidate the relevance of complement fixation in the innate immune 
response.
5.3.2 DEFENSIN
No previous study has investigated either the production of HBD-2 in a range of skin 
models or the production of HBD-2 in response to M. furfur. The work discussed here 
provides inconclusive evidence that fungal growth can stimulate HBD-2 expression on skin 
models. As measured by both the SEM/histological data and M. furfur growth curves, M. 
furfur growth on both LSE and BRT was slow but stable. Allthough it was not possible to 
test the antifungal ability of HBD-2 expression to suppress M. furfur growth, it is 
reasonable to assume that it has the same action on M. furfur as it does on C. albicans 
(Harder et al., 1997). While the results reported here were neither consistent or statistically 
significant it is tempting to speculate that when M. furfur is establishing gowth (in the first 
24hr on the LSE and BRT) it does not stimulate HBD-2 production. This would suggest 
that different phases of M  furfur growth may result in different antigen expression. It is 
possible that if some populations of M. furfur remain very slow growing, then they will not 
stimulate HBD-2 expression and would possibly not stimulate cytokine production. As 
discussed these experiments did not provide consistent results hence perhaps the most 
important aspect of this work is the detection of a large range of HBD-2 expression 
between donors, indicating widespread differences in the magnitude of HBD-2 expression. 
Despite the unreliable results obtained from the experimental work performed it is 
tempting to speculate about the effect of the apparent suppression and stimulation of HBD- 
2 expression in the skin models. It is possible that the individual’s different basal 
expression of HBD-2 could alter M. furfur colony growth, and consequently alter the 
metabolism of the organism on the skin. Thus, while HBD-2 expression alone cannot alter 
the pathology of the skin, it may exert some influence on the growth pattern of the 
organism on the skin. If the organism grows in a more antigen-producing population on the
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skin, then HBD-2 expression could inadvertently contribute to the initiation of pathology in 
M. furfur disease. It would be interesting to investigate this tenuous link by firstly 
examining metabolite production by M. furfur both in culture and on the skin models, to 
correlate the production of antigen with M. furfur stimulation. If a connection were 
detected then it would be logical to examine the expression patterns of HBD-2 in M. 
furfur-infected individuals, to determine if there is any association between in vitro and in 
vivo patterns. It would be beneficial to the overall investigation of M. furfur biology and 
the SIS to identify if it is indeed a PPPR that transduces the signal for HBD-2 expression, 
or IL -la expression, and the actual PPRR ligand component which originates from M. 
furfur and C. albicans which activates this receptor. It may be that M. jurfur growth is 
selected over M. sympodialis in some individuals; perhaps if HBD-2 is more toxic/ 
antifungal against M  jurjur then defensin production might alter growth of the commensal 
Malassezia population toward the pathogenic M. furfur. Only yeasts were tested in these 
models; hence, how the LSE, KC and BRT response to other commensals such as bacteria 
(S. epidermidis) may reveal a yeast-specific regulation of colonisation. Finally it should be 
remembered that these results were not standardly reproduced. Therefore it would be 
necessary to establish these trends in a larger population size, and examine their relative 
relevance in terms of how HBD-2 production affects M. jurfur colonization before further 
examining the role of HBD-2 production in controlling M. jurfur infection.
5.3.3 C y t o k i n e s
Some studies have investigated the cytokine response of various cells to M. furfur. Only 
one published study indicates that M. furfur can directly down-regulate the immune 
response by suppression of IL-lp production by peripheral blood mononuclear cells, while 
the IL l-a  expression is unaltered (Walters et al., 1995). Other studies have shown how M. 
jurjur induces granulocyte and macrophage production of IL -la  and IL-8 and opsonisation 
of M. jurfur is shown to induce stronger expression of IL-8 mRNA (Suzuki et al., 2000b). 
No study apart from that carried out by Walters et al has investigated the innate cytokine 
profile of KCs. As discussed, the cytokine profile of the KC is immense and alteration, 
however small, in the homeostasis of the skin stimulates pathological changes in the skin. 
It is possible that host differences in cytokine reaction to M. furfur may push the sldn 
homeostasis over the edge into disease pathology. Several studies could be considered to 
address these questions. Firstly, it would be interesting to examine IL la  production by 
infected donors both from involved and non-involved sites and compare this to controls. In
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addition, further semi-quantitative RT-PCR on both LSE and BRT colonised with M. 
jurjur could be carried out to compare the KC skin model cytokine mRNA production with 
both the BRT and LSE. It would also be interesting to test the reaction of the KCs to both 
cytoplasmic extract and viable M. furjur cells in an attempt to clarify the stimulatory 
element of the organism.
Cytokines, and in particular ET-1, may have a direct effect on melanin synthesis in the 
tissue and it would therefore be logical to assess the effect of anti-cytokine antibodies of 
melanin production. However as the IE-lot axis is the main homeostatic cytoldne of the 
skin, any release of IL -la , either via KC storage of the preformed cytokine or via targeted 
release, greatly alters the pathology of the skin. In addition to directly stimulating KC 
proliferation and MC melanin synthesis, IL -la  also amplifies other cytokine responses of 
the skin; thus it may amplify other reactions to the organism. One interesting point to note 
on IL-1 a  production is how it affects sebum production. IL -la  can stimulate both KC 
proliferation, seen in many M. /wr/wr-associated diseases, and increased sebum production. 
In this work IL -la  production by KCs was measured in response to M. jurjur cell walls. 
The growth phase of M. jurjur can have an effect on the immunostimulatory capacity of the 
organism. Here, freeze-dried cell wall isolated from organisms in the exponential phase of 
growth was used. This cell wall contains glucan, lipid and mannan which would of course 
be present when the organism is growing on skin. The cell wall was shown to significantly 
increase IL -la  production on KC monolayers. This result indicates the primary cytokine 
stimulation capacity of cellular components of M. furjur, which could account for the 
hyperproliferation seen in the SD epidermis. The cellular response in PV is of a mature cell 
type response with moderate cell infiltrates in both epidermis and dermis as compared to 
biopsies from normal-looking skin (Scheynius et al., 1984).
5 .4  S u m m a r y
By examination of the published data it is evident that little agreement on the pathogenic 
mechanisms of M. jurjur exists. Past evidence indicates that differences in the host reaction 
to M. jurfur could be responsible for some of the pathology associated with M. jurjur 
disease. These studies demonstrate that host differences in the innate immune response of 
the skin to the organism exist. Differing levels of basal HBD-2 expression exists between 
donors and this could influence the growth of the Malassezia populations on the skin. In
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addition M  furjur stimulates cytokine production by KCs indicating its ability to directly 
alter the proliferation of the skin (IL-la), the M. furfur specific antibody production (IL-8) 
and the melanin synthesis of the skin (ET-1). M. furfur metabolism also directly stimulates 
melanin synthesis thus indicating a mechanism by which the organism could alter the 
pigmentation of the skin. In addition these studies demonstrate that host tissue, and 
putatively host lipid content, greatly affects the growth and morphology of M. furfur on 
skin, suggesting that the stimulation of certain growth patterns on skin may contribute to 
the pathogenicity of the organism.
In closing while no singularly definitive host-derived factor can be identified, these studies 
indicate that the range of host reactions to M. furfur may well contribute to the 
establishment and progression of M. /iir/hr-associated infections.
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